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Abstract 
 
Part I Amyloidogenesis of Type III-dependent Hpa1 from Xanthomonas oryzae 
pv. oryzicola 
 
The first harpin, HrpN from Erwinia amylovora, the bacterium that causes fire blight 
of pear, apple and other rosaceous plants, was reported as an HR (hypersensitive 
response) elicitor in 1992. Similar harpins were found in Pseudomonas syringae, 
Ralstonia solanacearum, Xanthomonas campestris, X. axopnpodis and X. oryzae, and 
secreted through a Type III secretion system (TTSS), which is utilized by bacterial 
pathogens to invade the host. The wide presence and secretion pathway of harpins in 
plant pathogens indicate the important function of harpins in plant pathogenicity. 
 
Herein, I report that Hpa1, the harpin of X. oryzae pv. oryzicola, assembles into 
fibrils at acidic pHs. As determined by analytical gel filtration chromatography, 
purified Hpa1 is a decamer. Hpa1 has two predicted  helical domains, located 
towards its N- and C-terminus, respectively. The C-terminal  helix domain is 
responsible for the fibril assembly, since the synthesized polypeptide 
(ASPLTQMLMNIVGEILQAQ), corresponding to the C-terminal  helix domain of 
Hpa1, could form fibrils. The mature fibrils of this peptide consist of three strands of 
protofibrils. We propose that the fibril formation by full length Hpa1 involves a 
conformational transition from -helix to β-sheet structure, which exposes the C-
terminal  helix domain for fibril assembly. In contrast to the assembly of fibrils by 
full length Hpa1 at acidic pH, that of synthesized polypeptide 
(ASPLTQMLMNIVGEILQAQ) is at acidic and basic pH, which may be an inherent 
characteristic of the sequence component. Interestingly, the N-terminal  helix 
domain (ISEKQLDQLLCQLIQALL) of Hpa1 inhibits the assembly of fibrils by the 
C-terminal domain polypeptide, suggesting that the intramolecular interaction of 
Hpa1 between the two  helix domains keeps Hpa1 in a non-fibrillar state. 
 
In addition, the fibrils formed by full length Hpa1, the N-terminal truncated Hpa1 
(55-138) and synthesized polypeptide (ASPLTQMLMNIVGEILQAQ) disrupted the 
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membrane of liposomes prepared from extracted lipids from E. coli, which suggests 
a new function for Hpa1- targeting and damaging the cell membrane. 
 
 
Part II Crystallization and structure analysis of the Vibrio cholerae VceR drug-
pump repressor with bound DNA 
 
The VceR protein, from Vibrio cholerae, which is encoded by the vceR gene, 
represses transcription of the vceCAB operon, which encodes a multidrug efflux 
pump in this microorganism. This type of pump, composed of a tripartite protein 
complex that spans the inner and outer membranes, resembles type I secretion 
systems. VceR, which is a member of the TetR family of transcriptional repressors, 
binds specifically to a 28 bp inverted repeat (IR) located in the 107 bp vceR-vceCAB 
intergenic region. 
In order to completely understand the structural basis and functional mechanism by 
which VceR binds DNA, we performed crystallization trials on the VceR/DNA 
complex, with the aim of determining its crystal structure. A number of oligos were 
screened, including 30 bp, 28 bp, 27 bp, 26 bp and 24 bp duplex, depending on the 
published operator sequence bound by VceR, to obtain X-ray quality VceR/DNA 
complex crystals for structure analysis. These crystals have space group I 4122, with 
a=b=90.2 Å, c=298.1 Å, α=β=γ=90°.  
To retrieve phase information, Se-Met substituted VceR and Br labelled DNA 
oligonucleotides were prepared and crystallized with unlabelled DNA and native 
VceR, respectively. Several three-wavelength MAD data sets from these crystals 
were collected and analyzed. A merged Se-Met data set, obtained from 2 data sets of 
three wavelengths and one peak data set, yielded the correct positions of 12 Se by 
ShelxD. Sharp/Autosharp was used to refine these 12 Se positions and for calculating 
phases. A preliminary electron density map shows, after solvent flattening, clear 
helical characteristics in the VceR dimer and a partial DNA backbone. A model with 
one VceR dimer and an 11 base pair duplex was built in the preliminary electron 
density map. 
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Chapter 1  Introduction 
 
Part I  TTSS and harpin 
  
1.1  Type III secretion system 
 
The type III secretion system (TTSS) or type III secretion injectisome (different 
nomenclatures for the same system in various bacteria) is utilized by Gram-negative 
bacterial pathogens of animals and plants to deliver effectors (the substrate proteins 
of TTSS) to their host (Alfano and Collmer, 2004; Ghosh, 2004; Gurlebeck et al., 
2006). To date, TTSSs have been found in the plant pathogens Pseudomonas 
syringae, Xanthomonas, Ralstonia, Erwinia, and Pantoea (Alfano and Collmer, 2004) 
and animal pathogens Yersinia, Salmonella, Pseudomonas aeruginosa, Shigella, 
Bordetella and enteropathogenic Escherichia coli (EPEC) (Cornelis and Van 
Gijsegem, 2000).  
 
TTSSs consist of a basal body, which is embedded in the inner and outer membranes 
of the bacterium, and a needle in animal pathogens or a pilus in plant pathogens, 
through which contact is made with the host cell (Figure 1.1 a, b &c) (Alfano and 
Collmer, 2004; Cornelis, 2006; Ghosh, 2004; Tampakaki et al., 2004). TTSSs have 
been divided into seven different families, after the phylogenetic analyses of four 
conserved proteins, the cytoplasmic ATPase and the other three proteins from the 
inner membrane (Cornelis, 2006; Gophna et al., 2003). The seven families are 
Chlamydiales, Hrp1, Hrp2, SPI-1, SPI-2, Rhizobium and Ysc family. TTSSs of plant 
pathogens belong to two families, Hrp1 and Hrp2 family, whereas those of animal 
pathogens locate to three families, SPI-1, SPI-2 and Ysc family (Cornelis, 2006). The 
other two families, Chlamydiales and Rhizobium are limited to the Chlamydiae 
phylum and the Rhizobiales order, respectively (Cornelis, 2006). 
 
1.2 TTSSs and bacterial flagella 
Components of the TTSS share sequence and structural similarities with those of the 
bacterial flagellum, which is a motility organelle (Tampakaki et al., 2004).  Flagella 
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consist of a rotating long filament and a rotary motor, which correspond to the pilus 
or needle, and basal body in TTSS, respectively (Figure 1.1). Before effector export, 
TTSSs secrete the external components, including the needle (or pilus in plant 
pathogens) and translocator (or translocon in plant pathogens), which is similar to the 
flagellar system in secretion its own hook and filament subunits for the flagellum 
assembly (Cornelis, 2006; He and Jin, 2003; Ferris and Minamino, 2006; Macnab, 
2003; Tampakaki et al., 2004). The TTSS is thought to have evolved from the 
flagellum, or that the TTSS and the flagellum share a common ancestor (Gophna et 
al., 2003; He and Jin, 2003). 
          
Figure 1.1 Structure of the TTSSs. Schematic representation of Ysc TTSS (a), 
TTSS from EPECs (b) and the TTSS from plant pathogens (c) (Cornelis, 2006).  
 
  
a b c 
C ring 
YscQ 
Needle 
Complex 
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Plant pathogen 
Xanthomonas 
oryzae proteins 
Animal pathogen   
Yersinia pestis 
proteins 
Sequence 
identity (%) 
Function/ location 
HrcC YscC 27.9 Secretin                               
Outer membrane 
protein 
HrcJ YscJ 37.2 MS ring                      
Lipoprotein 
HrcN YscN 57.3 ATPase                                 
Ring with 6-fold 
symmetry 
HrcQ YscQ 21.4 Putative C ring 
HrcR YscR 49.5 Basal structure                     
Inner membrane 
protein 
HrcS YscS 38.3 Basal structure                     
Inner membrane 
protein 
HrcT YscT 27.6 Basal structure                     
Inner membrane 
protein 
HrcU YscU 32.3 Basal structure                     
Inner membrane 
protein 
HrcV YscV 41.5 Basal structure                     
Inner membrane 
protein 
Table 1.1  Nine core components of TTSS in plant and animal pathogen. 
Sequence alignment was performed by SIM at Expasy. (Alfano and Collmer, 1997; 
Cornelis, 2006; Macnab, 2003). 
 
1.3 Components of TTSS 
The TTSS has two components, the basal structure and the needle or pilus (Figure 
1.1 a, b & c). The basal structure spans the outer and inner membrane of the 
bacterium. There are approximately 25 proteins required to assemble the TTSS, nine 
of which form a core, including one outer membrane protein (secretin), 6 inner 
membrane proteins, one ATPase and one possible C-ring forming protein (Table 1.1)  
(Cornelis, 2006; Ghosh, 2004). 
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1.4   TTSS of Xanthomonas oryzae 
1.4.1 Xanthomonas oryzae  
 X. oryzae pv. oryzae (Xoo) and X. oryzae pv. oryzicola (Xoc) are bacterial pathogens 
of rice, which result in bacterial leaf blight and bacterial leaf streak, respectively 
(Gnanamanickam et al., 1999; Seo et al., 2008; Zou et al., 2006). Bacterial leaf 
blight and bacterial leaf streak are widely distributed in tropical and subtropical Asia, 
West Africa, South America, and Australia (Seo et al., 2008). Leaf streak can cause 
grain weight losses of up to 32% and leaf blight induces crop loss of up to 50% 
(Gnanamanickam et al., 1999). The main differences between Xoo and Xoc are in the 
invasion entry point and colonization location (Seo et al., 2008). Xoo gains access to 
the xylem through wounds or natural openings such as hydathodes and invades rice 
vascular tissue (Seo et al., 2008). Xoc enters the leaf mainly through stomata and 
colonizes the mesophyll parenchyma tissue (Seo et al., 2008). The genomes of Xoo 
and Xoc are similar with respect to size, G+C percent, and gene content (Seo et al., 
2008). The pathogenicity in susceptible host rice and the hypersensitive response in 
nonhost tobacco of Xoo and Xoc are dependent on TTSSs, which translocate 
effectors to host or nonhost (Alfano and Collmer, 2004; Gurlebeck et al., 2006; Zou 
et al., 2006). An understanding of the molecular mechanism of the pathogenicity of 
Xoo and Xoc on the basis of TTSS could provide new strategies for their 
management and the means to decrease the loss in rice yield.  
1.4.2 TTSS of Xanthomonas oryzae pv. oryzicola 
TTSSs of Xoo and Xoc are encoded by hrp (hypersensitive response and 
pathogenesis) genes cluster, including hrp, hpa (hrp-assoicated) and hrc (hrp 
conserved) genes (Alfano and Collmer, 2004; Zou et al., 2006). The nine hrp genes 
(encoded proteins are shown in Table 1.1) of Xanthomonas oryzae, which are highly 
conserved in plant and animal bacterial pathogens, are designated as the hrc genes 
(Bogdanove et al., 1996).  
The expression of the hrp gene cluster is induced by contact with the plant or in 
minimal media that mimics the condition of the plant apoplast (Alfano and Collmer, 
2004).  
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Substrates of TTSSs of Xoo and Xoc are the extracellular components (pilus, 
translocon and other uncharacterized parts) of the secretion apparatus, effectors 
(Section 1.4.3) and harpins (Section 1.5 for harpins) (Alfano and Collmer, 2004). 
Interactions between effectors of the TTSS and the plant result in resistance or 
susceptibility in pathogenesis (Bent and Mackey, 2007; Chisholm et al., 2006; Jones 
and Dangl, 2006). The phenotype of TTSS is hypersensitive response in nonhost 
plant and pathogenesis in host plant (Alfano and Collmer, 2004; Zou et al., 2006).   
Although Xoo and Xoc are important rice pathogens, little work is published about 
hrp and hrc genes from these two bacteria. Studies of X. campestris species would 
help us understand the TTSSs of Xoo and Xoc. Well studied proteins of TTSS in X. 
campestris are HrpE, HrpF, HrcN, HpaA, HpaB and HpaC.   
HrpE (9.7 kDa) was found to be the major component of X. campestris pv. 
vesicatoria Hrp pilus by the N-terminal sequencing of all the proteins purified from 
the Hrp pili and further HrpE-specific antibody labelling of the pilus (Weber et al., 
2005).  
HrpF in X. campestris, secreted by the TTSS, forms the translocon, which is a pore-
like structure that inserts into the host cell membrane for the translation of effectors. 
The N-terminus of HrpF has a signal sequence for secretion and its C-terminal 
hydrophobic region is the functional domain. In vitro, HrpF forms pores in planar 
lipid bilayers (Buttner et al., 2002).   
HrcN in X. campestris is the ATPase of TTSS, which is thought to provide the 
energy for the secretion process (Lorenz and Buttner, 2009). However, in flagellar 
type III secretion, the proton motive force is recognized as the energy source for 
TTSS secretion (Paul et al., 2008). The ATPase of the TTSS, which forms a ring 
structure, is located in the cytoplasm and associates with inner membrane protein 
HrcU from the TTSS (Pozidis et al., 2003; Lorenz and Buttner, 2009). Another 
function of the ATPase in the TTSS is to dissociate the effector and chaperone 
complex (Akeda and Galan, 2005; Lorenz and Buttner, 2009). HrcL in X. campestris 
interacts with and stabilizes HrpN; its homolog YscL in Yersinia is a negative 
regulator of the ATPase (Blaylock et al., 2006; Lorenz and Buttner, 2009).    
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HpaB in X. campestris is thought to be a general TTSS chaperone (Buttner et al., 
2004). Generally, chaperones of the TTSS have a low molecular weight (about 15 
kDa), low isoelectric points (<6) and a predicted amphipathic region in the C-termini 
(Alfano and Collmer, 2004). These chaperones interact with effectors and maintain 
them in a nonglobular state before secretion via passage through the narrow TTSS 
(Alfano and Collmer, 2004). HpaB interacts with several effectors, and promotes 
their secretion, but prevents the delivery of HrpF (translocon) (Buttner et al., 2004).  
HpaC, which interacts with HrcU, acts as a substrate specificity switch protein of 
Xanthomonas TTSS (Lorenz et al, 2008 b). The substrate specificity switch of TTSS, 
which is the mechanism used by TTSS to secrete the pilus, translocon and effector 
sequentially, is well characterized in animal pathogenic bacteria. This mechanism is 
achieved through a conformational change of a cytoplasmic part of the inner 
membrane protein, Spa40 of Shigella (Deane et al., 2008), YscU of Yersinia (Edqvist 
et al., 2003; Sorg et al., 2007) and EscU of EPEC (Zarivach et al., 2008), which have 
an autocleavage property. In X. campestris, HrcU has a similar autocleavage property 
(Lorenz et al, 2008 b). HpaC inhibits the secretion of HrpB2, which is required for 
pilus assembly (Lorenz et al, 2008 b). In addition, both HpaC and HrpB2 interact 
with the C-terminal domain of HrcU, but not with the full length protein (Lorenz et 
al, 2008 b). Given that HpaC promotes secretion of the translocon and effector, 
HpaC presumably switches the secretion of HrpB2 to that of translocon and effector 
(Lorenz et al, 2008 b). 
In addition, HpaA interacts with the C-terminal domain of HpaB. To achieve 
stepwise secretion of effector and pilus, binding of HpaA to HpaB was thought to 
prevent secretion of effectors during pilus assembly (Lorenz et al, 2008 a). 
1.4.3  TTSS effectors of Xoo and Xoc 
The effectors of phytopathogenic TTSSs are the Avr (avirulent) proteins, which are 
thus designated because they were detected through gain-of-function avirulence 
phenotypes (Alfano and Collmer, 2004), and the other class of proteins, including 
Hop (Hrp outer protein) in Pseudomonas (Alfano and Collmer, 2004), Xop 
(Xanthomonas outer protein) in Xanthomonas (Gurlebeck et al., 2006), and Pop 
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(Pseudomonas outer protein, as based on a previous genus designation) in Ralstonia 
(Arlat et al., 1994). 
 
Effectors of phytopathogenic TTSS are important virulence factors and suppress 
plant defenses (Alfano and Collmer, 2004; Kay and Bonas, 2009). Effectors of Xoo 
and Xoc include Avr proteins and Xops (Alfano and Collmer, 2004; Gurlebeck et al., 
2006; Kay and Bonas, 2009). The molecular function of most effectors from Xoo and 
Xoc is still unknown (Kay and Bonas, 2009).           
 
Pathogens secrete Avr proteins into hosts that carry cognate R (resistence) proteins, 
and results in the resistance interaction, hypersensitive cell death response (HR) 
(section 1.5.1 for HR) (Alfano and Collmer, 2004; Cornelis and Van Gijsegem, 2000; 
Gabriel, 1999). However, if the host is without the cognate R gene, the secretion of 
Avr proteins into the host results in susceptibility and the pathogen invades the host 
successfully (Alfano and Collmer, 2004; Cornelis and Van Gijsegem, 2000). There is 
another kind of resistance, nonhost resistance (Heath, 2000b), in which the pathogen 
secretes an Avr protein into the nonhost and the Avr protein is perceived by an R 
protein from nonhost that induces nonhost resistance. An example of nonhost 
resistance is that of the avrRxo1 gene from the rice pathogen Xoc that confers the 
nonhost defense reaction on maize with the resistance gene Rxo1 (Zhao et al., 2004; 
Zhao et al., 2005).  
 
AvrXa7, AvrXa10 and AvrXa21 are well studied effectors of Xoo. AvrXa7 and 
AvrXa10 are members of AvrBs3 family, which are targeted to the nucleus of the 
plant cell, where they modulate plant gene expression (Gurlebeck et al., 2006; Yang 
et al., 2000; Yang and White, 2004; Zhu et al., 1998). Different members of the 
avrBs3 family have diverse repeat numbers of 102–bp in the central repeat domain. 
avrXa10 and avrXa7 have 15.5 and 25.5 copies of this repeat domain, respectively 
(Zhu et al., 1998).  
 
AvrXa7 shows avirulence after injection into rice carrying Xa7 and virulence in rice 
lacking Xa7 (Yang and White, 2004). AvrXa7 has a C-terminal nuclear localization 
signal and acidic transcriptional activation domain, and central codon repeated 
domain (Yang and White, 2004). The central codon repeated domains of avrXa7 and 
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avrXa10 determine their avirulence specificity to Xa7 and Xa10, respectively (Zhu et 
al., 1998). The binding of AvrXa7 to double stranded DNA was confirmed, which 
indicates AvrXa7 may interact with host DNA (Yang et al., 2000).  
 
1.5  Harpins 
 
1.5.1 Harpins and HR  
 
Harpins are secreted by TTSS of bacterial pathogens of plants but are different from 
the other effectors of TTSS (Alfano and Collmer, 2004). Harpins are heat-stable, 
glycine-rich proteins that induce a hypersensitive response (HR) when infiltrated into 
the intercellular space of nonhost leaves (Alfano and Collmer, 2004; Gurlebeck et al., 
2006; Zou et al., 2006).  
 
Several harpins have been reported: HrpN of Erwinia amylovora (Wei et al., 1992), 
HrpZ of P. syringae (He et al., 1993; Lee et al., 2001), PopA of Ralstonia 
solanacearum (Racape et al., 2005), HpaG of Xanthomonas axopnpodis pv. glycines 
(Kim et al., 2004), Hpa1 of X. oryzae pv. oryzae (Zhu et al., 2000) and XopA of X. 
campestris pv. vesicatoria (Noel et al., 2002). These harpins have low sequence 
identity between each others. An example is HrpN, which has 13.6% sequence 
identity with HrpZ, 10.6% with PopA, 4.8% with HpaG, 5.8% with Hpa1 and 5.6% 
with XopA (Sequence alignment was performed by SIM at Expasy).  
 
The importance of harpins lies in that it is the first protein reported to be an HR 
elicitor (Wei et al., 1992). HR, analogous to the innate immune system found in 
animals, is a mechanism used by plants to prevent the spread of infection by 
microbial pathogens. The HR manifests as patches of localized cell death at the 
infection site, which limits the pathogen to the infection site (Greenberg, 1996; Heath, 
2000a).  
 
 1.5.2  Harpin’s beneficial function on plants  
 
Harpins can activate ethylene, salicylic acid (SA) and abscisic acid (ABA) signal 
transduction, which are plant defense pathways, and thus have some beneficial 
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effects on the plant, such as increasing disease resistance, insect defense and plant 
growth (Dong et al., 2005; Shao et al., 2008).  
 
Harpins induce the disease resistance after being sprayed on or expressed in the plant 
(Dong et al., 1999; Shao et al., 2008). HrpN, the harpin from E. amylovora, induces 
resistance to P. syringae pv. tomato DC3000 and Peronospora parasitica in 
Arabidopsis, after spraying on the plant (Dong et al., 1999). In this induction, harpin 
acts through an endogenous plant defence SA (salicylic acid) signal transduction 
pathway (Dong et al., 1999). 
 
HrpN also activates the ethylene signalling pathway and thus inhibits aphid 
reproduction after spraying onto Arabidopsis and enhances Arabidopsis growth 
(Dong et al., 2004). These two effects are dependent on the ethylene receptor gene 
and inhibition of ethylene perception also abolishes these two effects (Dong et al., 
2004).  
 
In the other research, HrpN was found to induce drought tolerance in Arabidopsis 
through initiating the ABA signalling relevant gene expression and promoting 
stomatal closure (Dong et al., 2005).  
 
Harpins are widely used to engineer pathogen-resistance and in crop improvement. 
Expression of Hrf1, the harpin from X. oryzae pv. oryzae, in rice confers resistance 
to Magnaporthe grisea (Shao et al., 2008) and in tobacco increases the resistance to 
tobacco mosaic virus, to the bacterial pathogen Ralstonia solanacearum and to the 
fungal pathogen Alternaria alternata (Peng et al., 2004). The transgenic tobacco 
plants expressing hrpN have accelerated growth and develop enhanced resistance to 
Botrytis cinerea, which is a necrotrophic fungal pathogen (Jang et al., 2006). HpaG, 
a harpin protein from X. oryzae pv. oryzicola, was found to increase yield and quality 
of green tea (Wu et al., 2007).  
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1.5.3  Harpin binding sites in plant 
 
Considering the important function of harpins in plants, there are a number of studies 
that indicate the target of harpin in plants, plant cell wall or plasma membrane and 
the target proteins of harpin were identified.  
  
Plant cell wall or plasma membrane 
 
HrpZPsph, the harpin of P. syringae pv. phaseolicola, was reported to bind to lipid 
membranes and induce ion-current fluctuations in planar lipid bilayers at 
concentrations as low as 2 nM, which indicates pore-forming acitivity of  HrpZPsph 
(Lee et al., 2001). As a result, HrpZPsph was thought to target plasma membranes.   
 
PopA, the harpin of Ralstonia solanacearum, also binds to membrane lipids in a 
Ca
2+
-dependent manner in vitro and forms Na
+
-conducting pores (Racape et al., 
2005). In vivo, immunogold labelling of PopA locates this harpin to the plasma 
membrane of plants (Racape et al., 2005). 
 
In other research, harpinPss, the harpin of P. syringae pv. syringae, was localized in 
the plant cell wall by fluorescent signal. Extraction of Ca
2+
 and pectins from cell 
walls by a chelating agent, EGTA, blocked the binding of harpin to the cell walls 
(Hoyos et al., 1996).  
 
Harpin interacting proteins 
 
A protein binding site located in HrpZ, the harpin of P. syringae, was reported (Li et 
al., 2005). A library of random peptides was used to screen for HrpZ interacting 
peptides, which confirmed a consensus amino acid motif to be bound by HrpZ (Li et 
al., 2005). This peptide binding domain was localized to the central region of HrpZ 
(Li et al., 2005). Further study using antiserum raised against this HrpZ binding 
peptide recognize acidic proteins in bean, tomato, parsley and Arabidopsis, and HrpZ 
shows affinity for the protein from bean (Li et al., 2005). However, the sequences of 
these proteins were not confirmed in this study.  
 
 25 
Proteins from Arabidopsis (Arabidopsis thaliana), rice (Oryza sativa), and apple 
(Malus) have been identified that interact with HrpN, the harpin from Erwinia 
amylovora (Oh and Beer, 2007). HIPM (HrpN-interacting protein from Malus) was 
first identified through yeast two-hybrid screens using the gene for the HrpN protein 
as bait to screen a cDNA prey library from Gala apple (Oh and Beer, 2007).  In 
addition, AtHIPM (Arabidopsis thaliana HIPM) and OsHIPM (Oryza sativa HIPM) 
were found in the genome databases of Arabidopsis and rice according to sequence 
of HIPM (Oh and Beer, 2007). HIPM, AtHIPM and OsHIPM are all small proteins, 
about 60 amino acids in length (Oh and Beer, 2007). They have a putative signal 
peptide at the N-termini and one transmembrane domain, which would locate them to 
the plasma membrane (Oh and Beer, 2007). In accordance with this prediction, 
HIPM and AtHIPM GFP fusion proteins were found to be localized to the plasma 
membrane (Oh and Beer, 2007). The N-terminus 198 amino acids of HrpN were 
found to be the functional domain for the interaction with HIPM (Oh and Beer, 2007). 
 
AtHIPM was found to be a negative regulator of plant growth, as the AtHIPM 
knockout mutation in Arabidopsis exerts a positive effect on the growth of the aerial 
parts (top growth) (Oh and Beer, 2007). HrpN also loses its effect on the growth of 
Arabidopsis with AtHIPM knockout mutation (Oh and Beer, 2007). In addition, 
overexpression of AtHIPM reduces Arabidopsis growth (Oh and Beer, 2007). These 
findings indicate that HrpN inhibits the function of AtHIPM and thus enhances plant 
growth (Oh and Beer, 2007). 
 
1.5.4  Harpin-like proteins 
 
There is another class of harpin-like proteins, which have a harpin domain and 
another domain that has an alternate function (Kvitko et al., 2007). HrpW of P. 
syringae pv. tomato and E. amylovora have an N-terminal domain that is similar to 
harpins, which is glycine rich and able to elicit the HR when the purified domain 
fragment is infiltrated into tobacco leaf, and a C-terminal domain homologous to 
pectate lyases from E. carotovora, E. chrysanthemi and Bacillus subtilis 
(Charkowski et al., 1998; Kim and Beer, 1998). The pectate lyase domain (32.5% 
sequence identity with fungal pectate lyase PelC from Nectria haematococca) of 
HrpW of P. syringae pv. tomato has no pectate lyase activity, but could bind to 
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pectate which suggests that the target of HrpW could be in the plant cell wall 
(Charkowski et al., 1998).  
 
HopAK1 and HopP1 of P. syringae pv. tomato DC 3000 have a C-terminal enzyme-
like domain, pectate lyase (56.1% sequence similarity to Bacillus licheniformis 
pectate lyase PelB) and lytic transglycosylase (HopP1 has three conserved sequence 
motifs which are predicted to be required for lytic transglycosylase activity), 
respectively, and an N-terminal harpin domain (HrpW-like domain, 45% similarity 
to HrpW from P. syringae pv. tomato) (Kvitko et al., 2007). Together with HrpZ1 of 
P. syringae pv. tomato DC 3000, there are four harpins in this strain (Charkowski et 
al., 1998; Kvitko et al., 2007).   
 
 1.5.5 Harpin forming fibrils 
 
The ability of harpin to form amyloid fibrils was initially reported in 2007 (Oh et al., 
2007). HpaG, the harpin of X. axonopodis pv. gylcines, was found to form β-sheet-
rich fibrils in hrp induction minimal medium XVM2 (XVM2: 20 mM NaCl, 10 mM 
(NH4)2SO4, 5 mM MgSO4, 1 mM CaCl2, 0,16 mM KH2PO4, 0.32 mM K2HPO4, 0,01 
mM FeSO4, 10 mM sucrose, 10 mM fructose and 0.03% casamino acid, at pH 6.7) or 
apoplastic fluid (Oh et al., 2007). Fibrils formed by HpaG produce green 
birefringence after staining with Congo red (Oh et al., 2007). Circular dichroism (CD) 
spectroscopic analysis of spherical oilgomers of HpaG shows an α-helix structure 
which transforms into a β-sheet after the fibrils form (Oh et al., 2007). In addition, 
amyloidogenesis has been taken as the cause of HR, after the finding that HR-null 
mutants lack the ability to form fibrils (Oh et al., 2007). 
 
Other harpins, XopA from X. campestris pv. vesicatoria, HrpZ of P. syringae pv. 
syringae and HrpN of E. amylovora, also formed fibrils in XVM2 (Oh et al., 2007). 
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1.6 Amyloid fibrils 
 
Amyloid fibrils are formed during the process of fibrillar protein aggregation, in 
which the protein adopts an ordered-β structure (Chiti and Dobson, 2006; Fändrich, 
2007).  
 
In vivo, amyloid fibril aggregation induces human neurodegenerative diseases, e.g., 
Alzheimer‘s and Parkinson‘s disease (Petkova et al., 2002) and nonneuropathic 
systemic amyloidoses, e.g., type II diabetes (Chiti and Dobson, 2006; Kajava et al., 
2005). It is thought that more than 100 different human pathological conditions are 
associated with amyloid fibril formation (Fändrich, 2007). Table 1.2 shows the main 
diseases and proteins or peptides involved.  
 
Main fibril constituent protein or fragment Disease 
Aβ40 peptide Alzheimer‘s disease 
huntingtin Huntington‘s disease 
α-synuclein Parkinson‘s disease 
human amylin Type II diabetes 
 
Table 1.2 A summary of the main diseases and the proteins or peptides involved 
(Stefani and Dobson, 2003).     
 
Nonpathological amyloid fibrils have specific functional roles, e.g., curli from E. coli 
facilitates binding to host proteins; prion from Saccharomyces cerevisiae terminates 
mRNA translation; and spidroin from Nephila edulis forms the silk fibers of the web 
(Chiti and Dobson, 2006). Nature uses the high elasticity and persistence of amyloid 
fibrils to build natural materials (Kelly and Balch, 2003). 
 
In vitro, several partially unfolded soluble proteins can form amyloid fibrils when 
they undergo a transition from a  helix to β sheet under conditions of high 
temperature, e.g. transthyretin (Ferrao-Gonzales et al., 2000); high pressure, e.g.  
truncated form of hamster prion protein (SHaPrP90–231) (Torrent et al., 2004; Torrent 
et al., 2006); low pH, e.g. human prion protein and calcium-binding equine lysozyme 
(Gerber et al., 2008; Kumar et al., 2007; Malisauskas et al., 2003); or moderate 
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concentrations of organic solvents, e.g. α-synuclein and beta2-microglobulin  
(Chaudhary et al., 2008; Chiti and Dobson, 2006; Lee et al., 2008).     
 
Besides these full-length proteins, there are several polypeptide segments of these 
fibril-forming proteins involved in amyloid fibril formation, e.g. Aβ40 peptide 
associated with Alzheimer‘s disease, and human amylin relevant to type II diabetes. 
Amyloid fibril forming polypeptide chains are dramatically diverse in their sizes and 
sequences. The poly-amino acids from myoglobin that form amyloid fibrils in vitro 
are α helical in their native state (Fändrich et al., 2001). Some poly-amino acids and 
short designed peptides are intrinsically unable to fold into globular conformations 
and revert into the alternative structural state, amyloid fibrils (Fändrich and Dobson, 
2002; Lopez De La Paz et al., 2002; Tjernberg et al., 2002). 
 
1.6.1 Common structure of amyloid fibrils 
 
Several studies suggest that amyloid fibrillization is a multistep process that involves 
various intermediate forms, including spherical oligomers, protofibrils and mature 
amyloid fibrils (Glabe, 2006).   
 
Spherical oligomers are an intermediate state in the pathway of fibril formation, 
which ranges from dimers up to particles of a million Dalton (Glabe, 2006), that have 
been observed by EM. These spherical oligomers, also called micelles, have a 
diameter of approximately 3-10 nm (Glabe, 2006). Protofibrils are thought to be 
curly and wormlike, have a thin diameter about 2-5 nm and consist of flat β-sheets 
with an overall long-range twist, which has minimal rotations (about 1-3°) between 
successive peptide strands (Jimenez et al., 1999; Jimenez et al., 2002; Uversky and 
Fink, 2004). Figure 1.2a shows the EM of apomyoglobin protofibrils. Mature fibrils 
consist of more than one protofibril wound around a core that may in some cases be 
hollow, which have a diameter 6-12 nm and a linear, straight and regular appearance 
(Uversky and Fink, 2004). A 3D reconstruction of an insulin amyloid mature fibrils 
is shown in Figure 1.2b.  
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Figure 1.2 Electron micrograph of fibrils (a) Electron micrograph of 
apomyoglobin protofibrils (Fändrich et al., 2003). (b) 3-D reconstruction of insulin 
mature fibrils twisted from protofilaments. Left is twisted by a pair of protofilaments. 
Middle is twisted by four protofilaments. Right is twisted by six protofilaments. 
(Jimenez et al., 2002) 
 
1.6.1.1 Structure models of Aβ1-40 fibrils and amylin 
 
 
Figure 1.3 A structural model for Aβ1-40 fibrils. (a) Schematic representation of a 
single molecular laryer. The yellow arrow indicates the direction of the long axis of 
the fibril. (Petkova et al., 2002) (b) A cross section of two laterally displaced 
molecular layers of the Aβ1-40 fibrils. The long axis of the fibril is perpendicular to 
the page. (Petkova et al., 2002)  
 
The Alzheimer‘s β-amyloid (Aβ) peptides are derived from partial proteolysis of the 
larger transmembrane protein, the β-amyloid precursor protein (Benzinger et al., 
2000). The Aβ fibril is a hydrogen-bonded, parallel β-sheet (Figure 1.3a) (Benzinger 
et al., 1998). A structural model for Aβ1-40 has been suggested, based on solid-state 
NMR, that a single protofilament is composed of two fundamental units (Figure 1.3b) 
(Petkova et al., 2002). Every fundamental unit is a double-layered β-sheet structure, 
a 
b 
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which is formed by residue 12-24 and 30-40 (Petkova et al., 2002). The mature 
amyloid fibril formed by Aβ1-40 peptide consists of two protofilaments (Sachse et al., 
2008).  
 
Human amylin, a 37 amino acid long peptide, produced by cleavage from a pro-
amylin precursor protein, forms amyloid fibrils and is associated with type 2 diabetes 
(Kajava et al., 2005). An amylin structural model has been proposed by Kajava, et al. 
(Figure 1.4) (Kajava et al., 2005). In this model, three β-strands consisting of 
residues 12-17, 22-27 and 31-37 form a serpentine core and the first eight residues 
form a disulfide-bonded loop (Kajava et al., 2005). Three amylin protofilaments 
(Figure 1.4b) coil to form fibrils with a left-handed coiling (Kajava et al., 2005). 
 
 
Figure 1.4 Amylin structure model. (a) Diagram of the proposed β-serpentine fold 
for human amylin. The model has three β-strands. (b) The protofilament model of 
human amylin. The three β-strands of the serpentine are marked by arrows with 
different colors (blue, yellow and purple). Ladders formed by H-bonding of Asn22, -
31 and -35, Ser19 and Tyr37 are shown by red broken lines. (Kajava et al., 2005) 
 
1.6.1.2 Atomic structure of fibril forming segments 
 
The availability of microfocus beamlines at the European Synchrotron Radiation 
Facility and Swiss Light Source allowed the crystal structure analysis of 
microcrystals formed by fibril forming segments, which range from 4 to 7 residues in 
length (Nelson et al., 2005; Sawaya et al., 2007). 
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The atomic structure of GNNQQNY, a fibril-forming segment from the yeast Sup35, 
presents that its fundamental unit is a pair of β-sheets, which are formed by 
unspecific van der Waals interactions of interdigitating side chains from each β-sheet, 
named ‗steric zipper‘ by the authors (Figure 1.5) (Nelson et al., 2005). Each pair of 
β-sheets is formed from parallel β-strands by hydrogen-bonds (Nelson et al., 2005). 
The interface between two sheets of a β-sheet pair only involves van der Waals 
interaction without water and thus is a dry interface. In contrast to the dry interfaces, 
the wet interfaces between pairs of β-sheets are lined with water molecules, which 
hydrate the polar side chains (Figure 1.5b). 
   
Figure 1.5 Structure of GNNQQNY. (a) The pair-of-sheets structure, showing the 
backbone of each -strand as an arrow, with side chains protruding. The dry 
interface is between the two sheets, with the wet interfaces on the outside surfaces. (b) 
The GNNQQNY crystal packing viewed down the sheets (from the top of panel a, 
along the b axis). Red crosses indicate the water molecule. The dry interface is 
shown in grey and the wet interface is shown in pink. (Nelson et al., 2005) 
 
Further studies of atomic structures of fibril-forming segments, NNQQ from yeast 
prion Sup35, VQIVYK from tau (a microtubule binding protein in Alzheimer‘s 
disease), GGVVIA and MVGGVV from amyloid-β, LYQLEN and VEALYL from 
insulin, SSTSSA from RNase, and SNQNNF from PrP, reveal similar β-sheet pairs 
and steric zippers formed by the interactions between the residue side chains of 
mating β-sheets, which might be a general characteristic in amyloid structures 
(Sawaya et al., 2007).  
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1.6.2 Mechanisms of amyloid fibril formation 
 
A possible mechanism for amyloid fibril formation, nucleation and growth, has been 
proposed (Chiti and Dobson, 2006; Collins et al., 2004; Serio et al., 2000; 
Vestergaard et al., 2007). The intermolecular contacts of specific segments of the 
protein form a nucleus, which is a slow reaction and the least stable intermediate 
(Chiti and Dobson, 2006; Vestergaard et al., 2007). Following a lag phase for 
nucleation, there is a rapid exponential growth phase in which there is further 
association of either monomers or oligomers within the nucleus (Chiti and Dobson, 
2006; Collins et al., 2004; Vestergaard et al., 2007). Fragmentation of already 
formed fibrils, taken as seeds, increases the reaction of nucleation by circumventing 
the beginning of nucleus formation (Stohr et al., 2008). 
 
1.6.3 Pathogenicity of amyloid fibrils  
 
Initally, amyloid fibrils were taken as the species responsible for cell toxicity and 
death. However, recent studies provide evidences that the intermediate state, the 
soluble amyloid oligomers, is the main cytotoxic species (Chiti and Dobson, 2006). 
 
Soluble amyloid oligomers of different amyloidogenic proteins and peptides were 
reported to have a common structural motif (Kayed et al., 2003).  In this publication, 
the antibody produced by rabbit vaccination with Aβ peptides not only specifically 
recognizes the oligomeric state of Aβ, but the soluble oligomers among all other 
types of amyloidogenic proteins and peptides, regardless of sequence, such as islet 
amyloid peptide, ployglutamine, lysozyme and human insulin (Kayed et al., 2003). 
Since the protein function is determined by the three-dimensional structure, the 
common structure of different amyloidogenic proteins and peptides implies that they 
also share a common pathological function and act on the same primary target of 
cells (Kayed et al., 2003). The plasma membrane is assumed to be the primary target 
of the amyloid oligomer (Kayed et al., 2003). 
 
In explanation of the pathogenicity or toxicity of soluble oligomers or fibrils, several 
mechanisms, including membrane disruption, ion channel forming and 
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permeabilization of membrane, have been proposed (Engel et al., 2008; Kayed et al., 
2004; Quist et al., 2005). 
 
Kayed et al., 2004 found that soluble oligomers from diverse amyloids (Abeta40 of 
Alzheimer disease, α-synuclein of Parkinson disease, IAPP of type II diabetes, 
polyglutamine of Huntington disease and prion [106-206] of prion disease) that 
increase lipid bilayer conductance independent of the sequence (Kayed et al., 2004). 
In their study, the increasing conductance is conformation-specific and no channel or 
pore is formed. 
  
Quist et al., 2005, showed that amyloid molecules form the ion channels, including 
Aβ of Alzheimer disease, α-synuclein of Parkinson disease, amylin of Type II 
diabetes, in membrane by AFM (Quist et al., 2005).  
 
However, Engel et al., 2008 reported the human islet amyloid polypeptide (IAPP) 
damaged the membrane through the fibril growing on the membrane (Engel et al., 
2008). In this study, the kinetic profile of IAPP-induced membrane leakage matches 
that of IAPP fibril formation, which correlates the membrane damage with fibril 
growth. Furthermore, seeding increased fibril formation and also membrane damage. 
Insulin, the inhibitor of IAPP fibril growth, protects against IAPP-induced membrane 
damage. 
 
In summary, the pathogenicity of amyloid fibrils, or their precursor oligmers, might 
lie in their effect on the plasma membrane, either disrupting the membrane or via the 
formation of ion channels in the membrane. 
 
1.7 Hpa1 
  
The Food and Agriculture Organization (FAO) of the United Nations pointed out that 
there are still 77 food-deficit countries all over the world (Crop prospects and food 
situation, No. 4, November 2009, FAO). Rice is the most important food for a large 
part of the world‘s human population and its bacterial pathogen Xoc induces rice loss 
of up to 50% (Gnanamanickam et al., 1999).  Thus, the management of Xoc to 
improve the rice yield is one practical way to provide more food.  
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A TTSS is used by Xoc to translocate effector proteins into host rice and is thus 
responsible for its pathogenicity (Alfano and Collmer, 2004; Zou et al., 2006). An 
understanding of the molecular mechanism of the TTSS of Xoc and its role in 
pathogenicity could provide a basis for the management of Xoc to bring about a 
decrease in the loss in rice yield. Hpa1, the harpin of Xoc, is secreted by the TTSS 
and induces HR in nonhost tobacco (Zou et al., 2006).  Although Hpa1 is a substrate 
of the TTSS, the pathogenicity of Hpa1 in host is still enigmatic. We sought to 
elucidate the structure and function of Hpa1 in order to further our understanding of 
its pathogenic role. 
 
Recently, HpaG, the harpin of X. axonopodis pv. glycines, was reported to form 
amyloid fibrils (Oh et al., 2007). The aggregation of amyloid fibrils in vivo is 
associated with about 100 human pathological conditions (Fändrich, 2007). Hpa1 has 
high sequence identity (59.7%) with HpaG; and so we sought to test whether Hpa1 
assembles into amyloid fibrils as does HpaG?  Assuming Hpa1 formed amyloid 
fibrils, we aim to address the following questions: (i) what are the conditions for 
amyloid fibril assembly of Hpa1; (ii) is there a segment or motif present within Hpa1 
responsible for fibril assembly; (iii) what is the function of Hpa1 fibrils in conferring 
pathogenicity? 
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Part II   Regulators of MDR transporter 
 
1.8 Multi-drug resistance (MDR) 
  
Although the development of resistance against antimicrobials is due to natural 
selection in response to naturally occurring environmental sources, the abuse of 
antibiotics in the clinic has resulted in an immense selective pressure and emergence 
of antibiotic resistance (Harrison and Svec, 1998). Multi-drug resistant (MDR) 
bacteria can survive in the presence of potentially lethal doses of structurally diverse 
drugs that now threaten to compromise effective chemotherapy. The emerging global 
crisis of MDR has led to an urgency in the development of new therapeutic 
approaches to circumvent resistance mechanisms (Harrison and Svec, 1998; 
McKeegan et al., 2004). Extensive study and understanding of the molecular 
mechanisms underlying the development of MDR could provide clues in developing 
new inhibitors to combat resistant bacteria. 
 
The mechanisms used by MDR bacteria to acquire resistance to antimicrobial agents 
are summarized in the following three types (Walsh, 2000). 
 
 1) Drug modification, e.g. production of β-lactamases for hydrolysis of the β-lactam 
ring. 
2) Modification of the cellular target, e.g. changes in fluoroquinolone binding sites of 
DNA gyrase resulting in resitance to ciprofloxacin. 
3)  Pumping out the antibiotic e.g. drug efflux pumps.  
Generally, drug efflux pumps consist of an inner membrane protein and a 
cytoplasmic membrane fusion protein, acting with an outer membrane protein to 
extrude drugs from cells (Borges-Walmsley et al., 2003; Zgurskaya and Nikaido, 
2000). MDR transporters can be divided into six families: the ATP binding cassette 
(ABC) transporters, which couple the hydrolysis of ATP to drug efflux; the major 
facilitator superfamily (MF); resistance nodulation division (RND) family; the 
drug/metabolite efflux (DME); small multidrug resistance transporters (SMR) family; 
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and multidrug and toxic compound extrusion (MATE) family (Borges-Walmsley et 
al., 2003; Kumar and Schweizer, 2005). MF, SMR, RND and DME family are 
proton-driven antiporters and MATE tranporters are Na
+
-driven transporters 
(Borges-Walmsley et al., 2003; Kumar and Schweizer, 2005). Figure 1.6 shows five 
well-characterised families of multidrug efflux pump. 
Figure 1.6 Five well-characterised families of multidrug efflux pump SMR 
family transports are proton-driven antiporters and have 4 TMS (transmembrane 
spanning helices); MATE family transports are Na
+
-driven transporters; RND family 
transports are proton-driven antiporters and have 12 TMS and MF family transports 
are proton-driven antiporters and have 12 TMS. ABC transporters are powered by 
ATP hydrolysis. (McKeegan et al., 2004). 
 
1.9 Transcriptional regulation of multidrug transport systems 
Excessive expression of bacterial MDR transporters could be deleterious, because 
this could cause the physical disruption of the membrane integrity or unwanted 
export of essential metabolites (Schumacher et al., 2001; Schumacher and Brennan, 
2002). The transcriptional regulation of MDR genes has been found in proton-motive 
force dependent efflux pumps, the major facilitator superfamily (MF) and resistance 
nodulation division (RND) family (Schumacher et al., 2001; Schumacher and 
Brennan, 2002). However, SMR family and partial RND and MF family pump genes 
express constitutively, which reflects unknown physiological roles for the 
unregulated pumps in normal cellular metabolism (Schumacher and Brennan, 2002). 
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In addition, two-component regulatory systems have also been characterized in 
regulation of MDR genes, in which a membrane-linked kinase senses the signal, and 
a corresponding response regulator affects the outcome (Schumacher et al., 2001; 
Schumacher and Brennan, 2002).  
The regulators of bacterial multidrug transport systems belong to one of four 
regulatory protein families, the AraC, MarR, MerR, and TetR families, the 
assignment of which is based on the similarities detected within the DNA-binding 
domains of the regulator (Schumacher and Brennan, 2002). The transcriptional 
regulation of MDR transporter acts at a local or global level (Schumacher and 
Brennan, 2002). Extensively studied local regulators of drug transporter are E. coli 
TetR, repressor of tetracycline efflux; Bacillus subtilis BmrR, activator of Bmr pump; 
and Staphylococcus aureus QacR, repressor of QacAB pump. Well characterized 
global regulators are E. coli MarA, the global activator of the AcrAB-TolC pump; 
and N. gonorrhoeae MtrA, the global activator of the MtrCDE pump. 
Considering that transcriptional regulatory proteins bind many of the diverse 
antimicrobials that are also substrates of the pumps they regulate, the study of 
cytosolic regulatory proteins will not only provide understanding of the regulation 
mechanism of MDR transportion, and thus provide a strategy in overcoming MDR, 
but could also reveal the drug recognition and binding of regulators, which could be 
targets for drug design to overcome antibiotic-resistant bacteria. 
1.10 TetR family of transcriptional repressors  
TetR family transcriptional repressors are widely distributed among bacteria and 
involved in the regulation of multidrug resistance pumps, catabolic pathways, the 
biosynthesis of antibiotics, osmotic stress, and the pathogenicity of Gram-negative 
and Gram-positive bacteria (Ramos et al., 2005). They are also involved in the 
adaptation to complex and changing environments (Ramos et al., 2005).  
Members of the TetR family exhibit a high degree of sequence similarity at the helix-
turn-helix (HTH) DNA binding domain, but low sequence similarity in the signal 
sensing domain, which indicates the differences in the function of this family (Ramos 
et al., 2005). It is proposed that members of the TetR family function in a similar 
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manner: the binding of an inducer molecule to the C-terminal signal sensing domain 
induces a conformational change in the conserved DNA-binding domain, resulting in 
the release of the repressor from the operator, allowing transcription of the regulated 
downstream genes (Grkovic et al., 2001; Ramos et al., 2005) 
1.10.1 TetR  
The broad-spectrum antibiotic Tc (tetracycline) binds to the small ribosomal subunit 
and thus interrupts polypeptide chain elongation (Buck and Cooperman, 1990). The 
tetracycline repressor TetR, regulates the expression of TetA, which acts to export 
the tetracycline-magnesium complex, [MgTc]
+
, and itself, by binding to specific 
DNA operators (Grkovic et al., 2001; Hinrichs et al., 1994; Kisker et al., 1995; Orth 
et al., 1998a). There are two adjacent inverted repeats, named tet operators O2 and O1, 
which overlap the tetA and tetR promoters. The binding of TetR to operator O2 
represses tetA alone and to operator O1 represses both the tetA and tetR genes. TetR 
has a fourfold-higher affinity to operator O2 than to operator O1 (Grkovic et al., 2001; 
Kisker et al., 1995; Orth et al., 1998a).   
Upon binding of [MgTc]
+
, TetR changes its conformation and dissociates from the 
operators, which results in the expression of TetR and TetA and subsequently the 
export of [MgTc]
+
 by TetA (Hinrichs et al., 1995). The affinity of TetR for [MgTc]
+
 
is greater than that of [MgTc]
+
 to ribosomes, subsequently ensuring tetA expression 
and [MgTc]
+
 export before the inhibition of protein synthesis (Orth et al., 1998b). 
TetR monomer has 10 -helices. Helices 2 and 3 constitute the helix-turn-helix 
(HTH) motif for DNA binding, which is connected to the regulatory domain, helices 
5- 10, through helix 4 (Ramos et al., 2005; Hinrichs et al., 1994; Orth et al., 
2000). The dimerization of TetR is achieved by the interaction of 8 and 10 with 
the symmetry-related 8‘ and 10‘ (Hinrichs et al., 1994; Kisker et al., 1995).   
1.10.1.1 TetR and [Mg-Tc]
+
 complex structure 
The crystal structures of the class D TetR in complex with [Mg-7HTc]
+
 (tetracycline) 
and [Mg-7ClTc]
+
 (7-chlorotetracycline, the hydrogen atom at C-7 is replaced by Cl) 
were determined (Hinrichs et al., 1994; Kisker et al., 1995). The TetR homodimer 
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binds two tetracycline-Mg
2+
 complexes in binding tunnels within the regulatory 
domains of TetR.  helices 4 to 8 and 8‘ and 9‘ (a prime refers to the second 
subunit of the dimer) form the first Tc binding pocket, and  helices 4‘ to 8‘ and 8 
and 9 form the second site (Orth et al., 1999).  
The interactions between TetR and Tc-Mg include hydrogen bonding, hydrophobic 
interactions and Mg
2+
 coordination (Hinrichs et al., 1994; Kisker et al., 1995; Orth et 
al., 1999). The functional groups of Tc involved in hydrogen bonding and Mg
2+
 
coordination determine the antibiotic activity of Tc, as modifications of them abolish 
the antibiotic activity (Hinrichs et al., 1994). In detail, Mg
2+
 is octahedrally 
coordinated by the chelating ketoenolate group O-11/O-12 of Tc, N
ε
of His-100, and 
by three water molecules. Two of these water molecules are hydrogen bonded to the 
carboxylate of Glu-147‘ (Figure 1.7) and the other one forms a hydrogen bond to the 
hydroxyl group O
γ
 of Thr103. In addition, the Nε of His-64 and NH of Gln-116 form 
hydrogen bonds with Tc amide oxygen in position 2 and negatively charged oxygen 
in position 3. The O-3 and N-4 of the Tc are bridged to the amide side chain of Asn-
82 by hydrogen bonds. The phenyl ring of Phe-86 forms an aromatic hydrogen bond 
with hydroxyl group O-121 of Tc. (Hinrichs et al., 1994; Orth et al., 1999). 
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Figure 1.7 Structure of TetR in complex with [Mg-Tc]
+
 (a) Ribbon drawing of the 
TetR/Mg-7ClTc dimer (PDB code: 2TRT), one complex in green, the other in red 
(Kisker et al., 1995). The figure was prepared using PyMOL (DeLano, 2002). (b) 
Chemical structure of tetracycline and schematic representation of the interaction 
between tetracycline and TetR. Hydrogen bonds are represented by dashed lines; 
hydrophobic interactions are shown by hashed lines. W1, W2 and W3 are water 
molecules in the octahedral coordination shell of Mg
2+
 and Me represent methyl. 
Charges are marked (+) and (-). (Hinrichs et al., 1994) 
a 
b 
N 
C 
α1 
α2 
α3 
α4 
α5 
α6 
α7 
α8 
α9 
α10 
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In the interaction with [Mg-Tc]
+
, the side chains of TetR were divided into three 
categories (Orth et al., 1999). Group I consists of His64, Asn82, Phe86 and Gln116, 
which are located at the far end of the binding tunnel. Functional groups of Tc ring A 
form hydrogen bonds with the side chains of these residues. Group II comprises 
Val113, Leu131, Ile134, Leu170‘, Leu174‘ and Met177‘, which form nonpolar van 
der Waals contacts to the hydrophobic part of [Mg-Tc]
+
. Group III consists of 
His100, Thr103 and Glu147‘, which are involved in direct or water-mediated Mg2+ 
coordination (Orth et al., 1999).  
The comparison of structures of [TetR]2 (TetR dimer, inducer-free), [TetR-7ClTc]2 
(TetR dimer complexed with two 7ClTc without Mg), [TetR-7ClTc]·[TetR-Mg7ClTc] 
(TetR dimer complexed with one 7ClTc and one Mg7ClTc) and [TetR-Mg7ClTc]2 
(TetR dimer complexed with two Mg7ClTc) shows the binding of [Mg-Tc]
+
 to TetR 
in sequential steps (Orth et al., 1999). The first step of [Mg-Tc]
+
 binding is the 
insertion of [Mg-Tc]
+
 into the binding tunnel and results in hydrogen bonding 
between ring A of Tc and group I residues. The second is the rotation of Tc around 
ring A, which produces the hydrophobic contacts and positions the chelated Mg
2+ 
appropriate for binding to His100. (Figure 1.7b) (Orth et al., 1999). There are two 
other amino acid residues, Thr103 and Glu147‘, involved in binding Mg2+. The 
binding of Mg
2+
 to Thr103 (the first amino acid residue of 6 C-terminus) forces its 
side chain to shift by 2.5 Å (Orth et al., 1999). Subsequently, 6 unwinds to adopt a 
β turn conformation and 4 performs a pendulum-like motion. Therefore, it is Mg2+ 
that initiates helix unwinding in TetR induction (Orth et al., 1999). 
1.10.1.2 TetR and its bound DNA 
The crystal structure of the class D TetR bound with its 15 bp operator DNA, which 
overlaps the promoters for tetA and tetR, shows the HTH motifs of TetR in contact 
with two major grooves in B-form DNA (Figure 1.8) (Orth et al., 2000; Grkovic et 
al., 2001). These two major grooves are widened to 14-14.5 Å, compared with the 
canonical B-DNA 11.7 Å (Figure 1.8) (Orth, et al., 2000). Another characteristic of 
TetR bound with its operator DNA is the bend of each half operator DNA, which is 
caused by kinking at base pair 2 from TetR and compensating by bending of base 
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pairs 3-6 to TetR , which results in the almost parallel ends of the 15-mer DNA (Orth, 
et al., 2000).  
 
Figure 1.8 Structure of the TetR-tetO complex. (a) Ribbon representation of the 
overall structure of the TetR-tetO complex. -helices of the homodimeric TetR are 
labelled in one monomer. The helices that form the DNA binding domain are colored 
blue; the helices that form the rigid scaffold are colored yellow, the rest of the helices 
that undergo conformational changes after the binding of inducer are colored green. 
(b) Schematic representation of the interactions of TetR dimer with its 15 bp operator. 
The interactions between specific nucleotides and polypeptides shown by arrows and 
those between phosphate backbones and polypeptides indicated by blue lines. 
(Grkovic et al., 2001; Orth et al., 2000)   
 
The interaction of TetR with operator DNA is shown in Figure 1.8. The central three 
pairs are taken as the spacer and do not contribute to the protein-DNA interaction. 
The TetR monomer A binds the main
 
strand from positions –4 to –7 and contacts the 
complementary strand from operator positions +4 to +2. The symmetric monomer A' 
binds the main strand from positions
 
+2 to +4 and the complementary strand from 
positions –4 to –7. The specific contacts between the side chains of TetR and bases in 
the operator DNA are A3-Gln38 and G2-Arg28 by bidentate hydrogen bonding, and 
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T4-Pro39 and T5-Tyr42 by van der Waals interactions.  Helix 3 (from Gln38 to 
His44) is the main element responsible for sequence-specific
 
recognition. Lys48 
from 4, out of the HTH motif, also establishes contacts with the target DNA region.  
1.10.1.3 The induction mechanism of TetR  
A structural comparison of induced (Mg-Tc bound) and non-induced TetR (DNA 
bound) found the center-to-center separation of recognition helices 3 and 3‘ in the 
operator complex changes from 36.6 Å to 39.6 Å after Mg-Tc binding. In 
explanation of the induction mechanism of TetR, signal transduction between the 
operator-binding interface and Mg-Tc binding site was proposed. This process is 
initiated from the shift of helix 6 in its C-terminal direction by 1.5 Å and the 
conformational change of its C-terminal turn to a type II β-turn (Orth et al., 2000). In 
concert, 8 is extended by one turn in its C-terminus and the N-terminal turn of 7 
adopts a 310-helical conformation on induction (Orth et al., 1998b). 
 
These changes force the central part of 4 to shift in the same direction, as the van 
der Waals contact between 4 and 6. Figure 1.9 shows the insertion of Mg-Tc into 
the binding tunnel to initiate the pendulum like motion of the N-terminus of4. This 
motion of 4 and 4‘ (a prime refers to the second unit of the dimer) shifts the N-
terminal DNA-binding domain apart, increases the separation of the recognition 
helices 3, 3‘ and causes the dissociation of the TetR/operator complex (Orth et al., 
2000).                              
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Figure 1.9 The conformational changes of TetR associated with [Mg-Tc]
+ 
binding Comparison of TetR in induced (yellow) and DNA-bound form (blue). The 
DNA phosphate-ribose backbone is shown in red, base in grey, Tc in orange and 
Mg
2+
 in red, the water molecules that constitute the water zipper in the induced 
conformation as blue spheres, which locks the DNA binding domain in a 
conformation unable to bind to the operator. (Grkovic et al., 2001; Orth et al., 2000) 
1.10.1.4 TetR peptide inducer  
Besides Tc and its derivatives, a 16-residue peptide (WTWNAYAFAAPSGGGS), 
called Tip (transcription inducing peptide), was found to mimic Tc, to induce TetR in 
E. coli, when fused to the N or C terminus of thioredoxin (Klotzsche et al., 2005; 
Luckner et al., 2007). Tip was identified from a phage display library. Tc could 
displace the peptide Tip from the TetR-Tip complex, indicating that there is 
competition between Tip and Tc for TetR binding (Klotzsche et al., 2005).  
  
The crystal structure of the Tip-TetR complex revealed that four residues (Trp1, Thr2, 
Trp3 and Asn4) of Tip occupy the Tc binding pocket (Figure 1.7b and Figure 1.10a), 
eight amino acids interact with residues to the surface of TetR and the other four 
residues are not visible in the electron density maps (Luckner et al., 2007). As there 
is an absence of Mg
2+
 in the structure of Tip-TetR, the indole nitrogen of Trp1 from 
Tip forms a hydrogen bond with the carbonyl oxygen of Thr103 of TetR. Tip 
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residues Thr2 and Asn4 form polar interactions with TetR residues Glu147‘, 
Asp148‘ and His 151‘ (Luckner et al., 2007) (Figure 1.10a).  
 
 
       
Figure 1.10 The structure of the Tip-TetR complex (a) Interactions occurring 
between TetR and Tip. Ionic interactions (dashed line) and van der Waals 
interactions (parallel lines) are marked. Tip residues are labeled with the single-letter 
code; the three-letter code is used for TetR residues. (b) Superposition of Tip-
induced TetR and uninduced TetR. Tip-induced TetR is shown in gray and red, while 
uninduced TetR in yollow and brown. The parallel lines hight intersubunit 
interactions that are unique to the Tip-TetR complex. (Luckner et al., 2007).    
 
The binding of Tip to TetR also repositions its DNA-binding domain in analogy to 
that of Tc by the pendulum-like motion of helix α4 (Section 1.10.1.3). However, the 
a 
b 
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repositioning of helix 4 is achieved by direct intersubunit interaction between loop 
8‘ to 9‘ and the beginning of helix 4, different to the conformational changes of 
the C-terminal turn of 6 and the N-terminal turn of 7 in the induction by Tc 
(Luckner et al., 2007) (Figure 1.10b).  
 
1.10.2  QacR 
The Staphylococcus aureus QacR binds to an operator DNA and negatively regulates 
qacA transcription (Grkovic et al., 1998). QacA is a multidrug transporter and 
confers resistance to a broad range of antimicrobial agents. QacR is a member of the 
TetR family but shows a very low overall sequence identity (13.8%) with TetR 
(Sequence alignment was performed by SIM at Expasy). In contrast to ten helices of 
TetR, QacR is 23 residues shorter than TetR (these 23 residues are corresponding to 
10 in TetR), and has nine helices: 1(3-18), 2(25-32), 3(36-42), 4(46-71), 
5(75-88), 6(96-108), 7(110-136), 8(145-162) and 9(168-185), which play 
different functions during the binding of DNA and drugs (Schumacher et al., 2001 
and 2002).  
1.10.2.1 DNA binding mechanism of QacR  
The first three helices act as a three-helix bundle DNA-binding domain (helix-turn-
helix motif) and helices 4 through 9 are responsible for drug binding and 
dimerization (Schumacher et al., 2002). Although QacR and TetR are members of 
TetR family, they bind DNA in different modes. The QacR/dsDNA complex consists 
of two QacR dimers and one 28 bp operator, and the two dimers are found to dock 
onto the two successive major grooves of the cognate DNA (Figure 1.11) 
(Schumacher et al., 2002).  
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Figure 1.11 Structure of QacR bound to its cognate DNA duplex. (a) Ribbon 
representation of the two QacR homodimers bound to target DNA. The monomers of 
each dimer are designated as distal (blue) or proximal (red). (b) Schematic showing 
QacR-DNA half-site contacts. The yellow and purple subunits are from different 
dimers. Nucleotide G7 is the location of the qacA transcription start site and this GC 
pair is shaded in purple (Grkovic et al., 2001; Schumacher et al., 2002).     
 
QacR binds its operator cooperatively, which is mediated by unwinding of the DNA. 
The unwinding of operator DNA bound by QacR is reflected by two characteristics. 
The DNA oligonucleotide bound by QacR has a twist of 32.1° and 11.2 bp per turn 
a 
b 
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pitch, which are 34.3° and 10.5 bp per turn in canonical B-DNA. In addition, the 
center-to-center distances between the recognition helices of each QacR dimer (the 
distance between amide nitrogens of Gly37) expands to 37 Å, in contrast to 34 Å for 
proteins that bind the consecutive major grooves of B-DNA. It is proposed that the 
binding of the first dimer, an energetically costly step, locks the 28 bp operator DNA 
into an unwound conformation, which is ready for the binding of the second QacR 
dimer (Schumacher et al., 2002).  
The two monomers of QacR dimer at each side of the operator DNA recognize 
different bases and have been taken as distal and proximal monomers, depending on 
the distances to the dyad (Schumacher et al., 2002) (Figure 1.11a). Proximal 
monomers make base-sepecific interactions with the 28 bp operator, while distal 
monomers make several base and phosphate contacts (Figure 1.11) (Schumacher et 
al., 2002). Two QacR dimers have 16 base and 44 phosphate contacts with the 28 bp 
dsDNA. The central six base pairs provide the appropriate spacing for QacR and the 
addition to or removal of two base pairs from this 6 bp spacer abolishes QacR 
binding. In addition, the four base pairs at the two ends of the DNA duplex could 
function as over hang bases for the crystal package, as there is no contact between 
them and QacR.  
1.10.2.2  Drug binding sites of QacR  
QacR binds different monovalent and bivalent cationic lipophilic compounds, which 
are also substrates of the efflux pump QacA (Murray et al., 2004; Schumacher et al., 
2001; Schumacher et al., 2004). According to the structures of QacR bound to six 
drugs individually (Rhodamine 6G, R6G; Ethidium Et; Dequalinium, Dq; Crystal 
Violet, CV; Malachite Green, MG; and Berberine, Be), the drug-binding pocket of 
QacR was divided into two sites: the Et pocket and the R6G pocket (Schumacher et 
al., 2001).  
Drug binding induces a coil-to-helix transition of residues Thr89-Tyr93 that results 
in the expulsion of Tyr92 and Tyr93 from the hydrophobic interior of the protein to 
the solvent and the formation of the expansive drug-binding pocket, which plays an 
important function in drug binding (Schumacher et al., 2001). Tyr92 and Tyr93 also 
stabilize the drug-binding pocket of QacR when no drugs are bound to QacR 
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(Schumacher et al., 2001). These functions of Tyr92 and Tyr93 are in agreement 
with the concept that aromatic residues are critical in drug binding and essential for 
the construction of the drug binding pocket (Schumacher et al., 2004).  
The coil-to-helix transition triggered by drug binding elongates the C-terminus of 5 
by a turn, and thus relocates 6 and its tethered DNA-binding domain. Similar to 
TetR drug induction, upon drug binding, 4 has a pendulum motion and the center-
to-center distance of the recognition helices increases to 48 Å from 37 Å of the 
DNA-bound form.   
The positively charged ethyl ammonium groups of drugs are neutralized by 
negatively charged glutamate: Glu90 in the QacR-R6G complex; Glu57, Glu58 and 
Glu120 in the QacR-Dq complex; Glu90 and Glu120 in QacR-CV complex and 
QacR-MG complex; Glu57 and Glu58 in QacR-Be complex; and Glu120 in QacR-Et 
complex serves this function (Schumacher et al., 2001). 
In the crystals of the QacR-diamidine complex, a novel drug charge neutralization 
was proposed (Murray et al., 2004): not only is glutamate involved in the 
neutralization of positively charged drugs, but the oxygen atoms of a carbonyl and 
side chain also serve the same function (Murray et al., 2004). 
In the ternary QacR-Pf-Et compex, Pf is still bound in the R6G pocket, and protein-
drug contacts are similar to those in QacR-Pf binary complex, with stacking against 
the aromatic side chains of residue Trp61 and Tyr103, hydrogen bonding with Gln96 
and Thr89, and ionic interactions with the side chains of residues Glu57 and Glu58. 
However, Et slides into a new position, close to the binding sites of QacR-Et binary 
complex. In the new location, Et interacts with Pf through van der Waals interactions. 
Figure 1.12 shows the structures of QacR-Pf-Et and QacR-R6G.  
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Figure 1.12 The structure of the ternary QacR-pf-Et and QacR-R6G  
a: A ribbon diagram of the QacR-pf-Et ternary complex; the nine helices are 
numbered and the pf and Et are presented as yellow and red sticks respectively. b: 
The superimposition of QacR DNA-bound conformation (yellow) and QacR drug 
binding conformation (blue). The coil-to-helix transition is illustrated. The location 
of rhodamine 6G (red) in the drug-bound structure is indicated, as are 4 to 9, the 
HTH recognition helix (Hr), and the N and C termini of the protein (Schumacher and 
Brennan, 2002; Schumacher et al., 2002). 
In the TetR family repressors of multidrug efflux pumps, besides the structures of 
QacR and TetR, the crystal structures of AcrR, CmeR and SmeT have been 
determined. Furthermore, EthR is a well studied regulator in the TetR family and its 
structure provides a new clue to develop drugs for the therapy of tuberculosis 
(Frenois et al., 2004); MtrR is a regulator of the MtrCDE efflux pump in Neisseria 
gonorrhoeae, but could act as a global regulator (Folster and Shafer, 2005; Folster et 
al., 2007).  
1.10.3 AcrR 
AcrR, the transcriptional repressor of AcrAB multidrug efflux pump in E. coli, has a 
three helix DNA-binding domain, and a diverse C-terminal drug binding domain, 
forming the ligand-binding sites (Li et al., 2007). The AcrAB pump, which belongs 
to the RND efflux pump family, acts with the outer membrane protein TolC, to 
assemble a tripartite drug efflux pump and thus expels antibacterial agents (Touze et 
al., 2004). The 2 and 3 of AcrR form a typical helix-turn-helix motif, which is 
well conserved among members of the TetR family (Li et al., 2007). The 
a 
b 
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dimerization of AcrR involes mainly 8 and 9. The C-terminal drug binding 
domain of AcrR forms a large internal cavity for drug binding located at the center of 
the binding pocket (Li et al., 2007). Figure 1.13 shows a ribbon diagram of the AcrR 
homodimer. 
                   
Figure 1.13 Ribbon diagram of the AcrR homodimer (PDB code: 2QOP) generated 
by crystallographic symmetry (Li et al., 2007). The nine helices are numbered.  The 
figure was prepared using PyMOL (DeLano, 2002). 
1.10.4 CmeR  
CmeR, a member of TetR transcriptional regulator family, represses the 
transcriptional expression of CmeABC in Campylobacter jejuni (Cagliero et al., 
2007; Gu et al., 2007; Lin et al., 2005a and b). The CmeABC pump, a RND type 
efflux pump, functions in the export of antimicrobial agents and bile resistance, 
which is essential for Campylobacter colonization of the animal intestinal tract (Lin 
et al., 2005a and b). The cyrstal structure of CmeR revealed that the N-terminal DNA 
α1 
α2 
α3 
α4a 
α4b 
α5 
α6 
α7 α8 
α9 
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binding domain and C-terminal drug binding domain are similar to other members of 
the TetR family (Gu et al., 2007). However, one of the critical characteristics for 
DNA binding in this family, the HTH motif usually consists of 2 and 3, is found 
to be deficient in 3 in CmeR (Gu et al., 2007). The expected 3 region forms a 
random coil, rather than an helix (Gu et al., 2007). The C-terminal drug binding 
domain of CmeR encompasses helices 4-10 (Gu et al., 2007). Helices 6, 8, 9 and 10 
contribute to the dimerization of CmeR. There is a large tunnel-like cavity in the C-
terminal drug binding domain of CmeR, which is about 20 Ǻ long (Gu et al., 2007). 
Figure 1.14 shows a ribbon diagram of the AcrR homodimer.      
                       
Figure 1.14 Ribbon diagram of the CmeR dimer (PDB code: 2QCO) generated by 
crystallographic symmetry (Gu et al., 2007). The ten helices are numbered. The 
figure was prepared using PyMOL (DeLano, 2002). 
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1.10.5 SmeT 
SmeT is the repressor of the multidrug efflux pump SmeDEF in Stenotrophomonas 
maltophilia (Hernandez et al., 2009; Sanchez et al., 2002). Similar to other members 
of TetR family, SmeT has an N-terminal HTH DNA binding domain and a C-
terminal dimerization and ligand binding domain (Hernandez et al., 2009). The two 
subunits of the SmeT dimer in the crystal are different (Hernandez et al., 2009). 
There is an unknown ligand occupying the ligand pocket in subunit A but no putative 
ligand for subunit B (Hernandez et al., 2009). The binding of the unknown ligand in 
subunit A stabilizes its N-terminus, whereas in subunit B the DNA-binding domain is 
almost completely disordered (Hernandez et al., 2009). Figure 1.15 shows a ribbon 
diagram of the SmeT dimer. DNase I footpringting assays show SmeT binds to a 28-
bp pseudopalindromic region, which overlap the promoters of smeT and smeDEF, 
indicating the function of SmeT in simultaneously regulating smeT and smeDEF 
transcription (Hernandez et al., 2009).  
                 
Figure 1.15 Ribbon diagram of the SmeT dimer (Hernandez et al., 2009; PDB code: 
2W53). The nine helices are numbered. The figure was prepared using PyMOL 
(DeLano, 2002). 
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1.10.6 EthR  
EthR, a member of TetR transcriptional regulator family, binds the ethA promoter 
region and inhibits the expression of ethA in Mycobacterium tuberculosis (Dover et 
al., 2004). EthA is a FAD-containing enzyme that catalyses two steps in the 
activation of ethionamide (ETH), which is the major antituberculosis drug, and thus 
the repression of ethA expression by EthR affects the therapy of tuberculosis by ETH 
(Dover et al., 2004; Engohang-Ndong et al., 2004; Frenois et al., 2004). EthR exists 
as a dimer in solution. Unlike QacR, TetR and other regulators in TetR family, EthR 
binds cooperatively to the 55bp operator as octamer (Engohang-Ndong et al., 2004). 
The octamerization of EthR requires the presence of the operator DNA (Engohang-
Ndong et al., 2004). The crystal structure of EthR expressed and purified from E. 
coli shows EthR is unexpectedly bound with hexadecyl octanoate (HexOc), which 
provides a new clue to develop drugs for the therapy of tuberculosis (Frenois et al., 
2004). Figure 1.16 shows a ribbon diagram of the EthR dimer.                     
 
Figure 1.16 Ribbon drawing of the EthR dimer (Frenois et al., 2004; PDB code: 
1U9N) generated by crystallographic symmetry. The nine helices are numbered and 
the ligand HexOc is shown in a stick model. The figure was prepared using PyMOL 
(DeLano, 2002). 
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1.10.7 MtrR 
MtrR, a member of TetR transcriptional regulator family, represses the transcription 
of the MtrCDE efflux pump in Neisseria gonorrhoeae (Hoffmann et al., 2005; Lucas 
et al., 1997). The MtrCDE pump, an RND family export pump, confers the 
resistance of gonococci to several antimicrobials. The intergenic sequence between 
the mtrR and mtrC genes is bound by MtrR was confirmed by gel mobility shift and 
DNase I footprint assays (Lucas et al., 1997). In the DNA binding assay, higher salt 
(200 mM NaCl) affected the binding affinity, compared with lower salt 100 mM 
NaCl (Hoffmann et al., 2005).   
MtrR also indirectly regulates the farAB-encoded efflux pump, which confers N. 
gonorrhoeae resistance to fatty acids (Lee et al., 2003). The FarAB pump consists of 
the FarA membrane fusion protein and the FarB cytoplasmic membrane transporter 
protein, which act with the outer membrane channel MtrE (Lee et al., 2003). The 
FarAB pump is regulated by the transcriptional repressor FarR, a member of the 
MarR family (Lee et al., 2003). MtrR was reported to bind to the FarR promoter and 
repress the expression of FarR (Lee et al., 2003). Thus, MtrR would positively 
regulate the FarAB pump through inhibition of the expression of the FarR repressor 
(Lee et al., 2003). 
In addition, MtrR was reported to regulate ponA, which encodes penicillin-binding 
protein 1, the pilMNOPQ operon, which encodes components of the type IV pilus 
secretion system, and mtrF, which encodes MtrF that acts in conjunction with the 
MtrCDE pump to confer gonococci resistance to certain drugs, indicating MtrR 
could act as a global regulator (Folster and Shafer, 2005; Folster et al., 2007).  
1.10.8 VceR 
Vibrio cholerae is the causative agent of cholera, which is characterized by a severe 
watery diarrhea, through colonizing the small intestine and producing cholera toxin 
(Faruque et al., 1998). Multi-drug resistant V. cholerae, which were first reported in 
1980, has been a leading cause of cholera outbreak in the following two decades 
(Glass et al., 1980; Faruque et al., 1998). The active expulsion of antibiotics, 
catalyzed by efflux pumps, is an important resistance mechanism in V. cholera 
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(Faruque and Nair, 2008) and consequently the study of these efflux pumps and their 
regulation could contribute to combating multidrug resistant V. cholerae. 
The vceCAB genes of V. cholerae encode a tripartite drug pump that consists of an 
inner-membrane protein (IMP) VceB, a periplasmic membrane fusion protein (MFP) 
VceA and an outer-membrane protein (OMP) VceC, which is a homologue of the 
EmrAB/TolC multiple-drug resistance transporter found in E. coli (Borges-Walmsley 
et al., 2005; Federici et al., 2005; Woolley et al., 2005). 
VceR, which belongs to the TetR family of transcriptional regulators, negatively 
regulates the vceCAB operon, by binding to a 28 bp inverted-repeat within the vceR-
vceC intergenic region (Borges-Walmsley et al., 2003). Using size-exclusion 
chromatography (SEC) and dynamic light-scattering, VceR was shown to bind the 
vce promoter as a tetramer. It is thought that VceR binds the vce promoter in a 
similar manner to the binding of QacR to the qacA promoter, which binds a pair of 
homodimers to a 28 bp inverted repeat within the promoter.  
 
The role of the vceR-vceABC operon in conferring antibiotic resistance has been 
established from several studies. Knocking-out vceR in V. cholerae increased the 
resistance of the cells to CCCP (carbonyl cyanide m-chlorophenyl-hydrazone) and 
deoxycholate (Alatoom, et al., 2007). On the other hand, a plasmid carrying the 
vceAB genes conferred resistance to CCCP, DOC, rifampicin, erythromycin, 
nalidixic acid and chloramphenicol in E. coli. The repressor VceR also binds CCCP 
that is the substrate of the VceCAB pump, inducing its release from the vceCAB 
promoter and allowing expression of the VceABC pump (Borges-Walmsley et al., 
2005). Figure 1.17 shows the the vceCAB operon and the vceR-vceC intergenic 
region. 
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Figure 1.17 Schematic representation of the vceRCAB operon. The 120 bp 
intergenic region is shown with vceR and vceC genes italicised. Predicted 
transcription signals are underlined and marker -35 and -10 with transcript initiation. 
28bp duplex bound by VceR is indicated in bold (Borges-Walmsley et al., 2005). 
 
Our knowledge of the repression and derepression mechanism of TetR family has 
largely come from structural studies of individual proteins and the TetR/DNA and 
QacR/DNA complexes (described in Section 1.20). In spite of the overall structural 
similarity of TetR and QacR, the induction mechanism and the mode of DNA 
recognition varies greatly in the TetR family. TetR binds as a dimer to a 15 bp 
inverted repeat, whilst QacR binds as a pair of dimers to a 28 bp inverted repeat. 
There would be value in determining the structure for additional members of the 
family, to obtain further information on the mechanism of operation. VceR shares 
low sequence identity with QacR (17.7%) and TetR (14.7%); and consequently the 
determination of the VceR/DNA complex structure could expand our understanding 
of the transcriptional repression mechanism in the TetR family. In addition, this 
complex structure could also reveal the drug binding domain of VceR, which has not 
been determined. Furthermore, the structure of the VceR/DNA complex might be 
useful in the design of small molecules to switch-off the expression of the drug pump 
as a strategy in combating drug resistance in V. cholerae.  
 58 
Chapter 2   Material and Method 
 
2.1 Computational methods 
 
Adobe Photoshop was used for modification of diagrams/illustrations.  Vector NTI 
Advance 10 (Invitrogen), was used for the analysis, and design of oligonucleotides 
and for the construction of alignments of DNA and protein sequences for comparison.  
 
The National Center for Biotechnology Information (NCBI, 
http://www.ncbi.nlm.nih.gov) was used as a resource for structural, functional and 
comparative analysis of genomes. The Protein Data Bank (http://www.RCSB.org) 
was used as a resource for protein structures. 
  
A secondary structure prediction server, NPS@ HNN secondary structure prediction 
(http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_hnn.html) was 
used to predict the secondary structure.             
 
2.2 Media, antibiotics and reagents 
 
General chemical reagents such as salts with analytical purity grade were acquired 
from Sigma (UK). Detergents n-dodecyl-β-D maltoside (DDM) and 10% Triton were 
purchased from Calbiochem. Reductive reagents Tris hydroxypropyl phosphine 
(THP) was purchased from Novagen and dithiothreitol (DTT) was purchased from 
Melford. 
 
2.2.1 Bacterial medium 
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The following bacterial media were prepared as described below and sterilised by 
autoclaving at 121
o
C for 20 min. 
 
Luria-Bertani medium 
Tryptone (Oxoid) 10 g 
Yeast extract (Oxoid) 5 g 
NaCl 10 g 
dH2O To 1000 ml 
 
Luria-Bertani agar 
LB medium 1 litre 
Agar (Merck) 15 g 
 
2X YT  broth 
Tryptone (Oxoid) 16 g 
Yeast extract (Oxoid) 10 g 
NaCl 5 g 
dH2O To 1000 ml 
 
SOC medium 
Tryptone (Oxoid) 4 g 
Yeast extract (Oxoid) 1 g 
NaCl 0.117 g 
KCl 0.0373 g 
dH2O To 200 ml 
After autoclaving, the following components were added: 
1 M MgCl2•6H2O 2 ml 
1 M MgSO4 2 ml 
 
 
2.2.2 Antibiotics 
 
Antibiotic stock solutions 
Antibiotic Concentration 
Working 
concentration 
Manufacturer 
Carbenicillin 
disodium 
100 mg/ml in dH2O 100 µg/ml 
Melford 
laboratories 
All antibiotics were filter-sterilised, with a 0.2 µm filter, and stored in 1 ml aliquots 
at -20
o
C 
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2.2.3 Reagents 
 
Reagent stock solutions 
Reagent Concentration Manufacturer 
IPTG 1 M in dH2O Melford laboratories 
IPTG 200 mg/ml in dH2O Melford laboratories 
X-gal 
20 mg/ml in N,N‘ –
dimethylformamide (DMF) 
Melford laboratories 
L-arabinose 20% in dH2O Sigma 
IPTG and L-arabinose were filter-sterilised, with a 0.2 µm filter, and stored 
in 1 ml aliquots at -20oC 
 
2.3 Bacterial strains and plasmids 
 
The bacterial strains and plasmids used in this study are listed in Table 2.1. 
Cryogenic stocks were generated by mixing 800 l of an overnight culture with 200 
l of sterile 80% glycerol in sterile 2 ml cryogenic vials and stored at -80oC. Samples 
were retrieved by scraping and streaking a small amount of the frozen stock, with a 
sterile loop, and then plating onto solid growth medium for incubation at 37
o
C 
overnight. 
 
Table 2.1 Bacterial strains  
Strain Key feature(s) Source/Reference 
E. coli NovaBlue (DE3) 
 
endA1 hsdR17 (rk12-mk12+) 
supE44 thi-1 recA1 
gyrA96 relA1 lac 
[F‘proA+B+ 
lacI
qZΔM15::Tn10(tetR)]; 
for cloning, plasmid preps 
Novagen 
E. coli BL21 (DE3) F
-
 ompT hsdSB(rB
-
mB) gal 
dcm met (DE3); for protein 
expression 
Novagen 
XL10-Gold Tet
R
 Δ (mcrA) 183 Δ 
(mcrCB-hsdSMR-mrr) 
173 endA1 supE44 thi-1 
recA1 gyrA96 relA1 lac 
Hte [F‘ proAB 
lacl
qZΔM15 Tn10 (TetR) 
Amy Cam
R
]
a
 
Stratagene 
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Table 2.2   Plasmids 
 
Plasmid Key feature(s) Source/Reference 
pGEM-T easy Ampicillin resistance; for 
TA cloning 
Promega 
pET21a(+) N-terminal T7-tag and C-
terminal His6-tag; For 
protein expression; 
Ampicillin resistance. 
Novagen 
VceR-His6-pET21a(+) vceR ligated with 
pET21a(+) using NdeI and 
XhoI restriction 
endonuclease sites with C-
terminal His6-Tag, for 
VceR-His6 expression 
Borges-Walmsley et al., 
2005 
 
2.4 Cloning genes to pGEM-T easy vector 
 
2.4.1 DNA amplification by PCR (polymerase chain reaction) 
 
PCR (polymerase chain reaction) was used to amplify genes from genomic DNA or 
to certify inserted genes in plasmids used in this study. Primers (Table 2.2) were 
designed with restriction endonuclease sites and synthesized by Invitrogen. Usually, 
primers were reconstituted in distilled water to a concentration of 50 pmol/µl. 
 
Table 2.3  The oligonucleotides for PCR used in this study. 
Oligonucleotide Sequence 
NdeI- hpa1 
Forward* 
CAT ATG AAT TCT TTG AAC ACA CAA TTC GGC 
XhoI- hpa1 
Reverse 
CTC GAG CTG CAT CGA TCC GCT GTC GTT CG 
 NdeI-163-414-
hpa1 Forward 
CAT ATG CAG CCG AAC AAA AAT GCT GAG GAA GG 
XhoI-1-158-hpa1 
Reverse 
CTC GAG GCC ATT CTC CTT CCC GGC CTG CTG 
    *Note: Sequences in bold indicate restriction endonuclease sites.   
 
PCR was carried out according to the manual of the product providers. A typical 
reaction composition is given below. 
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Master mix Component Volume (μl) Final concentration 
10xPCR Buffer 
(containing 15 mM 
MgCl2) 
5 1x 
dNTP mix (10 mM of 
each) 
1.5 
200 μM of each dNTP 
F primer 1 50 pmol/μl 
R primer 1 50 pmol/μl 
HotStar Taq DNA 
Polymerase (Qiagen) 
0.5 2.5 units/reaction 
Distilled water (dH2O) 41 - 
Colony DNA Variable ≤1 μg/reaction 
Total volume 50 - 
  
A thermal cycler (Eppendorf mastercycler gradient) was programmed for the PCR 
reaction as follows: 
 
Cycle Temperature Time 
Activation of HotStar Taq 
DNA polymerase 
95
o
C 15 min 
Denaturation 94
o
C 1 min 
Annealing 58
o
C 1 min 
Extension 72
o
C 50 sec 
Number of cycles 34 
Final extension 72
o
C 10 min 
Hold 4
o
C Indefinitely 
 
The amplified DNA samples were stored at -20
o
C.  
 
2.4.2 Gel electrophoresis  
 
For positive identification of the DNA, 10 μl of the amplified DNA plus 2 μl of a 6x 
DNA loading buffer, together with a 1 kb DNA marker (Invitrogen) was loaded on a 
1% agarose gel containing ethidium bromide and electrophoresed for 35 minutes at 
120 volts. The gel was visualised on a UV transilluminator (Gene, BioImaging 
System, Syngene) equipped with a camera to capture an image of the gel.  
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DNA Gels 
 
1% Agarose gel 
Laboratory grade agarose 1% 
Ethidium bromide 0.004% 
1x TAE buffer 100% 
 
DNA Buffers 
 
1x TAE buffer 
Tris-HCl 4.84 g 
Acetic acid 1.142 ml 
0.5 mM EDTA 2 ml 
dH2O To 1000 ml 
 
6x DNA loading buffer 
Bromophenol blue 0.025 g 
100% Glycerol 3 ml 
dH2O 7 ml 
 
  
2.4.3 Gel extraction of DNA  
 
The DNA was excised from the gel and 300 μl buffer QG from QIA quick gel 
extraction kit was mixed with it. After 10 min incubation at 50
o
C, dissolved gel was 
loaded to QIAquick spin column and centrifuged for 1 min. 0.75 ml buffer PE was 
added to QIAquick column and centrifuged for 1 min. Finally, 50 μl buffer EB (10 
mM Tris-Cl, pH 8.5) was used to elute the DNA from the column. 
   
2.4.4 Ligation into pGEM-T easy vector (Promega) 
 
All components were added, in order as listed below, to a 0.5 ml microcentrifuge 
tube. The ligation mixture was stored at 4
o
C overnight (for maximum transformants) 
for transformation the following day.  
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Component Volume (μl) 
2 x Ligation buffer 7.5 
pGEM-T easy  vector 1.5 
PCR product 4.5 
T4 DNA ligase 1.5 
                                                                                     Total Volume = 15 μl 
 
2.4.5 Preparation of chemically competent E. coli 
 
A chemical method for the induction of competence in E. coli is described as follows. 
A single colony was used to inoculate 5ml liquid LB medium and incubated 
overnight at 37
o
C with 225 rpm rotary agitation. A millilitre of overnight culture was 
used to inoculate 50 ml of pre-warmed liquid LB medium in a 250 ml flask. The cells 
were incubated at 37
o
C with 220 rpm rotary agitation until an optical density at 600 
nm (OD600) of 0.5 was reached. The culture was cooled on ice for 5 minutes, 
harvested at 4,000×g for 5 minutes at 4
o
C and the supernatant carefully discarded. 
The bacterial cell pellet was resuspended in 30 ml cold, sterile TFB1 buffer and the 
suspension kept on ice for 90 minutes. The cells were harvested at 4,000×g for 5 
minutes at 4
o
C, and the supernatant discarded. The cell pellet was resuspended in 2 
ml cold TFB2 buffer
 
and kept on ice for a further 45 minutes. Following this 
incubation period, competent cells were harvested furthermore as described 
previously and resuspended in 2 ml cold TFB2 buffer. Aliquots of 50 l were 
transferred to 1.5 ml microcentrifuge tubes and flash frozen in a dry ice/ ethanol bath. 
Chemically competent cells were stored at -80
o
C. 
 
TFB1 buffer – 100 mM rubidium chloride, 50 mM manganese chloride, 30 mM 
potassium acetate, 10 mM calcium chloride, 15% glycerol, pH 5.8. 
TFB2 buffer- 10 mM MOPS, 10 mM rubidium chloride, 75 mM calcium chloride, 
15% glycerol, pH 6.8.  
 
2.4.6 E. coli strain NovaBlue transformation 
 
4 μl of the pGEM-T-gene ligation mixture was added to a 50 μl aliquot of NovaBlue 
competent cells (prepared as section 2.4.5). The transformation mixture was 
incubated on ice for 30 min, a 42
o
C water bath for 50 seconds, and incubated on ice 
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for a further 2 min. 250 μl of SOC medium was added to the cells and incubated at 
37
o
C with 250 rpm shaking for 90 minutes. 100 μl of cells were spread onto 
LB/carbenicillin (LB/Carb) medium (plus IPTG [200 mg/ml] and X-gal [20 mg/ml]) 
and incubated at 37
o
C overnight. 
 
Plates from the above transformation were stored at 4
o
C for 3 hours to allow the 
blue/white colour in the colonies to fully develop. Blue colonies contained active 
galactosidase whilst the white colonies were thought to harbour the recombinant 
plasmids. Nine white colonies were re-streaked onto an LB/Carb plate and incubated 
at 37
o
C overnight for PCR identification of positive recombinants the following day.  
 
2.4.7 Purification of plasmid DNA [pGEM-T-easy-gene]   
 
Overnight cultures of E. coli NovaBlue were harvested by centrifugation (Jouan 
CR3i centrifuge) at 4,000 rpm for 10 minutes at 4
o
C. Plasmid DNA was prepared as 
instructed in the QIA prep
®
 Miniprep Handbook. The eluted plasmid DNA was 
stored on ice or at -20
o
C. 
 
10 μl of the pGEM-T-easy-gene plasmid was sent to the University of Durham (DBS 
Genomics) to ensure sequence integrity. The sequencing result was aligned with the 
original gene sequence using Vector NTI Advance 10 (Invitrogen). 
 
2.5 Subcloning of desired genes into pET21a(+) for protein expression 
  
2.5.1 Restriction enzymes digestion of pGEM-T-easy-gene and pET21a (+) 
 
The components, as listed below, were added to a 0.5 ml microcentrifuge tube and 
incubated at 37
o
C for 3 hours. The restriction endonuclease I and restriction 
endonuclease II (Promega) were then heat inactivated at 65
o
C for 15 min. The 
samples were stored at 4
o
C. 
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pGEM-T-easy-gene 
Component Volume (μl) 
dH2O 4.5 
10x Buffer 5 
Bovine serum albumin (BSA) 0.5 
Restriction endonuclease I 2.5 
Restriction endonuclease II 2.5 
pGEM-T-gene 25 
                                                                                Total volume = 40 μl 
 
pET21a(+) 
Component Volume (μl) 
dH2O 15.5 
10x Buffer 5 
 BSA 0.5 
Restriction endonuclease I 2 
Restriction endonuclease II 2 
pET21a(+) 25 
                                                                                 Total volume = 50 μl 
 
 
2.5.2 Identification and purification of DNA and linear pET21a (+)  
 
Performed as described in sections 2.4.2 and 2.4.3.  
 
2.5.3 Ligation of pET21a(+) and desired DNA 
 
All components were added, in order as listed below, to a 0.5 ml microcentrifuge 
tube. The ligation mixture was stored at 4
o
C for 12 hours (for maximum 
transformants) for transformation the following day.  
 
Component Volume (μl) 
10 x Ligation buffer 1.5 
pGEM-T easy  vector 1.5 
PCR product 4.5 
T4 DNA ligase 1.5 
                                                                 Total volume = 15 μl 
 
 2.5.4 E. coli strain NovaBlue transformation with pET21a (+)-gene 
 
Performed as described in section 2.4.6 with the following changes:  
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5 μl of pET21a(+)-gene was added to 150 μl of competent E. coli NovaBlue cells 
(prepared as section 2.4.5); 1 ml of SOC medium was added following heat shock 
and no blue/white selection was required.  
 
2.5.5 Analysis of putative pET21a (+)-gene colonies by PCR 
 
Performed as described in sections 2.4.1 and 2.4.2  
 
2.6 Site directed mutagenesis 
 
The in vitro site directed mutagenesis experiments in this thesis were performed as 
described using the QuikChange site-directed and multi site-directed mutagenesis 
system (Stratgene). The mutagenic primers were designed to incorporate a centrally 
located desired point mutation in specific amino acid sites (Table 2.4).   
 
Table 2.4 Mutagenic oligonucleotides used for site directed mutagenesis. 
 
Oligonucleotide Sequence 
  hpa1-C47S 
Forward*  
5‘-CTGGACCAGTTGCTGAGCCAGCTCATCCAGGCCCTG -3‘ 
  hpa1-C47S 
Reverse 
5‘-CAGGGCCTGGATGAGCTGGCTCAGCAACTGGTCCAG-3‘  
vceR-C148S- 
Forward 
5‘-TGTGGTTCATTGAAAGAGAGCGATCCTTGGATCGCC-3‘ 
vceR-C148S-
Reverse 
5‘GGCGATCCAAGGATCGCTCTCTTTCAATGAACCACA-3‘ 
vceR-C138S-
C142S-Forward 
5‘-GTCGCTACATTACGTCGCAAATTGAAAGCGGTTCAC 
TGAAAGAG-3‘ 
vceR-C138S-
C142S-Reverse 
5‘-CTCTTTCAGTGAACCGCTTTCAATTTGCGACGTAATGT 
AGCGAC-3‘ 
vceR-H156R-
Forward 
 5‘-CCTTGGATCGCCGCCATGAGATTCAAAGCGTTGCTA-3‘ 
vceR-H156R-
Reverse 
5‘-TAGCAACGCTTTGAATCTCATGGCGGCGATCCAAGG-3‘ 
*Note: Sequences in bold indicate mutation sites.   
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Mutant strand synthesis reaction was carried out according to the manual of the kit. 
A typical reaction composition is given below. 
 
Master mix Component   Volume (μl)  Final concentration  
10x reaction buffer 5 1x 
dNTP mix 1 200 μM of each dNTP 
F primer 1.25 2.5 ng/μl 
R primer 1.25 2.5 ng/μl 
PfuTurbo DNA 
polymerase 
1 0.05 units/reaction 
dsDNA template X μl (5-50 ng) - 
Distilled water (dH2O) Variable  
Total volume 50 - 
 
A thermal cycler (Eppendorf mastercycler gradient) was programmed for 
mutagenesis reaction as follows:  
 
Cycles Temperature Time 
1 95
 o
C 30 seconds 
12-18 95
o
C 30 seconds 
 55
o
C 1 min 
 68
o
C 1 minute/kb of plasmid 
length 
 
Dpn I restriction enzyme was added to the mutagenesis reaction to digest the parental 
supercoiled dsDNA. The Dpn I-treated DNA was transformed into XL1-Blue 
supercompetent cells for site-directed mutagenesis or XL1-Gold supercompetent 
cells for multi site-directed mutagenesis. The desired mutation was sequenced for the 
final usage. 
 
2.7 Protein expression, purification and visualization 
 
2.7.1 Expression of cloned genes in E. coli BL21 (DE3) 
 
A single colony from a freshly streaked plate was picked and inoculated into 100 ml 
LB broth containing the appropriate antibiotic(s) in a 250 ml flask. The cells were 
grown in an orbital shaker at 37
 o
C, 220 r.p.m. overnight. One litre of prewarmed 
2×YT broth (with antibiotic) in a 2 litre baffled flask was inoculated with 5 ml of the 
overnight cultures. 6 litres of the cells were grown in an orbital shaker at 37
 o
C, 220 
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rpm. The cells were induced at mid log phase (approx. A600=0.5-0.6) with 0.5 mM 
IPTG. The temperature was dropped to 30
 o
C and the growth was continued with 
shaking at 200 rpm for 5 hours for soluble proteins or overnight for membrane 
proteins. The cells were harvested by centrifugation and stored as a frozen pellet at -
80
 o
C or continued with purification.  
 
2.7.2 Purification of His6-tagged proteins by Ni-NTA affinity chromatography 
  
Frozen cell pellets were typically resuspended with 200 ml buffer (25 mM Tris-HCl, 
300 mM NaCl, pH7.5). One EDTA-free protease inhibitor tablet (Roche Molecular 
Biochemicals) was added to inhibit protease activity. The cells were lysed by 
mechanical disruption in a constant cell disruption system (Constant Systems Ltd) at 
a pressure of 27 kpsi two times. The cell lysate was fractionated into membrane and 
soluble components by high-speed ultracentrifugation at 43,000 rpm for 1 hour 
(Beckman Ti-50 rotor). For membrane proteins, the membrane pellet was 
resuspended in buffer A and solubilised using 1% DDM. High-speed 
ultracentrifugation at 43,000 rpm for 1 hour (Beckman Ti-50 rotor) was performed to 
separate the soluble protein-detergent complex from membrane lipids. 
The soluble component or soluble protein-detergent complex was, after high-speed 
ultracentriguation, loaded onto a Ni-NTA column (GE Healthcare).  The column was 
washed with buffer containing 50 mM imidazole to remove contaminant proteins. 
The protein was eluted with buffer containing 500 mM imidazole. 
   
2.7.3   Purification of recombinant proteins by gel filtration chromatography 
 
Gel filtration chromatography was used to purify the proteins, initially purified by 
Ni-NTA affinity chromatography. HiLoad 16/60 Superdex 200 prep grade and 
HiLoad 16/60 Superdex 75 prep grade columns (GE Healthcare) were used in this 
study. 
 
The column was equilibrated with three column volumes of dH2O at 30 cm/h (1 
ml/min), and three column volumes of buffer at 30 cm/h (1 ml/min). The sample was 
injected into the column and eluted with 1.5 column volumes of buffer. Purified 
samples were collected on a fraction collector (GE Healthcare) for SDS-PAGE 
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analysis. After purification, the column was washed with 2 column volumes of dH2O 
and then with 2 column volumes of 20% ethanol for long storage. All buffers and 
water were filter-sterilised, with a 0.22 µm filter, and degassed.   
 
 2.7.4 Ion-exchange chromatography 
  
Ion-exchange chromatography was also used to purify proteins and performed using 
an AKTA purifier (GE Healthcare). A HiTrap Q HP 5 ml column (GE Healthcare) 
was utilised in this study. The column was stored with 20% ethanol. Firstly, the 
column was rinsed with five column volumes of dH2O and then equilibrated with 
start buffer to change sample buffer into start buffer. Samples were pumped into the 
column and washed with 3 column volumes of start buffer. A NaCl gradient elution 
was performed with start buffer and elution buffer. Proteins were monitored by UV 
280 nm and collected for SDS-PAGE analysis. All buffers and water were filter-
sterilised, with a 0.22 µm filter and degassed.   
 
2.7.5   SDS-PAGE 
 
All SDS-PAGE (Sodium dodecyl sulfate polyacrylamide gel electrophoresis) 
experiments were performed using the NuPAGE
®
 Novex pre-cast gels and XCell 
SureLock mini-cell (Invitrogen). The NuPAGE
®
 LDS sample buffer (4X) (Invitrogen) 
was used for preparing samples for denaturing gel electrophoresis with the 
NuPAGE
®
 gels. SeeBlue
® 
prestained standard (Invitrogen) was added to the gels to 
indicate the molecular weight of the proteins. After electrophoresis in MES buffer, 
gels were incubated in a staining container containing 100 ml of staining buffer and 
gently shaken for 30 minutes at room temperature on an orbital shaker. The stain 
buffer was decanted and the gel was rinsed once with deionized water. Then the gel 
was placed in a staining container with 100 ml of destain buffer and gently shaken at 
room temperature on an orbital shaker until the desired background was achieved. 
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MES buffer 
MES 9.76 g 
Tris-base 6.05 g 
SDS 1 g 
EDTA 0.29 g 
Add dH2O to 1 L 
 
Protein staining solutions  
Coomassie blue stain buffer 
Acetic acid 33% 
Methanol 33% 
dH2O 33% 
Coomassie brilliant blue R-250 0.1% 
 
Destain buffer 
Acetic acid 10% 
Methanol 10% 
dH2O 80% 
 
2.7.6 Western blotting 
 
Transfer buffer Wash buffer 
Glycine 2.9 g 1 M Tris-HCl, pH 7.5 10 ml 
Tris base 5.8 g 5 M NaCl 30 ml 
Methanol 200 ml Tween 20 1 ml 
SDS 0.37 g dH2O   to 1000 ml 
dH2O   to 1000 ml   
 
 
The protein samples were run with SeeBlue markers (Invitrogen) on NuPAGE
®
 
Novex pre-cast gels. The gel was soaked in the methanol-transfer buffer for 15-30 
minutes. The blotting cassette holds the gel and the PVDF membrane 
(Polyvinylidene fluoride, 0.2 µm, Bio-Rad) while a nylon sponge and of the 
Whatman chromatography paper (3 MM) on both sides provide complete contact 
within the gel sandwich. The cassette was inserted vertically into the blotting tank. 
 
The blotting tank was topped up with transfer buffer and electroblotted at 170 mA 
for 1 hour. Then the blotted gel was stained with coomassie blue stain buffer (section 
2.7.5) to confirm successful transfer. The PVDF membrane was transferred to 25 ml 
of blocking buffer (wash buffer plus 3% BSA) in a square Petri dish, the PVDF 
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membrane was blocked for 90 minutes at room temperature with gentle agitation, 
and then was stored at a 4 
o
C overnight. The PVDF membrane was washed three 
times with wash buffer at room temperature, for five minutes each time. The PVDF 
membrane was incubated with the first antibody (1:3000 dilution) in 25 ml fresh 
blocking buffer (wash buffer plus 0.5% BSA and 8 μl monoclonal antipolyhistidine 
antibody, Sigma) at room temperature for 1 hour. The PVDF membrane was rinsed 
in wash buffer three times, for 10 minutes each time, and incubated with the second 
antibody (1:3000 dilution) in 25 ml fresh blocking buffer (wash buffer plus 0.5% 
BSA and 8 μl goat anti-mouse IgG- AP [Alkaline Phosphatase conjugate], Sigma) at 
room temperature for 1 hour. The PVDF membrane was rinsed in wash buffer three 
times, for 10 minutes each time. The PVDF membrane was transferred to a sheet of 
cling film and 2 ml substrate (Immun-Star
TM
 AP substrate, Bio-Rad) was added. The 
PVDF membrane was wrapped with the film and left on bench for 5 minutes. The 
PVDF membrane was transferred to between two sheets of plastic and taped around 
four sides in an autorad cassette. In the dark room, a sheet of X-ray film was inserted 
and left for 1 minute. An XO Graph imaging systems compact X4 film processor was 
used to fix and develop the X-ray film. 
 
2.7.7 Protein dialysis 
 
Slide-A-Lyzer
®
 dialysis cassettes (Pierce) were utilized in this study to change the 
protein buffer. Different cassette volumes of 0.1-0.5 ml, 0.5-3 ml or 3-15 ml were 
selected according to the sample volume. The protein samples were collected with a 
syringe and injected into hydrated cassettes, which were left in dialysis buffer with 
gentle stirring at 4
 o
C for 2 hours. This procedure was repeated after changing the 
buffer once. Finally, the samples were recovered from the dialysis cassettes. 
 
2.7.8 Protein concentrating 
 
The protein samples were concentrated using the disposable ultrafiltration device 
Vivaspin concentrators (Viva Science). The samples were pipetted into the 
concentrators and spun (Beckman, Avanti™ J-20 XP, JA-10 rotator, 15 ml tube 
adaptor) at low speed (usually 3000 g). Then the samples were recovered from the 
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bottom of the concentrating pocket with a pipette, once the desired concentration was 
achieved. 
 
2.7.9 Protein concentration determination 
 
The BCA™ protein assay kit (Pierce) was used to determine the protein 
concentration. The ‗test tube procedure‘ for this kit (Pierce) was adopted according 
to the instructions, which was summarized as follows. 0.1 ml of each standard and 
unknown protein sample and 2 ml of the reagent were added to each tube and mixed 
well. The tubes were incubated at 37°C for 30 minutes and the 562 nm absorbance 
measurement of each standard and protein sample was performed. A standard curve 
was prepared by plotting the average 562 nm measurement for each BSA standard vs. 
its concentration in μg/ml. Then the standard curve was used to determine the protein 
concentration of each unknown sample. 
 
2.8   Analytical gel filtration chromatography 
 
The analytical gel filtration chromatography column Superdex 200 PC 3.2/30 column 
(GE Healthcare), and high and low molecular weight gel filtration kits (GE 
Healthcare) were used to determine the molecular weight of proteins. To determine 
the Mr of proteins, a calibration curve was constructed (Microsoft Office Excel 2003), 
using bovine serum albumin (62.9 kDa), ovalbumin (46.7 kDa), catalase (213 kDa) 
and adolase (182 kDa) as standards for a plot of the log of the Mr of the standards 
versus Kav. The Kav values of the protein standards were calculated as follows: 
 
Kav= (Ve-Vo)/(Vt-Vo), 
Ve = elution volume for the protein 
Vo = column void volume 
    = elution volume for blue dextran 200 (From high and low molecular weight gel 
filtration kits) 
Vt = total bed volume, 2.4 ml for Superdex 200 PC 3.2/30 column 
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After purification, the column was rinsed with 3 column volumes of dH2O and then 
with 2 column volumes of 20% ethanol for long storage. All buffers and water were 
filter-sterilised, with a 0.22 µm filter, and degassed.   
   
2.9 Peptide synthesis 
Peptide 1 (H2N-ISEKQLDQLLCQLIQALL-COOH) and peptide 2 (H2N-
ASPLTQMLMNIVGEILQAQ-COOH) used in the study were synthesized, purified 
and analysed by mass spectrometry by Genscript corporation (China). 
 
2.10 Transmission electron microscopy   
  
Transmission electron microscopy (TEM) was used to study fibril formation. 
Purified protein or synthesized peptides were diluted to a low concentration; 10 µl 
samples were loaded onto a carbon-coated grid (Agar scientific, UK) and incubated 
at RT for 1 min. After drying, 1% uranyl acetate solution was used as stain, and 
loaded to carbon-coated grids for 30 sec. Prepared samples were displayed under a 
transmission electron microscope (TEM-H7600, Hitachi) at an accelerating voltage 
of 100 keV.  
 
2.11 Circular dichroism spectroscopy 
 
Circular dichroism (CD) spectroscopy was used to study the secondary structure of 
proteins. The spectra of prepared samples and the corresponding blanks were 
recorded between 190 and 260 nm on a spectropolarimerter (Jasco J-810) using 
quartz cells with a 2 mm path length at 27
 o
C. After the subtraction of the appropriate 
blank, binominal smoothing was carried out within the Jasco Spectra analysis 
program. The resulted spectra were analysized by program Selcon3 via Dichroweb 
(Whitmore and Wallace, 2004). The protein reference set (dataset 4 from Dichroweb) 
was used. 
 
2.12 Congo red (CR) binding and chemical cross-linking 
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A Congo red binding assay was carried out as described previously (Oh et al., 2007). 
Congo red (Sigma) was prepared in a buffer of 20 mM Tris-HCl pH 8.5, and 20 mM 
NaCl. Absorbance spectra in the region between 400 and 700 nm were recorded for a 
100 µM Hpa1 fibril and 20 µM Congo red mixture and for Cong red using a Jasco V-
550 spectrophotometer. 
 
Proteins were dialyzed against the cross-linking buffer (20 mM Na2HPO4, pH 8.5, 
100 mM NaCl) for 6 h. DSP (Dithiobis [succinimidyl propionate]) or EGS 
(EthylGlycol bis [succinimidyl succinate]) was added to a final concentration of 0.5 
mM. After incubation for 30 min at 37
 o
C, 1 M Tris pH 8.5 was added to a 
concentration of 20 mM to stop the reaction. The effect of Ca
2+
 and E. coli liposomes 
on the oligomerization of Hpa1-His6 was tested, in the presence of 2 mM CaCl2 and 
0.1 mg E. coli liposome, respectively and together. The samples were loaded onto a 
12%  SDS-PAGE gel and stained with coomassie brilliant blue. 
 
2.13 Liposome disruption assay 
 
1 ml of 10mg/ml E. coli polar lipid extract (Avanti
®
, component: 
phosphatidylethanolamine, phosphatidylglycerol, cariolipin) was dried under the 
steam of nitrogen to form a thin film. The dried lipid was rehydrated in 1ml of MES 
buffers (20 mM MES, 20 mM NaCl, pH 6.5) by vortexing. The lipid was heated to 
50
 o
C for complete rehydration. The lipid was further passed through the extruder 
(Avanti
®
) with 400 nM polycarbonate membrane filter (Whatman
®
) at 50
 o
C to 
produce unilamellar vesicles. 100 µM purified soluble Hpa1, N-terminal truncated 
Hpa1 and peptide 2 were incubated with 500 µl 5 mg/ml liposomes, respectively, for 
6 h at room temperature.  
 
For membrane protein reconstitution into membrane, 10% Triton X-100 
(Calbiochem
®
) was added to the liposome with a final molarity of 1.5 mM.  100 µl of  
0.4 mg/ml protein sample was added to 1 ml of 2 mg/ml destabilized liposomes to 
give a final lipid to protein ratio of 50:1 (w/w) and incubated with shaking at 25
 o
C 
for 15 min. 40 mg Bio-bead SM-2 absorbent (Bio-Rad
®
) was added to the protein 
and liposome solution and shook at 25
 o
C for 30 min. The solution was removed and 
transferred to a 1.5 ml micro-centrifuge tube containing 80 mg Bio-beads and 
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incubated at 25
 o
C for 60 min with shaking. This step was repeated and incubated at 
4
 o
C overnight. The proteoliposomes were pelleted by centrifugation at 43000 rpm at 
4
 o
C for 1 hour and resuspended in 0.5 ml phosphate buffer.  
 
Liposomes disrupted by soluble Hpa1, N-terminal truncated Hpa1 and peptide 2, and 
the resuspended proteoliposome of Hpa1 and C47S were displayed under a 
transmission electron microscope (TEM-H7600, Hitachi) at an accelerating voltage 
of 100 keV by the negative staining  with a 1% uranyl acetate solution on carbon-
coated grids (Agar scientific, UK) (section 2.10). 
 
For sucrose gradient centrifugation, a 500 µL sample (protein-liposome mixture) was 
mixed with 3.5 ml 70% (w/w) sucrose and subsequently by overlaying 6.5 ml 55% 
and 2 ml 10% sucrose solution onto the protein-liposme-sucrose mixture. 
Centrifugation was performed in a Beckman SW55 rotor at 32 000 r.p.m. for 16 h at 
4
 o
C. Fractions were collected from the 70% and 10% sucrose layers and aliquots 
were separated by 12.5% SDS/PAGE. The bands were detected with coomassie blue 
staining.  
  
2.14 Protein crystallization 
 
The purified, concentrated and quantified protein was submitted to crystallization 
trials. The screening was performed by Screenmaker from Innovadyne.  85 µl 
crystallization buffer was transferred into a reservoir and two sitting drops were set 
up, 200 nl complex plus 100 nl precipitating solution and 100 nl complex plus 100 nl 
precipitating solution.   
 
Kits used for VceR/dsDNA co-crystallization screen: 
(1) Cryo I & II from Emerald 
(2) JCSG-plus from Molecular Dimensions 
(3) The PEGs suite from Qiagen 
(4) Clear strategy screen from Molecular Dimensions 
 
For crystallization condition optimization, the experiments were set up manually 
according to the hanging drop vapour diffusion method, using a 24 well plate (24 
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crystallization buffer wells) with 24 crystallization supports (six protein wells for 
holding crystallization buffers and proteins), or the sitting drop vapour diffusion 
method using a 24 well plate with bridge and cover slip. All the buffers and 
precipitants were purchased from Sigma, Fluka and Hampton. An additive kit was 
obtained from Hampton.  
 
Crystallization solution (0.5ml) was pipetted to the bottom of the plate well. 1µl 
protein sample and 2 µl crystallization buffer were mixed and the mixture was 
transferred to the protein well of the crystallization support. The crystallization 
support was screwed into place above the well from which the crystallization buffer 
was taken. The crystallization trial plates were incubated at 20
 o
C, 18
 o
C or 4
 o
C 
(Cooled Incubators, Rumed
®
) for two weeks or longer, depending on the growth rate 
of crystals. Stereo zoom microscope (Leica, MZ125) was used in this study to 
observe the crystals. A digital camera (Nikon, coolpix 4500) was used to take photos 
of crystals.  
 
An additive screen kit (Hampton Research) was utilized to search for additives to 
improve the crystal shape and/or quality. This kit evaluates the factors of multivalent 
cations, salts, amino acids, dissociating agents, linkers, polyamines, chaotropes, co-
factors, reducing agents, polymers, chelating agent, carbohydrates, polyols, non-
detergents, amphiphiles, detergents, osmolyte and organic agents (Hampton 
Research). 0.3 µl of each additive from the kit was added into the crystallization 
drops, consisting of 1 µl protein and dsDNA mixture and 2 µl reservoir buffer. After 
incubation at 4
 o
C for 4 weeks, all 96 drops with 96 additives from the kit were 
compared to find out the suitable additives for the VceR/dsDNA crystallization. 
 
2.14.1 Selenomethionine protein over-expression and purification for phasing 
 
The medium (medium base, nutrient mix, methionine solution and selenomethinone 
solution) was purchased from Molecular Dimensions and prepared as described in 
the instructions from the product. 
 
One colony was inoculated into a 100 ml culture containing L-methionine  and 
incubated at 37
 o
C in a shaking incubator over night. The cells were pelleted, washed 
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3 times in 100 ml of sterile water and resuspended in 1 ml sterile water. 1 L medium 
containing selenomethionine was inoculated with 1 ml resuspended cells and 
incubated with shaking until an OD600 of 0.5 was reached.  IPTG was added and 
cells were incubated for a further 6 hours before cell harvest. The purification of 
selenomethionine VceR follows the protocol in section 2.7.2 and 2.7.3. 
 
2.14.2 Oligonucleotides for VceR co-crystallization 
 
The oligonucleotides (Table 2.5) used for VceR co-crystallization were ordered from 
MWG and Sigma.  Oligonucleotides were delivered as lyophilised powder. Before 
use, oligonucleotides were dissolved in annealing buffer (10 mM Tris-HCl, pH 7.5, 
50 mM NaCl, 1 mM EDTA, 10 mM MgCl2). Complementary pairs of 
oligonucleotides were mixed, heated to 95
 o
C for 5 minutes and cooled down 
overnight in a heat block. All oligonucleotide duplexes used in VceR co-
crystallization are summarized in Table 2.5. 
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Table 2.5  The oligonucleotide duplexes used for VceR/DNA co-crystallization 
 
 
P56 
5‘-AGTATAACTGTACGGTACGGTTTAGTTATA-3‘ 
3‘-TCATATTGACATGCCATGCCAAATCAATAT-5‘ 
 
P56-1 
5‘-  TATAACTAAACGGTACGGTTTAGTTATA-3‘ 
3‘-  ATATTGATTTGCCATGCCAAATCAATAT-5‘ 
  
P56-2 
5‘- TATAACTGTACGGTACGGTACAGTTATA-3‘ 
3‘- ATATTGACATGCCATGCCATGTCAATAT-5‘ 
 
P56-3 
5‘-  TATAACTGTACGGTACGGTTTAGTTATA-3‘ 
3‘-  ATATTGACATGCCATGCCAAATCAATAT-3‘ 
 
P56-4 
5‘-    AGTATAACTGTACGGTACGGTTTAGTTATAA-3‘ 
3‘- TTCATATTGACATGCCATGCCAAATCAATAT -5‘  
 
P56-5 
5‘-   AGTATAACTGTACGGTACGGTTTAGTTATA    -3‘ 
3‘-TTCATATTGACATGCCATGCCAAATCAATATT-5‘ 
 
P56-6 
5‘-     TATAACTGTACGGTACGGTTTAGTTATAAG-3‘  
3‘-CTATATTGACATGCCATGCCAAATCAATAT     -5‘  
 
P56-7 
5‘-AGTATAACTGTACGGTACGGTTTAGTTATAA -3‘  
3‘ TCATATTGACATGCCATGCCAAATCAATATT-5‘  
 
P56-28 
5'- TATAACTAAACGGTACCGTTTAGTTATA-3' 
3'- ATATTGATTTGCCATGGCAAATCAATAT-5' 
 
P56-27 
5'-TATAACTAAACGGTACCGTTTAGTTAT-3‘ 
3'-ATATTGATTTGCCATGGCAAATCAATA-5' 
 
P56-26 
5‘-ATAACTAAACGGTACCGTTTAGTTAT-3‘ 
3‘-TATTGATTTGCCATGGCAAATCAATA-5‘ 
  
P56-24 
5‘-TAACTAAACGGTACCGTTTAGTTA-3‘ 
3‘-ATTGATTTGCCATGGCAAATCAAT-5‘ 
 
 
2.14.3 Data collection 
 
At the beginning of this work, crystals were tested at the laboratory of Professor Rick 
Lewis, Institute for Cell and Molecular Bioscience, the Medical School, Newcastle 
University, using the in-house diffractometer. All data sets were collected by Dr. 
Santina Russo (SLS) and Dr. Ehmke Pohl (Department of Chemistry, Durham 
University) at the Swiss Light Source (SLS) using X10SA (Pohl et al., 2006), X06D 
and X06SA; and Diamond Light Source using beamline 102. 
 
Several cryo-solutions (glycerol, saturated salt, PEG and sucrose) were screened to 
find the appropriate cryo-condition for crystal freezing in liquid nitrogen. To 
optimize the soaking time, seconds to minutes or sequential transfer of crystals from 
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low concentration of cryo-solution to a high one were tested. The rotation method 
was used in data collection. A typical data collection had a 1-2 second exposure time 
at the SLS or 10 second at the DLS, 0.5° or 1° per frame which is dependent on the 
survival of crystals from radiation damage.  
 
2.14.4 Data processing  
 
The HKL2000 program package (Denzo, Scala) (Otwinowski and Minor, 1997) was 
used to process data. The site definition containing the X-ray detector and camera 
information (the detector name, the goniostat misalignment, direction of rotation, 
detector orientation, X-ray beam properties) was obtained from the DLS or SLS 
beamlines. The autoindexing in Denzo was used to find the lattice system and refine 
the unit cell, beam and detector parameters. Each set of frames was integrated to 
obtain the intensity of each reflection. The diffraction intensities were scaled and 
symmetry-related reflections were merged to a reduced dataset of unique reflections.  
  
The fluorescence emission spectrum of the Se-VceR/DNA crystals or VceR/Br-DNA 
crystals was used to show the presence of Se or Br in the crystals and to select the 
wavelengths for MAD experiments. The f’ and f’’ values for Se and Br at peak, 
inflection point and high energy remote were obtained from 
http://skuld.bmsc.washington.edu/scatter/AS_form.html. Xprep (Bruker AXS, 
Madison, USA) was used to assess the anomalous signal of MAD (Multiple-
wavelength anomalous diffraction) or SAD (single-wavelength anomalous 
diffraction) data sets, and produce the input files for substructure determination. 
ShelxD (Schneider and Sheldrick, 2002; Sheldrick, 2008) was used to locate the 
heavy atom positions. The resolution cutoff in ShelxD is determined by finding 
where the correlation coefficient between the signed anomalous differences for two 
wavelengths falls below about 30%. Several parameters in ShelxD were used to 
indicate a good solution, most importantly CC (correlation coefficient between 
observed and calculated E values). Usually, for MAD, a CC of 40 to 50% indicates a 
good solution. 
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2.14.5 Structure solution 
 
The .sca files from HKL2000 were converted to mtz format in ccp4i by 
Scalepack2mtz, which were merged into one .mtz file by CAD in ccp4i 
(Collaborative computational project, Number4, 1994) with columns containing 
native and three wavelength data sets. The phases were calculated by Sharp 
(Bricogne et al., 2003), using 12 Se atom sites from ShelxD as input. The high 
energy remote data set was used as the reference for scaling, and the default setting 
of Sharp was used. Solvent flattening (54%) was run after phasing by DM (Cowtan, 
1994). Coot (Emsley and Cowtan, 2004) was used to show the electron density map 
and build the model manually. To obtain an initial poly-alanine model, the 
combination of position of Se sites within the secondary structures (predicted by the 
HNN secondary structure prediction method; Whitmore and Wallace, 2004) was 
used to fit each helix into the obtained electron density manually. For the DNA 
model, 11 bp duplex of B-DNA from Coot was manually modelled on the electron 
density map.    
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Chapter 3 Amyloid fibril formation by Hpa1 from 
Xanthomonas oryzae pv. oryzicola 
 
 
In this chapter, I report the construction, expression and purification of Hpa1, harpin 
of X. oryzae pv. oryzicola. The ability of Hpa1 to form fibrils at different pHs was 
tested. The secondary structure transition during the fibril assembly was studied by 
CD spectroscopy. The fibrils formed by Hpa1 were found to damage the liposomes 
made from extracted E. coli lipids. 
 
3.1 Cloning, overexpression and purification of Hpa1 
 
3.1.1 Cloning of hpa1 into pET21a expression vector 
 
The hpa1 gene was amplified by PCR from genomic DNA of the X. oryzae pv. 
oryzicola (provided by Prof. Gongyou Chen, Nanjing agricultural University, 
Nanjing, China) with primers NdeI-hpa1 Forward and XhoI-hpa1 Reverse (Table 
2.2). Figure 3.1 shows the successful amplification of hpa1 (Lane 1), which is 
consistent with the predicted size of 414 bp. The amplified hpa1 gene was extracted 
and purified from the agarose gel and ligated into the commercial T-A propagation 
vector, pGEM-T Easy (section 2.4.3 and 2.4.4). The ligation mixture was 
transformed into chemically competent E. coli NovaBlue (section 2.4.6). Positively 
identified recombinant clones were used in the following expression vector sub-
cloning procedure. Plasmid DNA purified from recombinant colonies was digested 
with NdeI and XhoI to confirm the presence of inserted DNA. After restriction 
enzyme digestion of the vector with NdeI and XhoI, the resulting hpa1 fragment was 
ligated into pET21a generating a construct to express the hpa1 gene with a C-
terminal His6-tag. The successful constructs were sequenced and aligned with 
sequence of hpa1 from Genebank (ACCESSION   AY875714 REGION: 940-1353). 
The construct was transformed into E. coli strain BL21(DE3) for Hpa1 
overexpression.   
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Figure 3.1 PCR amplification of hpa1 gene from X. oryzae pv. oryzicola strain 
RS105. Lane 2 shows a molecular weight (Mr) marker. Lanes 1 shows individual 
PCR amplification reaction.       
 
3.1.2 Over-expression of Hpa1-His6 
 
Expression of Hpa1 from pET21a results in a fusion of the Hpa1 protein to a His6-tag 
at the C-terminus and is referred to as Hpa1-His6. 
 
Bacterial cultures were prepared as described in section 2.2.1, incorporating 100 
g/ml carbenicillin. The protocols for protein expression were as described in section 
2.7. At an OD600 of 0.5-0.6, Hpa1- His6 from BL21(DE3) was induced with 0.5 mM 
IPTG at 25
o
C with 120 rpm rotary agitation for 5 hours. The cells were harvested, 
resuspended in buffer A (20 mM Tris-HCl pH 8.5, 300 mM NaCl, 10% glycerol) and 
stored at -80
 o
C for purification. 
 
3.1.3 Purification of soluble and membrane faction Hpa1-His6 
 
The soluble fraction containing Hpa1-His6 from 4 litres of culture was obtained by 
differential centrifugation (Section 2.7.2) and purified by metal affinity 
chromatography using Ni
2+
 agarose (Section 2.7.2). The packed column was washed 
with 10 ml of 20 mM Tris-HCl pH 8.5, 300 mM NaCl, 10% glycerol, 50 mM 
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imidazole. Hpa1-His6 was eluted from the column using buffer A containing 500 
mM imidazole.  
 
Hpa1-His6 purified by metal affinity chromatography was loaded onto a gel filtration 
column, Hiload 16/60 superdex 200 column (GE Healthcare), pre-equilibrated with 3 
column volumes (CV) of buffer A, for further purification. Figure 3.2 shows the 
elution chromatogram of Hpa1-His6 on a Hiload 16/60 superdex 200 prep grade size-
exclusion column. Hpa1 has low UV280 absorbance as there is no Trp or Tyr in 
Hpa1 (Calculated extinction coefficient of Hpa1 at 280 nm is 120 cm
-1
M
-1
). Figure 
3.3 shows the efficiency of expression and purification of Hpa1-His6 on an SDS-
PAGE gel. The calculated molecular weight of Hpa1-His6 is 14682.45 Da (Vector 
NTI, Invitrogen). However, on the SDS-PAGE gel, the migration of the protein band 
(Figure 3.3A 2-3 lanes) is around the 20 kDa standard of the SeeBlue protein marker 
(Lane 1). His6-tag western blot (Section 2.7.6) was used to confirm the identification 
of expressed Hpa1-His6. Figure 3.3B lanes 1 and 2 show the western blot signals of 
Hpa1-His6 and its dimer. 
 
The mass spectrum was determined by positive ion electrospray with up-front liquid 
chromatographic separation in the Chemistry Department, Durham University. The 
experimental mass is 14698 Da and the theoretical mass is 14682 Da calculated from 
the empirical formula of Hpa1-His6. The difference of 16 Da between these two 
values might originate from the gaining of protons in ionization, or other adduct 
(possibly an oxygen atom), or the average mass from isotopic C
12
 and C
13
.   
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Figure 3.2 The elution chromatography profile of Hpa1-His6 from a Hiload 
16/60 superdex 200 gel filtration column. The peak with about 40 ml elution 
volume is the aggregation of Hpa1 or the contaminated proteins.                   
 
 
                                               
Figure 3.3 SDS-PAGE and Western blot of Hpa1-His6. (A) Lane 1 is a protein 
molecular weight (Mr) marker. Lanes 2 and 3 show Hpa1-His6 on a SDS-PAGE gel. 
(B) Lanes 1 and 2 are the signals for Hpa1- His6 in a western blot corresponding to 
lane 2 and 3 in A, respectively.  
 
A 
B 
     1        2         3     
  1            2               
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To test whether over-expressed Hpa1-His6 could bind to E. coli membrane in, the 
membrane pellet was resuspended in buffer A (20 mM Tris-HCl, pH 8.5, 300 mM 
NaCl, 10% glycerol) and solubilised using 1% DDM (n-dodecyl-β-D maltoside, 
Calbiochem, UK). High-speed ultracentrifugation at 220,000 g for 60 min was 
performed to separate soluble protein-detergent complex from membrane lipids. The 
soluble protein-detergent complex was further purified by affinity chromatography 
using a 1-ml HiTrap chelating column (GE Healthcare) immobilized with Ni
2+
 
equilibrated with buffer B (20 mM Tris-HCl, pH 8.5, 300 mM NaCl, 10% glycerol, 
0.1% DDM). The column was washed with 50 mM imidazole added to buffer B, and 
the bound protein was eluted with 500 mM imidazole in buffer B. 
 
Ion-exchange chromatography (Section 2.7.4) was used to further purify the 
membrane fraction Hpa1-His6. The buffer of Hpa1-His6 was changed into starting 
buffer (20 mM Tris-HCl, pH 8.5, 50 mM NaCl, 10% glycerol, 0.1% DDM) using a 
desalting column (GE Healthcare). The HiTrap Q HP 5 ml column (GE Healthcare) 
stored in 20% ethanol was washed with 5 CVs of degassed water, and then 
equilibrated with starting buffer. Hpa1-His6 was loaded onto the HiTrap Q HP 5ml 
column and washed with 3 CV of starting buffer. A NaCl gradient elution was 
performed with start buffer and elution buffer (20 mM Tris-HCl, pH 8.5, 500 mM 
NaCl, 10% glycerol, 0.1% DDM). The protein peaks were collected and analyzed by 
on an SDS-PAGE gel. Figure 3.4A lane 3 shows the membrane fraction Hpa1-His6 
after the ion-exchange chromatography. A His6-tag western blot (Section 2.7.6) was 
used to confirm the identity of the expressed membrane fraction Hpa1-His6 (Figure 
3.4B lane 2) 
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Figure 3.4 SDS-PAGE and western blot of Hpa1-His6 and C47S purified from E. 
coli membrane. (A) Lane 1 is Hpa1 derivative C47S; Lane 3 is Hpa1-His6 purified 
from membrane; Lane 2 is a molecular weight marker. (B) Lane 1 is the western blot 
signal for C47S corresponding to lane 1 in A; Lane 2 is the signal for Hpa1-His6 
from the membrane in a western blot corresponding to lane 3 in A.   
 
3. 2  Analytical size exclusion chromatography of soluble Hpa1-His6 
 
Analytical size exclusion chromatography (SEC) (Section 2.8) was used to determine 
the molecular weight of soluble Hpa1-His6. The buffer composition used for all 
experiments (including for the molecular weight standards) was 20 mM Tris-HCl pH 
8.5, and 100 mM NaCl. The column was pre-equilibrated with 1 CV of water and 
then 2 CV of buffer prior to all chromatographic elution. Dextran blue 2000 (GE 
Healthcare) was applied to the column prior to the protein standards to determine the 
void volume (Vo) of the column. bovine serum albumin (62.9 kDa), ovalbumin (46.7 
kDa), catalase (213 kDa) and adolase (182 kDa) (GE Healthcare) were dissolved in 
buffer  at 5 mg/ml, injected into the Superdex 200 PC 3.2/30 column (GE Healthcare) 
and eluted with 1 column volume of buffer to get the elution volumes of these 
proteins (Table 3.1). Figure 3.5 shows that after purification Hpa1-His6 is not a 
single species and that the maximum species has the elution volume 1.53±0.02 ml. 
1                2                  3     
dimer 
Hpa1 
purified 
from  
membrane 
C47S 
A 
B   1                               2    
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The Kav of Hpa1-His6 and each protein standard were calculated as in Section 2.8. 
The Kav values for the protein standards were plotted on a logarithmic scale against 
the corresponding Mr and a line of best fit was drawn (Figure 3.6). The molecular 
weight of Hpa1-His6 was calculated according to this curve, which is 142.3 kDa 
(Table 3.1), suggesting that Hpa1-His6 could be a decamer. 
 
 
 
                             
Figure 3.5 The elution chromatography of Hpa1-His6 from a superdex 200 PC 
3.2/30 gel filtration column (Molecular weight determination of Hpa1-His6) 
A=aldolase (182 kDa), B= bovine serum albumin (62.9 kDa), C= catalase (213 kDa), 
O= ovalbumin (46.7 kDa).  
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 Protein Molecular Weight Elution Volume* Kav  
Aldolase 182 kDa 1.49±0.02 ml 0.3228 
Catalase 213 kDa 1.44±0.02 ml 0.2861 
Bovine Serum Albumin 62.9 kDa 1.59±0.02 ml 0.3962 
Ovalbumin 46.7 kDa 1.69 ±0.02 ml 0.4695 
Hpa1-His6 142.3 kDa 1.53±0.02 ml 0.3521 
Blue Dextran More than 2000 kDa 1.05±0.02 ml 0 
 
Table 3.1 Molecular weights and elution volumes of standard proteins and 
Hpa1-His6 . * errors estimated from the calibration curve (data not shown), 0.02 ml= 
6 kDa. 
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Figure 3.6 The log of the Mr of the standards versus Kav calibration curve. 
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3.3  Overexpression and purification of Hpa1 derivative C47S 
 
Harpins share several characteristics, such as a low isoelectric point, enrichment for 
glycines, and a lack of cysteine residues (Charkowski et al., 1998). Hpa1, similar to 
other harpins, has a low isoelectric point of 4.06, and high percent of glycines of 
13.5% (calculated by Vector NTI). However, there is one cysteine residue in Hpa1. 
To study the function of this residue, the mutation of the cysteine to serine (C47S) 
was performed to determine if cysteine cross linking was essential for correct protein 
folding in Hpa1. The QuikChange multi site-directed mutagenesis system (Stratgene) 
was employed for in vitro site directed mutagenesis experiments. 
 
Site directed mutagensis of Hpa1-His6 was performed as described in Section 2.6. 
The mutagenic primers hpa1-C47S Forward and hpa1-C47S Reverse were used as 
detailed in Table 2.4. The pET21a-hpa1 ds-DNA was used as the template. Mutant 
strand synthesis using PCR was achieved with an extension time of 6 minutes. The 
clones were sequenced to confirm the desired mutant. The correct clones were 
transformed into BL21(DE3) for overexpression.  
 
We attempted to purify Hpa1 C47S from the soluble fraction; however, no C47S was 
found in the soluble fraction. The membrane fraction of C47S was purified as 
membrane fraction Hpa1-His6 in section 3.1.3. His6-tag western blot (Section 2.7.6) 
was used to confirm the correct expression of the membrane fraction C47S. Figure 
3.4A lane 1 shows the purification of C47S from E. coli membranes. Figure 3.4B 
lane 1 shows the western blot of C47S. The discussion of Hpa1 derivative C47S is 
given in section 3.9.2. 
 
3.4 Amyloid fibrils formation of Hpa1-His6 at acidic pHs 
 
The Type III-dependent harpins from plant pathogenic bacteria, HpaG from X. 
axonopodis, HrpN from E. amylovora and HrpZ from P. syringae pv. syringae were 
found to form amyloid fibrils in XVM2, the hrp induction minimal medium (Oh et 
al., 2007). Hpa1 has 59.7% sequence identity with HpaG, 17.2 % with HrpN, and 
14.5 % with HrpZ. 
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In this study, the amyloid fibril formation of soluble Hpa1-His6 was tested at 
different pHs. The purified Hpa1-His6 in buffer (20 mM Tris-HCl pH 8.5, 300 mM 
NaCl), was concentrated and diluted into buffers at pH 8.5 (20 mM Tris-HCl, 50 mM 
NaCl), pH 8.0 (20 mM Tris-HCl, 50 mM NaCl), pH 7.5 (20 mM Tris-HCl, 50 mM 
NaCl), pH 7.0 (20 mM MES, 50 mM NaCl),  pH 6.5 (20 mM MES, 50 mM NaCl), 
and pH 6.0 (20 mM MES, 50 mM NaCl) in 40 µM, respectively. Samples were 
screened by TEM immediately after dilution for the Hpa1-His6 fibrils in each buffer 
(Figure 3.7 A and D, 3.8 A and D, 3.9 A and D).  
 
Our TEM studies revealed that purified Hpa1-His6 is prone to aggregate in buffers at 
pH 8.5 and 8.0 (Figure 3.9 A and D). After incubation of Hpa-His6 at each buffer for 
1 day at room temperature (RT), the morphology of Hpa1-His6 in each buffer was 
observed under TEM. Hpa1-His6 forms ribbon fibrils with a 10 nm width at pH 6.0 
and pH 6.5 after 1 day incubation at RT (Figure 3.7 B and E); however, at pH 7.0, 
7.5, 8.0 and 8.5 (Figure 3.8 B and E, 3.9 B and E) no fibrils formed .  
 
After a 12 day incubation at RT, the Hpa1-His6 at each pH was observed again under 
TEM. Ribbon fibrils formed by Hpa1-His6 after 1 day incubation in pH 6.0 and pH 
6.5 were expected to form twisted fibrils after the long incubation time. However, 
there was no difference found between fibrils of 1day incubation at pH 6.0 and 6.5 
and those after 12 days incubation (Figure 3.7 C and F). 
  
After 12 days incubation at RT, Hpa1-His6 aggregated at pH 7.5 (Figure 3.8 F) and 
pH 8.0 (Figure 3.9 C).  
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Figure 3.7 Amyloid fibrils formed by Hpa1 at pH 6.0 and 6.5.  (A), (B) and (C) 
show 40 µM of Hpa1-His6 in buffer 20 mM MES, pH 6.0, 50 mM NaCl, 0 day, 1 day 
and 12 days respectively. (D), (E) and (F) show 40 µM of Hpa1-His6 in buffer 20 
mM MES, pH 6.5, 50 mM NaCl, 0 day, 1day and 12 days respectively. The time 
point 0 day is defined as the moment immediately following dilution of the protein in 
each buffer. (Scale bar = 100 nm) 
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Figure 3.8 TEM analysis of Hpa1 at pH 7.0 and 7.5.  (A), (B) and (C) show 40 
µM of Hpa1-His6 in buffer 20 mM Tris-HCl, pH 7.0, 50 mM NaCl, 0 day, 1 day and 
12 days respectively. (D), (E) and (F) show 40 µM of Hpa1-His6 in buffer 20 mM 
Tris-HCl, pH 7.5, 50 mM NaCl, 0 day, 1day and 12 days respectively. The time point 
0 day is defined as the moment immediately following dilution of the protein in each 
buffer. (Scale bar = 100 nm) 
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Figure 3.9 TEM analysis of Hpa1 at pH 8.0 and 8.5.  (A), (B) and (C) show 40 
µM of Hpa1-His6 in buffer 20 mM Tris-HCl, pH 8.0, 50 mM NaCl, 0 day, 1 day and 
12 days respectively. (D), (E) and (F) show 40 µM of Hpa1-His6 in buffer 20 mM 
Tris-HCl, pH 8.5, 50 mM NaCl, 0 day, 1 day and 12 days respectively. The time 
point 0 day is defined as the moment immediately following dilution of the protein in 
each buffer. Arrows show the aggregation of Hpa1. (Scale bar = 100 nm) 
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To determine whether the fibrillar form of Hpa1 is amyloid, a Congo red binding 
assay was performed: 40 µM Hpa1-His6 was diluted in buffer 20 mM MES, pH 6.5, 
50 mM NaCl and incubated at RT for 1 day to form fibrils. 20 µM Congo red was 
dissolved in the same buffer. The absorbance spectrum of Congo red from 400 to 700 
nm was recorded as a control (Figure 3.10 dotted line). 20 µM Congo red was then 
mixed with 40 µM fibrils formed by Hpa1-His6 and the absorbance spectrum of 
Congo red from 400 to 700 nm was recorded again (Figure 3.10 solid line). The 
binding of Hpa1 fibrils to Congo red causes a maximum absorbance shift of Congo 
red from 495 nm to 516 nm (Figure 3.10), which indicates that the Hpa1 fibrils are 
amyloid fibrils.  
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Figure 3.10 Congo red binding of Hpa1-His6 fibrils. Absorbance spectrum of the 
CR solution in the absence (dotted line) and presence (solid line) of Hpa1-His6 fibrils. 
 
 
3.5  Chemical cross-linking of Hpa1-His6 
 
In order to show the oligomeric state of Hpa1-His6, cross-linking experiments were 
undertaken. Cross-linkers are chemical reagents used to conjugate molecules 
together by a covalent bound. Hpa1-His6 crosslinking in vitro was performed using 
DSP and EGS, with 12 Å and 16.1 Å spacer arms, and analyzed by gel 
electrophoresis.  
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The buffer of purified Hpa1-His6 was exchanged into 20 mM Na2HPO4, 100 mM 
NaCl, pH 8.5, prior to crosslinking. An EGS solution was freshly prepared in DMSO. 
The protein sample and EGS solution were mixed and left at room temperature for 1 
hour. The reactions were terminated by adding 1M Tris buffer. The samples were 
then analysed on a 4-12% SDS-PAGE gel. Figure 3.11 shows approximately seven 
bands, corresponding to the different oligomeric states of Hpa1.  
  
 
                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11   Chemical cross-linking of Hpa1-His6 
Lane 1: A protein molecular weight (Mr) marker  
Lane 2: 1 mg/ml Hpa1-His6 in buffer 20 mM NaHPO4, 100 mM NaCl, pH 8.5   
Lane 3-5: 1 mg/ml Hpa1-His6 in buffer 20 mM NaHPO4, 100 mM NaCl, pH 8.5, 
crosslinked with 8 mM, 16 mM and 30 mM EGS, respectively, at 37
 o
C, for 30 mins.   
 
 
PopA, a harpin-like protein from the bacterial plant pathogen R. solanacearum, was 
thought to be a Ca
2+
-dependent lipid binding protein, for which Ca
2+
 could promote 
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oligomerization (Racape et al., 2005). 2 mM CaCl2 and 0.1 mg E. coli lipsomes 
(Section 2.13 for liposomes preparation) were mixed in the crosslinking buffer 
respectively or simultaneously to show their effects in the oligomerization of Hpa1. 
However, no significant difference was found in the presence of 2 mM CaCl2, or 0.1 
mg E. coli liposome, or both of them simultaneously, compared with Hpa1 only 
(Figure 3.12).  
 
                   
Figure 3.12   Chemical cross-linking of Hpa1-His6 in the presence of CaCl2 and 
liposomes.  Lane 1: 1 mg/ml Hpa1-His6 mixed with 0.5 mM DSP, 2 mM CaCl2 and 
0.1 mg E. coli lipsomes, 37
 o
C, 0.5 hour. Lane 2: 1 mg/ml Hpa1-His6, mixed with 0.1 
mg E. coli liposomes and 2 mM CaCl2, 37
 o
C, 0.5 hour. Lane 3: 1 mg/ml Hpa1-His6, 
mixed with 0.5 mM DSP and 0.1 mg E. coli liposomes, 37
 o
C, 0.5 hour. Lane 4: 1 
mg/ml Hpa1-His6, mixed with 0.5 mM DSP and 2 mM CaCl2, 37
 o
C, 0.5 hour Lane 5:  
1 mg/ml Hpa1-His6, mixed with 0.1mg E. coli liposomes, 37
 o
C, 0.5 hour. Lane 6: 1 
mg/ml Hpa1-His6, mixed with 2 mM CaCl2, 37
 o
C, 0.5 hour. Lane 7: 1 mg/ml Hpa1-
His6, mixed with 0.5 mM DSP, 37
 o
C, 0.5 hour. Lane 8: 1 mg/ml Hpa1-His6. 
 
 
In conclusion, our cross-linking data indicates that the maximal oligomer state of 
Hpa1 is a heptamer, which is inconsistent with the decamer from SEC (Section 3.2). 
This difference might be explained by the spacer arm being sub-optimal for cross-
linking the active site in the Hpa1 oligomers. In addition, although Ca
2+
 and 
liposomes were reported to promote oligomerization of harpin (Racape et al., 2005); 
in this study, such effects could not be detected in our experiments. A detailed 
discussion of these findings is given in Section 3.9.3. 
 98 
3.6   Circular dichroism (CD) spectroscopy of Hpa1-His6 
 
The formation of amyloid fibrils accompanies a secondary structure change and 
amyloid fibrils are β-sheet rich structures (Chiti and Dobson, 2006). In order to study 
the secondary structure transition of Hpa1-His6 during fibril formation, CD 
spectroscopy was used. In order to minimize the strong absorbance from Cl
-
 in the 
far UV region, the Hpa1-His6 buffer was changed to Tris-base or NaH2PO4, with 
NaF as salt. 
 
4 µM Hpa1-His6 in 20 mM Tris-base pH 8.5 (pH adjusted by H2SO4), 20 mM NaF, 
generated a CD spectrum from 260-190 nm. Meanwhile, Hpa1-His6 was diluted into 
20 mM NaH2PO4 pH 6.5, 20 mM NaF to have a final concentration 5 µM and 
incubated at room temperature for 1 day. The CD spectrum of this 5 µM Hpa1-His6 
at pH 6.5 was recorded. All CD spectra were analyzed using the software Dichroweb 
online (Section 2.11, Whitmore and Wallace, 2004 and 2008). 
 
Our CD analyses indicated that Hpa1-His6 at pH 8.5 has a structural content of 
34.8% helix, 7.5% sheet, 27.9% turn, and 29.9% unordered (Figure 3.13). After 
incubation of Hpa1 at pH 6.5 for 1 day, the spherical oligomer Hpa1 formed 
curvilinear fibrils under TEM (Figure 3.7 E), and the percentage of helix decreased 
to 14.5%, whereas the sheet content increased to 29.2%, with 23.4% turn, and 32.9% 
unordered structure (Figure 3.13). In conclusion, the formation of fibrils of Hpa1 
increases the sheet content, but not all the secondary structure of the Hpa1 fibrils is 
β-sheet structure.  
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Figure 3.13 CD spectroscopic analysis of soluble Hpa1-His6 at pH 8.5 and pH 
6.5. 5 µM soluble Hpa1 at pH 8.5 (solid line), 5 µM soluble Hpa1 at pH 6.5, 1 day 
incubation (dotted line). 
 
 
3.7 Membrane disrupted by Hpa1-His6 
 
 Liposomes were prepared from E. coli extracted lipids as described in Section 2.13   
and incubated with 5 mg Hpa1 at different pHs (pH 6.0, 6.5, 7.0, 7.5, 8.0 and 8.5). 
After 1 day incubation, the bound Hpa1 with liposomes and unbound Hpa1 were 
separated using sucrose gradient centrifugation (Section 2.13). The liposome 
fractions were pipetted and loaded onto a SDS/PAGE gel to show bound Hpa1. Only 
at pH 6.0 and 6.5, Hpa1 could bind to liposomes (Figure 3.14). In addition, these 
liposomes bound with Hpa1 were observed under TEM (Figure 3.15 D, E and F), 
revealing that these liposomes were broken by the Hpa1 at pH 6.0 and pH 6.5.  
 
 100 
                
 
Figure 3.14 A SDS/PAGE gel shows the Hpa1-His6 bound with liposome after 
sucrose gradient centrifugation Lane 1: 1 mg/ml Hpa1-His6. Lane 2, 3, 4: Hpa1-
His6 from 10% sucrose fraction of liposome, at pH 6.5. Lane 5, 6, 7:  Hpa1-His6 
from10% sucrose fraction of liposome, at pH 6.0  
  
 
To test the function of membrane fraction Hpa1-His6 and the C47S derivative on the 
membrane, we reconstituted the detergent solubilised Hpa1-His6 and C47S into 
membranes as described in Section 2.13. The liposomes were prepared and mixed 
with detergent solubilised Hpa1-His6 and C47S. The detergents in the system were 
moved by Bio-bead SM-2 absorbent (Bio-Rad
®
) and integrated membranes were 
spun down. TEM observations show both the membrane fraction Hpa1-His6 and 
C47S disrupt membranes (Figure 3.15 B and C).  
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Figure 3.15  Negative-staining electron microscopy analysis shows that Hpa1-
His6 purified from soluble and membrane fraction of E. coli disrupt liposomes 
(A) Intact liposomes. (B) Liposomes lysed by membrane fraction Hpa1-His6. (C) 
Liposomes lysed by membrane fraction C47S. (D) and (E) Liposomes lysed by 
soluble Hpa1-His6 at pH 6.5 (F) Liposomes lysed by soluble Hpa1-His6 at pH 6.0. 
The black arrow points to the lysed liposomes (scale bar = 100 nm) 
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3.8  Crystallization of Hpa1 
 
Hpa1-His6 (20 mM Tris-HCl buffer at pH  8.5, 100 mM NaCl, and 4 μM DTT), was 
purified as described in section 3.1.2 and 3.1.3, and concentrated to 10 mg/ml for 
crystallization trials. 
 
The following crystallization suites were used: 
1 The classics suites (Nextal Biotech) 
2 The classics Lite suites (Nextal Biotech) 
3 Structure Screen 1, 2 (Molecular Dimensions) 
4 Random sparse matrix crystallization screen Wizard I, Wizard II (Emerald 
Biosystems.) 
 
1ml crystallization buffer from each crystallization suite was transferred into the 
wells of crystallization plates. 2 µl 10 mg/ml Hpa1-His6 was mixed with 2 µl 
reservoir buffer from the kits, and loaded on the cover slip of each well, to form the 
hanging drops at 18 
o
C.  
 
The crystallization of the above screening conditions did not yield any crystals or 
even needles. Self-prepared buffer conditions were used to screen for buffers suitable 
for crystallization of Hpa1. PEG4000 and PEG400 were taken as precipitants, 
concentration from 5% to 25%, in 100 mM Tris-HCl at different pHs from 7.0 to 8.5. 
Fortunately, some small needles or spherulites could be found in buffer containing 
15% PEG4000, 100 mM Tris-HCl at pH 7.8 (Figure 3.16). However, these needle-
like spherulites or crystallines were too small to obtain any diffraction and not 
reproducible. Further trials did not get any promising result than these needle-like 
crystals. 
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Figure 3.16 Needle-like crystallines or aggregation formed by Hpa1-His6 at 100 
mM Tris-HCl buffer at pH 7.8 and 15% PEG4000. 
 
  
3.9 Discussion 
 
Harpins play an important function between the plant and plant pathogen (Alfano 
and Collmer, 2004). They act by eliciting a complex natural defence mechanism in 
plants, analogous to a broad spectrum immune response in animals (Alfano and 
Collmer, 2004). The harpin-like protein PopA, from the bacterial plant pathogen 
Ralstonia solanacearum, has a high affinity for sterols and sphingolipids in vitro and 
requires Ca
2+
 for lipid binding and oligomerization (Racape et al., 2005). Recently, 
HpaG was found to form amyloid fibrils (Oh et al., 2007). In order to investigate the 
biochemical characteristic of Hpa1, we over-expressed and purified it from E. coli 
and found fibril forming conditions for Hpa1. 
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3.9.1 Over-expression and purification of Hpa1 
  
The low mobility of harpins on an SDS-PAGE gel is reported in several publications 
and could be a general characteristic of harpins (Charkowski et al., 1998). In this 
study, Hpa1 has a similar low mobility on SDS-PAGE gels, shifting from 14 kDa to 
around a 20 kDa position (Figure 3.3). Western blot and mass spectra confirmed the 
correct expression of Hpa1 (Section 3.1.3), and eliminated the unexpected 
contamination of proteins. This characteristic of harpins could reflect the special 
amino acid composition of harpins, or unique structure of harpins, which has to be 
determined in future work.  
 
3.9.2 Function of cysteine in Hpa1 
 
Although the lack of cysteine is considered as a general characteristic of harpins 
(Charkowski et al., 1998), Hpa1 has one cysteine residue. To investigate the function 
of this residue, we mutated Cys to Ser (C47S) and purified this derivative from E. 
coli. In contrast to the WT Hpa1, only the membrane fraction of C47S was purified 
successfully. As expected, the lack of cysteine in Hpa1 led to the dissociation of 
dimer to monomer (Figure 3.4). In addition, the formation of intermolecular disulfide 
bonds could also stabilize Hpa1 in the soluble state, as the derivative C47S was 
absent in the soluble fraction in its purification (Section 3.3).   
  
3.9.3 Oligomerization of Hpa1 
 
The oligomeric state of harpin was reported for HpaG, which forms a tetramer (Oh et 
al., 2007).  PopA was thought to be a Ca
2+
-dependent lipid binding protein, for 
which Ca
2+
 could promote oligomerization (Racape et al., 2005). In this study, in 
vitro cross-linking of Hpa1 was performed with SEC used to analyse the oligomeric 
state of Hpa1. Analytical SEC shows Hpa1 is not a single species in buffer and the 
major species has a molecular weight 142.3 kDa (Table 3.1), which indicates that 
this species of Hpa1-His6 may be a decamer in solution.  
 
To understand the effect of Ca
2+
 and lipids on oligomerization of Hpa1, liposomes 
and Ca
2+
 were mixed with Hpa1 and cross-linking was performed. In contrast to 
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PopA, Ca
2+
 and lipids had no effect on the oligomerization of Hpa1 (Figure 3.12). 
However, the possibility of an effect of Ca
2+
 and lipids on the oligomerization of 
Hpa1 can not be ruled out, since the purified Hpa1 is already in its oligomeric state, a 
decamer rather than a monomer. The equilibrium between monomeric and 
oligomeric state of fibril forming proteins was reported and some parameters are 
found to shift this equilibrium, e.g. anionic strength in the buffer (Cruz et al., 2005). 
The possible shift between monomer and oligomer of Hpa1 could be studied in 
future work. 
  
3.9.4 Amyloid fibril formation of Hpa1 
 
A pH-dependent folding transition has been widely reported in amyloid forming 
proteins (Cruz et al., 2005; Lai et al., 1996; Morozova-Roche et al., 2000; Smith et 
al., 2003; Uversky and Fink, 2004). The Type III-dependent harpins from plant 
pathogenic bacteria, HpaG from X.axonopodis, HrpN from E. amylovora and HrpZ 
from P. syringae pv. syringae were found to form amyloid fibrils in XVM2, the hrp 
induction minimal medium (Oh et al., 2007). However, the effect of pH on fibril 
formation by harpins is still enigmatic. In this study, a series of buffers with different 
pHs (6.0, 6.5, 7.0, 7.5, 8.0 and 8.5) were prepared to determine their influence on 
fibril formation of Hpa1. As observed by TEM, short curved fibrils formed by 
soluble Hpa1 at pH 6.0 and 6.5 after 1day incubation at RT (Figure 3.7 B, C, E and 
F). A Congo red binding assay indicated that these fibrils are amyloid-like, similar to 
the fibrils formed by HpaG of X. axonopodis (Oh et al., 2007). The CD spectrum 
shows that the formation of fibrils by Hpa1 at acidic pH involves the transition of 
secondary structure from helix to strand (Section 3.6), similar to those observed in 
the fibrils formed by HpaG (Oh et al., 2007). 
 
Hpa1 and the C47S derivative purified from membrane cannot form fibrils. The 
possible explanation is that the detergents bound to the protein, used in the 
purification of protein from the membrane, mask the surface for fibril-assembly.  
 
Although decreasing the net charge of proteins was thought to be the reason for the 
formation and stabilization of fibrils (Chiti et al., 2002; Schmitts and Scholtz, 2003); 
in this study, a lower pH of 4-5 around the pI (4.06, calculated by Vector NTI) of 
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Hpa1, were found to induce the precipitation of Hpa1 (data not shown), which 
indicates that the formation of fibrils needs electrostatic conditions to allow folding 
of Hpa1.   
  
The possible mechanism for fibril formation of Hpa1 at acidic pHs is that the shift of 
pH changes conformation of Hpa1 and thus exposes the protein surface for fibril-
assembly. Further work will be required to support this hypothesis or find out 
another mechanism by which fibril-assembly occurs at acidic pH of Hpa1.  
 
3.9.5 Membrane binding and disruption of Hpa1 
 
The membrane binding characteristic of PopA, an harpin-like protein, was reported 
(Racape et al., 2005). In this study, successful purification of Hpa1 from the 
membrane of E. coli (Figure 3.4) indicates that membrane binding is a characteristic 
of Hpa1 in vivo. Sucrose gradient centrifugation revealed that Hpa1 can bind 
liposomes at pH 6.0 and 6.5 in vitro (Figure 3.14). TEM observation also indicated 
that liposomes are disrupted by Hpa1 at these pHs (Figure 3.15 D, E and F). These 
results together with fluoresce studies that revealed the location of Hpa1-GFP 
(localized Hpa1 at the plasma membrane, communication with Prof. Gongyou Chen, 
Nanjing Agricultural University, China) suggest Hpa1 localizes to  and disrupts the 
membrane. More discussion about function of Hpa1 in TTSS of Xanthomonas will 
be given in Section 6.1.2.  
 
 3.9.6 Crystallization of Hpa1 and harpin proteins  
 
Harpin protein crystallography is still a challenge, as no harpin structure has been 
determined until now after their discovery in 1992 (Wei et al., 1992). In this work, 
only 1000 commercial screening conditions have been screened in the Hpa1 
crystallography, but no crystal were formed from these conditions. Although needles 
or spherulites of Hpa1 (Figure 3.16) were successfully grown in self-prepared buffer, 
it was not reproducible and could not be optimized further. 
 
More buffer conditions need to be screened for Hpa1 crystallization. In addition, 
other commonly employed tactics, such as crystallization additives, small molecules 
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known to bind harpin and limited proteolysis, could be tried for harpin 
crystallography. The higher percent of unordered structure of Hpa1 (Section 3.6) 
could be a reason for the difficulties in the crystallization and the method to improve 
the folding of Hpa1 could be beneficial in crystallization. The other factor in Hpa1 
crystallization is the pH-dependent fibril formation of Hpa1 (Figure 3.7), which 
makes the selection of pH range critical to get the crystals.   
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Chapter 4  Fibril formation domain study of Hpa1 
 
 
HpaG, the harpin of X. axonopodis pv glycines, was reported to have two predicted 
-helical domains in the N- and C-terminal regions, and a Gln and Gly repeated 
sequence (QGQGQGQGG) (Figure 4.1), which is located between the two  helices 
and homologous to the prion-forming domain (PrD) of yeast prion protein (Oh et al., 
2007). The N-terminal -helix region was found to be essential for inducing HR and 
fibril formation (Oh et al., 2007). A single amino acid change of this region from 
leucine to proline abolished HR induction and fibril formation (Oh et al., 2007).  
 
In this chapter, I report the N-terminal -helix region truncated Hpa1 (55-138) is 
sufficient for amyloid fibril formation, different from HpaG. The synthesized poly-
peptide  (ASPLTQMLMNIVGEILQAQ), corresponding to the C-terminal -helix 
region, is responsible for fibril formation. The fibrils formed by the N-terminal -
helix region of truncated Hpa1 and a synthesized poly-peptide could damage 
membranes by analogy to full length Hpa1. The N-terminal -helix region interacts 
with the C-terminal one and inhibits its fibril formation. 
 
4.1 Amino acid sequence alignment of Hpa1 and HpaG, and secondary 
structure prediction 
 
In order to study the domains of Hpa1, sequences of Hpa1 and HpaG were aligned 
using Vector NTI advance 10 (Invitrogen) and secondary structures of Hpa1 and 
HpaG were predicted by HNN secondary structure prediction method (Whitmore and 
Wallace, 2004 and 2008).  
 
Hpa1 and HpaG show 59.7% identity. Hpa1 has N- and C-terminal -helices and one 
GGGQGGNQQ domain between them (Figure 4.1 and 4.2). Hpa1 has one cysteine 
amino acid located in the N-terminal -helix domain (Figure 4.1).  
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     1                                                   50 
     cccccccccc cccceeeccc cccccccccc cccccchhhh hhhhhhhhhh  
Hpa1 MNSLNTQFGG SASNFQVDQS QNAQSDSSQG SNGSQGISEK QLDQLLCQLI 
HpaG MNSLNTQLGA NSSFFQVDPG QNTQSSPNQG N...QGISEK QLDQLLTQLI 
     Cccccccecc cceeeeeccc cccccccccc c   ccchhh hhhhhhhhhh 
 
     51                                                 100 
     hhhhcccccc cccccccccc cccccccccc cccccchhh   hhhhhhhhh   
Hpa1 QALLQPNKNA EEGKGQQGGE NGGGQGGNQQ AGKENGASP. .LTQMLMNIV 
HpaG MALLQQSNNA EQGQGQGQGG DSGGQGGNPR QAGQSNGSPS QYTQALMNIV 
     hhhhhhcccc cccccccccc cccccccccc cccccccccc hhhhhhhhhh 
 
      101                                     139 
      hhhhhhhccc cccccccccc cccccchhhc ccccccccc  
Hpa1  GEILQAQNGG GAGGAGGSSG GDFGGSFASS FSNDSGSMQ 
HpaG  GDILQAQNGG GFG...GGFG GGFGGILVTS LASDTGSMQ 
      hhhhhhhccc ccc   cccc cccceeeeee ecccccccc 
 
 Alpha helix(h),Extended strand (e),Random coil(c)      
 
Figure 4.1 Amino acid sequence alignment between Hpa1 and HpaG, and their 
protein secondary structure predictions. Hpa1 and HpaG display 59.7% identity, 
and identical residues are underlined, while alpha helix indicated with h, extended 
strand indicated with e, and random coil indicated with c; the alpha helix, extended 
strand and radom coil content of prediction of Hpa1 and HpaG are h (29%), e (2%), c 
(69%) and h (27%), e (10%), c (63%), respectively.   
 
 
 
 
 
 
 
 
 
 
 
 
 110 
4.2 Cloning, over-expression and purification of N-terminal truncated Hpa1   
 
In order to study the function of two helical domains in Hpa1, different constructs to 
truncate the N-terminal and C-terminal helical domains (Figure 4.2) were made. 
 
 
Figure 4.2 Schematic representation of Hpa1 domains and synthesized peptides.  
 
4.2.1 Cloning of truncated hpa1 into pET21a expression vector 
 
The truncated hpa1 genes (1-258 and 163-414) were amplified by PCR from 
pET21a/hpa1 with primer pairs NdeI- hpa1 Forward and XhoI- 1-258-hpa1 Reverse, 
NdeI-163-414-hpa1 Forward and XhoI- hpa1 Reverse, respectively (Table 2.3). The 
amplified truncated hpa1 genes (1-258 and 163-414) were extracted and purified 
from the agarose gel and ligated into the commercial T-A propagation vector, 
pGEM-T Easy. The ligation mixture was transformed into chemically competent E. 
coli NovaBlue. Positively identified recombinant clones were used in the following 
expression vector sub-cloning procedure. Plasmid DNA purified from recombinant 
colonies was digested with NdeI and XhoI to confirm the presence of inserted DNA. 
After restriction enzyme digestion of the vector with NdeI and XhoI, the resulting 
hpa1 fragments were ligated into pET21a generating constructs to express the hpa1 
1 138 
1 86 
138 55 
87 106 54 37 
  Hpa1 
Hpa11-86 
Hpa155-138 
Peptide 1(domain of Hpa1): ISEKQLDQLLCQLIQALL 
Peptide 2 (domain of Hpa1): ASPLTQMLMNIVGEILQAQ 
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1-258 and 163-414 genes with C-terminal His6 tags.  The two constructs were 
sequenced to guarantee the correct sequence as expected. The constructs were 
transformed into E. coli strain BL21(DE3) for overexperssion. 
 
4.2.2 Over-expression and purification of N-terminal truncated Hpa1-His6 
 
2L Hpa1 (1-86) and (55-138) cells were grown and induced by 1 mM IPTG as 
described in Section 2.7.1. Cells were harvested and resuspended in buffer (20 mM 
Tris-HCl, 300 mM NaCl, 10% glycerol, pH 8.5). Cells were lysed by mechanical 
disruption (Section 2.7.2).  
 
The soluble fraction containing Hpa1 (1-86) and (55-138) from 2 litres of culture was 
obtained by differential centrifugation (Section 2.7.2) and purified by metal affinity 
chromatography using Ni
2+
 agarose (Section 2.7.2).  
 
The packed column was washed with 10 ml of 20 mM Tris-HCl pH 8.5, 300 mM 
NaCl, 10% glycerol, 50 mM imidazole. Protein was eluted from the column using 
buffer A containing 500 mM imidazole. We failed to purify Hpa1 (1-86), as it 
aggregated and blocked the column during purification. In addition, there was no 
Hpa1(1-86) purified from E. coli membrane. Soluble Hpa1(55-138) (N-terminal 54 
residue truncated) was purified successfully by the following procedure.  
 
Hpa1 (55-138) purified by metal affinity chromatography was loaded onto a gel 
filtration Hiload 16/60 superdex 200 column (GE Healthcare), preequilibrated with 3 
column volumes of buffer, for further purification. Figure 4.3 shows the elution 
profile of Hpa1-His6 on a Hiload 16/60 superdex 200 prep grade size-exclusion 
column. Hpa1 (55-138) has low UV280 absorbance as there is no Trp or Tyr in 
truncated Hpa1 (55-138). Figure 4.4 lane 1 shows the efficiency of expression and 
purification of Hpa1-His6 on an SDS-PAGE gel. The predicted molecular weight of 
Hpa1 (55-138) is 8343.51 Da (Vector NTI advance 10, Invitrogen). A His6-tag 
western blot (Section 2.7.6) was carried out to confirm the correct expression and 
purification of Hpa1 (55-138). Figure 4.4 lane 3 shows the western blot of Hpa1 (55-
138).  
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Figure 4.3 The elution chromatography profile of Hpa1 (55-138) from a  
Hiload 16/60 superdex 200 prep grade size-exclusion column. 
  
 
                                              
Figure 4.4 SDS-PAGE and western blot of Hpa1 (55-138). (A) Lane 1 shows the 
purified Hpa1 (55-138); Lane 2 Mr marker; (B) Lane 1 is the western blot signal of 
Hpa1 (55-138) corresponding to lane 1 in A. 
 
 
Hpa1 
(55-138) 
Hpa1 (55-138) 
A B 
1 
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4.3 Amyloid fibrils formed by Hpa1 (55-138) 
  
In order to study the fibril forming ability of Hpa1 (55-138), the purified protein was 
diluted into pH 8.0 buffer containing 20 mM Tris-HCl, 50 mM NaCl, and  pH 6.5 
buffer containing 20 mM MES, 50 mM NaCl to give a final protein concentration of 
40 µM, respectively. Samples were immediately observed by TEM after dilution of 
the Hpa1 (55-138) in each buffer. Purified Hpa1 (55-138) formed fibrils at pH 8.0 
and pH 6.5. Hpa1 (55-138) might form fibrils in the process of protein preparation or 
TEM sample preparation. After incubation of Hpa1 (55-138) at each buffer for 1 day 
at room temperature (RT), the morphologies of the Hpa1 (55-138) fibrils were 
observed under TEM again. The Hpa1 (55-138) fibrils had about 10 nm width at pH 
6.5. In conclusion, Hpa1 (55-138) forms fibrils at acidic and basic pHs (Figure 4.5).  
      
Figure 4.5 Negative-staining electron microscopy of fibrils forming of N-
terminal truncated Hpa1 (55-138). (A) Fibril formation of 40 µM Hpa1 (55-138) in 
20 mM MES (pH 6.5) and 20 mM NaCl, 0 day and 1 day, repectively. (B) Fibril 
formation of 40 µM Hpa1 (55-138) in 20 mM Tris-HCl (pH 8.5) and 20 mM NaCl, 0 
day and 1 day, respectively. The time point 0 h is defined as the moment 
immediately following dilution of the protein in each buffer. (Scale bar = 100 nm).   
 
A 
B 
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4.4 Membrane lysis by Hpa1 (55-138) 
 
Full length Hpa1 could damage the membranes prepared from E. coli lipid extraction 
(Section 3.7). Membrane disruption might be an important characteristic of amyloid 
fibrils that contributes to the toxicity of these fibrils. Liposomes were prepared as 
described in section 2.13. Purified Hpa1 (55-138) was mixed with the liposomes and 
incubated at RT for 1 day. The mixture of liposome and purified Hpa1 (55-138) were 
loaded onto carbon coated grids and stained with 1% uranyl acetate. TEM 
observation shows Hpa1 (55-138) could lyse the liposomes as did full length Hpa1 
(Figure 4.6).  
 
                                    
Figure 4.6 Liposomes lysed by Hpa1 (55-138). A and B, Liposomes lysed by 
Hpa1(55-138); C, the intact liposome control. Scale bar = 100 nm. Black arrows 
point to the disrupted liposomes. 
 
 
 
 
C 
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4.5 Amyloid fibrils formed by peptides 
 
In the study of HpaG, the N-terminal α-helix domain was synthesized and found to 
be the domain responsible for fibril formation (Oh et al., 2007). One site located in 
this N-terminal α-helix was thought to be the functional site, the mutation of which 
blocked fibril formation (Oh et al., 2007). Similar fibril forming peptides have been 
found in Alzeimer‘s β-amyloid peptides, Human amylin, and yeast prion sup35. 
Hpa1 has two -helix domains located at the N- and C-terminus. In this study, the N-
terminal and C-terminal -helix domains were synthesized and nominated as peptide 
1 and 2, respectively (Figure 4.2).  
 
The ability of peptide 1 and peptide 2 to form amyloid fibrils at different pHs was 
tested. Peptide 1 and peptide 2 were dissolved in different buffers at pH 6.5, 7.0 and 
8.0. The TEM observation was performed immediately after dilution to show the 
morphology of the peptide 1 and 2 in each buffer condition, or after 1 day incubation 
at room temperature (Figure 4.7). Peptide 1 could not form fibrils at any pH (Figure 
4.7A). In contrast, peptide 2 formed fibrils at pH 6.5, 7.0 and 8.5 (Figure 4.7 B and 
C). These fibrils are straight with about a 12nm width, different from those formed 
by Hpa1-His6 (Figure 3.7 B, C, E and F) and Hpa1-His6 (55-138) (Figure 4.5). They 
clearly have 3 stands of protofibrils twisted together to form a mature fibril, as shown 
in Figure 4.7 B. 
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Figure 4.7  Negative-staining electron microscopy of fibril formation of peptide 
1 and peptide2 of Hpa1. (A) 40 µM peptide 1 of Hpa1 in buffer (20 mM MES, pH 
6.5 and 20 mM NaCl), at 0 day and 1 day, respectively. (B) The fibril formation of 
40 µM peptide 2 of Hpa1 in 20 mM MES (pH 6.5) and 20 mM NaCl at 0 day and 1 
day. The mature fibrils twisted by 3 strands of protofibrils shown in the amplified 
figure. (C) The fibril formation of 40 µM peptide 2 of Hpa1 in 20 mM MES (pH 7.0), 
20 mM NaCl, and 20 mM Tris-HCl (pH 8.0), 20 mM NaCl. The time point 0 h is 
defined as the moment immediately following dilution of the protein in each buffer. 
(Scale bar = 100 nm) 
 
0 day 1 day 
0 day 1 day 
 
pH 7.0 pH 8.0 
Peptide1 
Peptide2 
Peptide2 
A 
B
 
A  
C
 
A  
 117 
 
4.6 Membrane lysis by peptides 
 
Full length Hpa1 and Hpa1 (55-138) assemble into fibrils and damage the liposomes 
prepared from E. coli lipids (Section 3.7 and 4.4). Membrane disruption could be an 
important characteristics of amyloid fibrils that contributes to the toxicity of these 
fibrils. Liposomes were prepared as described in section 2.13. 50 µM peptide 2 was 
mixed with 5 mg liposomes and incubated at RT for 1 day. The mixture of liposome 
and peptide 2 were loaded onto carbon coated grids and stained with 1% uranyl 
acetate. Compared with the control, intact liposomes (Figure 4.6 C), TEM 
observation shows peptide 2 could lyse liposomes as did full length Hpa1 and Hpa1 
(55-138) (Figure 4.8). Fibrils formed by peptide 2 were also visible (white arrows 
point to fibrils in Figure 4.8). 
 
        
Figure 4.8 Liposomes lysed by fibrils formed by peptide 2  A, B, C and D, 
Liposomes lysed by fibrils formed by peptide 2 of Hpa1 at 20 mM MES (pH 6.0) and 
20 mM NaCl, the white arrows point to the fibrils and the black arrows point to the 
broken liposome. (Scale bar = 100 nm) 
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4.7 Circular dichroism spectroscopy  
 
Amyloid fibrils have a β-sheet rich structure. In order to study the secondary 
structure of Hpa1 (55-138) and peptide 2 during fibril formation, CD spectroscopy 
was performed. In order to minimize the strong absorbance from Cl
-
 in the far UV 
region, the buffer of Hpa1 (55-138) and peptide 2 was changed to Tris-base or 
NaH2PO4, with NaF as salt. All CD spectra were analyzed using the software 
Dichroweb online (Whitmore and Wallace, 2004 and 2008).  
 
Truncated Hpa1 (55-138) has a high percentage of sheet structure at both pH 8.0 and 
6.5, of 28.3% and 38.3%, respectively (Figure 4.9 A), which are fibrils under TEM 
(Figure 4.5). These CD spectra data combined with TEM results suggest that the 
fibril formed by Hpa1 (55-138) are beta sheet rich structures.  
 
In the CD study of peptide 2, at pH 8.5, peptide2 has 15.5% helix, 43.6% sheet, 12% 
turn, and 28.9% unordered structure (Figure 4.9 B).  After 30 min incubation at 
pH6.5, peptide 2 has 40.6% helix structure, 16.9% sheet structure, 22.2% turn 
structure and 21.3% disordered structure (Figure 4.9 C). 
 
In conclusion, both the fibrils formed by Hpa1 (55-138) and by peptide 2 have sheet 
rich structures, but, in each case, not all the secondary structure is β-sheet structure. 
Considering that peptides as short as 4 residues can form amyloid fibrils and their 
atomic structures only have β-sheet structure (Nelson et al., 2005; Kajava et al., 
2007), peptide 2 is unlikely to be the minimal sequence in Hpa1 for fibril assembly.  
 
 
 
 
 
 119 
 
 
 
Figure 4.9 CD spectroscopic analysis of Hpa1 (55-138) at pH 8.0 and pH 6.5, 
peptide 2 at pH 8.0 and 6.5. (A) 5 µM Hpa1 (55-138) at pH 8.0 after 1 day 
incubation (solid line), 5 µM Hpa1 (55-138) at pH 6.5 after 1 day incubation (dotted 
line). (B) 10 µM peptide 2 at pH 8.0 (solid line), 10 µM peptide 2 at pH 6.5, 30 min 
(dotted line).  
 
4.8 Intramolecular interaction of Hpa1 
 
To study the possible intramolecular interaction of Hpa1, the effect of peptide 1 on 
peptide 2‘s fibril formation was tested. 40 µM peptide 1 and 40 µM peptide 2 were 
diluted into pH 6.5 buffer (20 mM MES, 50 mM NaCl), and co-incubated at room 
temperature for 1 day, after which the mixture was loaded onto carbon coated grids 
and observed under TEM (Figure 4.10A). Compared with Figure 4.7 B and C, 
peptide 2 cannot form fibrils in the presence of peptide 1. To rule out the low 
concentration of samples resulting in the absence of fibrils during observation, the 
concentrations of peptide 1 and peptide 2 were increased to 400 µM. After 1 day 
incubation at RT in pH 6.5 buffer (20 mM MES, 50 mM NaCl), the mixture was 
observed under TEM (Figure 4.10 B): no fibrils were observed, which indicates that 
peptide 2 cannot form fibrils in the presence of peptide 1.  
A 
B 
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The ability of peptide 1 to block fibril formation by the full length and N-terminal 
truncated Hpa1 was also tested. We found the fibrils formed by the full length and N-
terminal truncated Hpa1 survived in the presence of peptide 1 under EM.  
 
 
                  
 
Figure 4.10 Intramolecular interaction of Hpa1 (A) 40 µM peptide 1 inhibited the 
fibrils formed by 40 µM peptide 2 in 20 mM MES (pH 6.5) and 20 mM NaCl. (B) 
400 µM peptide 1 inhibited the fibrils formed by 400 µM peptide 2 in 20 mM MES 
(pH 6.5) and 20mM NaCl.   
 
 
4.9 Discussion  
 
Polypeptides from fibril formation precursor proteins are widely reported to be the 
segment responsible for the amyloid fibril formation (Table 1.2). They are the 
products after the protease digestion of full length protein, e.g. Aβ40 and Aβ42 peptide 
associated with Alzheimer‘s disease (Benzinger et al., 2000), or the predicted  helix 
domains of full length precursors of amyloid fibril formation, e.g. the poly-amino 
acids from myoglobin (Fandrich et al., 2001) and amyloid forming peptide of HpaG 
(Oh et al., 2007). To obtain the segment of Hpa1 involved in amyloid fibril 
formation, we firstly truncated the N-terminus (1-54) of Hpa1 and then synthesized 
two predicted -helical domains to localize the fibril forming segment. 
 
 
A B 
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4.9.1 Domains of Hpa1 
 
To study the function of the two predicted helix domains located at the N-terminus 
(37-54) and C-terminus (87-105) of Hpa1, truncated Hpa1 (1-86 and 55-138) was 
constructed and over-expressed (Figure 4.1 and 4.2). Hpa1 (1-86) failed to purify 
because of the blockage of the Ni-column, which is probably due to the aggregation 
of protein in vitro. In vivo fluorescence localization of Hpa1 (1-86) shows this 
domain is responsible for binding to plant plasma membranes (communication with 
Prof. Gongyou Chen, Nanjing Agricultural University). Hpa1 (55-138) functions as 
the domain for fibril formation (Figure 4.5). In contrast to the full length Hpa1, this 
segment forms fibrils at acidic and basic pH (Figure 4.5). 
 
Even though HpaG and Hpa1 share 59.7% identity and similar secondary structures 
(Figure 4.1), they have different domains for fibril formation. The N-terminal helix 
domain of HpaG forms fibrils (Oh et al., 2007), in contrast with the C-terminal 
helix domain of Hpa1. This difference might indicate the evolution of harpins in X. 
oryzae pv. oryzicola and X. axonopodis pv glycines to fulfil their function in 
different hosts.  
 
4.9.2 Fibril-forming peptide of Hpa1 
 
Polypeptides, derived from the segment of precursor proteins for amyloid fibril 
formation have been widely studied to understand the mechanism for amyloid fibril 
formation, as the basis for designing new inhibitors in amyloid fibril associated 
diseases. The minimal length for amyloid fibril formation is a tetrapeptide, e.g. 
NNQQ of yeast prion protein Sup35 (Sawaya et al., 2007). The C-terminal helix 
domain, 19 amino acids (ASPLTQMLMNIVGEILQAQ), of Hpa1 forms fibrils at all 
pHs tested (Figure 4.7), which indicates that the fibrils formed by peptide 2 is pH-
independent and an inherent characteristic of the sequence component. 
 
CD spectrum analyses show fibrils formed by peptide 2 are a mixture of  helix and 
β sheet (Section 4.7). The secondary structure transition of peptide 2, recorded by 
CD, found high percentage of sheet (43.6%) at pH 8.5, but a high percentage of helix 
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structure (40.6%) at pH 6.5. A possible explanation is that the precipitation of mature 
fibrils at pH 6.5, which decreases the sheet structure content in the soluble state for 
CD spectrum. Further work will be required to re-construct the 3-D structure of the 
mature fibrils of peptide 2 by cryo-EM, and to establish the interaction between the 3 
strands of protofibrils in the mature fibril assembly. 
 
In addition, considering that the minimal segment for fibril formation is a 
tetrapeptide (Sawaya et al., 2007; Tjernberg et al., 2002) and that the peptide Aβ(1-
42) lacking residues 14-23 is not fibrillogenic (Tjernberg et al., 1999), the minimal 
segment of peptide 2 of Hpa1 for fibril formation could be determined in future work.   
 
4.9.3 Membrane disrupted by fibrils 
 
Several mechanisms have been proposed to explain the pathogenicity of amyloid 
fibrils, e.g. membrane disruption, ion channel formation and permeabilization of 
membranes (Engel et al., 2008; Kayed et al., 2004; Quist et al., 2005). The 
intermediate state, soluble amyloid oligomers, has been assumed as the main 
cytotoxic species. The function of fibril formation of Hpa1 in the pathogenicity of 
Xoc on plants is still unclear.   
 
In this study, the fibrils formed by the segment or polypeptide of Hpa1 could damage 
the membranes directly after mixing them (Figure 4.6 and 4.8). Engel et al., 2008 
reported that the human islet amyloid polypeptide (IAPP) damaged the membrane 
through fibril growth on the membrane (Engel et al., 2008). However, in this study, it 
is fibrils that damage the membrane, since the fibrils had already formed by Hpa1 
(55-138) and peptide 2 of Hpa1 before mixing with liposomes (Figure 4.5, 4.5, 4.7 
and 4.8).  This direct function of membrane damage by the fibrils formed by Hpa1 
raises the possibility that harpins not only trigger signal transduction to induce cell 
death (Alfano and Collmer, 2004) but also damage the cell membrane directly after 
being infiltrated into the intercellular space of nonhost leaves. Further work is 
required to support this hypothesis in vivo. 
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4.9.4 Intramolecular interaction of Hpa1 
 
Peptide 2 (C-terminal helix domain) of Hpa1 forms fibrils, whereas peptide 1 (N-
terminal helix domain) of Hpa1 can not assemble into fibrils (Figure 4.7). However, 
fibrils formed by peptide 2 of Hpa1 were disassembled by peptide 1 (Figure 4.10 A 
and B). These results suggest that the assembly of fibrils by Hpa1 requires the 
separation of the fibril forming domain (peptide 2 segment) from the N-terminal 
domain (peptide 1), which is consistent with the report that the intermolecular 
contacts and separation of regions from the N-terminal region of Sup35 are both 
required for fibril assembly (Krishnan and Lindquist, 2005). In addition, the presence 
of such domains in preventing fibril assembly provides clues to developing methods 
to prevent fibril assembly or dissemble preformed fibrils.   
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Chapter 5 Crystallization and preliminary structure analysis of the 
Vibrio cholerae VceR drug-pump repressor in complex with bound 
DNA 
 
In this chapter, I report on the crystallization and structure analysis of VceR in 
complex with bound DNA. In optimizing the crystallization process, I have used 
different lengths and end designs of synthetic DNA oligonucleotides whilst 
purification of the protein/DNA complex was carried out to improve the diffraction 
power of the native VceR/DNA crystals. A native data set was processed to 3.15 Å. 
In phasing, anomalous scattering from Br labelled DNA and Se-Met substituted 
VceR was used. The positions of Se were located successfully by ShelxD and an 
interpretable electron density map was obtained. A preliminary model with one 
VceR dimer and an 11 bp base pair DNA duplex was built. 
 
 
5. 1   VceR and QacR sequence alignment 
 
VceR and QacR are both members of the TetR family of repressors (Borges-
Walmsley et al., 2005). It has been suggested that two dimers of VceR bind the 28 bp 
region of vceCAB operon, similar to the interaction of QacR with its cognate DNA 
(Borges-Walmsley et al., 2005). To determine the sequence similarity of VceR and 
QacR, the VceR and QacR sequences were aligned with Vector NTI. QacR and 
VceR display 17.7% overall identity, but higher identity, 29.8%, in the DNA binding 
domain (1-3). Compared with QacR, VceR has an 8 amino acid insertion in the 
drug binding domain between helix 7 and helix 8 (Figure 5.1), which could reflect 
differences in the ligands bound. VceR also has 5 extra amino acids at the beginning 
of the N-terminus (Figure 5.1). 
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              1                                               50 
     VceR    (1) MRVKSEEKRQAILEIAKDSFTKQGFEQTSMSHIAKMLGGSKATLYNYFSS 
     QacR    (1) -----MNLKDKILGVAKELFIKNGYNATTTGEIVKLSESSKGNLYYHFKT 
                        hhhhhhhhhhhhhhhh      hhhhhhhh   hhhhhhh    
 
                 51                                             100 
     VceR   (51) KEEIFTAVM---ESSATEQIALSFLSLDHNRELKPALLEFGYNFLNSVLT 
     QacR   (46) KENLFLEILNIEESKWQEQWKKEQIKCKTNREKFYLYNELSLTTEYYYPL 
                 hhhhhhhhhhhhhhhhhhhhhhhhhh   hhhhhhhhhhhhhh        
 
 
                 101                                            150 
     VceR   (98) QDAMSIYRMAIHEADRSAIGRHFYENGPKRGWARLSRYITCQIECGSLKE 
     QacR   (96) QNAIIEFCTEYYKTNSINEKMNKLENKYIDAYHVIFKEGNLNGEW----- 
                 hhhhhhhhhhhhh hhhhhhhhhhhhhhhhhhhhhhhhhhh     
 
  
                 151                                            200 
     VceR  (148) CDPWIAAMHFKALLSAQYFEPFSLGAIEKPTSSELKATTQRAVEAFLCLY 
     QacR  (141) ---CINDVNAVSKIAANAVNGIVTFTHEQNINERIKLMNKFSQIFLNGLS 
                        hhhhhhhhhhhhhhhhhh     hhhhhhhhhhhhhhhhhh 
  
 
                 201 
     VceR  (198) AAD 
     QacR  (188) K-- 
  
Figure 5.1 VceR and QacR sequence alignment and secondary structures.   
VceR and QacR display 17.7% identity, and identical residues are underlined. h 
shows -helix structure of QacR (Schumacher et al., 2002; PDB code: 1JT0). 
 
5. 2 Oligodeoxynucleotide preparation 
To obtain VceR/DNA complex crystals, the operator sequence bound by VceR was 
studied (Borges-Walmsley et al., 2005) and the oligodeoxynucleotides from this 
study were ordered from MWG purified by HPSF (high purity salt free) purification. 
Purified P5 and P6 oligodeoxynucleotides were dissolved to a final concentration 1 
mM in 10 mM MgCl2, respectively. Equal volumes of these two corresponding 
oligodeoxynucleotides were mixed, placed in a heating block at 95
o
C for two 
minutes and then allowed to cool to ambient temperature for annealing, which 
formed the duplex (Figure 5.2)  at a concentration of 500 µM for crystallization.  
 
 
 
   
  
  
  
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Figure 5.2 P56 duplex used for VceR/dsDNA co-crystallization. The inverted 
repeats (IR) are shown in bold letters. (Borges-Walmsley et al., 2005). 
 
 
5.3  VceR purification 
 
VceR-His6-pET21a(+) (Table 2.1) was transformed into BL21(DE3) for over-
expression (Section 2.4.8). The over-expression of VceR-His6 was achieved as 
described in Section 2.7.1 and purification was carried out as described in Section 
2.7.2. The column was washed with buffer (50 mM Tris-HCl, 300 mM NaCl, 10% 
glycerol, 100 mM imidazole, 0.5 mM THP, pH 7.0) to remove contaminating 
proteins. The protein was eluted with buffer (50 mM Tris-HCl, 300 mM NaCl, 10% 
glycerol, 500 mM imidazole, 0.5 mM THP, pH 7.0). 20 µl aliquots of the VceR-His6 
protein (23.4 kDa) were run out on a 12% SDS-PAGE gel (Figure 5.3).   
 
                          
Figure 5.3 A Coomassie blue stained SDS-PAGE gel of VceR-His6 (23.4 kDa) 
purified by Ni
2+
 affinity chromatography. Lane 1-9: VceR-His6. Lane 10: See blue 
marker (Invitrogen) in MES buffer 
 
5‘-AGTATAACTGTACGGTACGGTTTAGTTATA-3’ 
3‘-TCATATTGACATGCCATGCCAAATCAATAT-5‘  
30-mer with blunt end (P56): 
28 kDa 
18 kDa 
VceR 
          1       2       3      4       5      6     7     8       9     10 
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VceR-His6 was further purified using a Hi-load 16/60 Superdex 200 prep grad 
column (GE Healthcare) according to the protocol described in Section 2.5.3 (Figure 
5.4). 20 µl aliquots of the VceR purified from the gel filtration chromatography were 
run out on a 12% SDS-PAGE gel (Figure 5.5).   
 
 
 
 
 
Figure 5.4 The elution chromatography of VceR-His6 from a Hi-load 16/60 
Superdex 200 prep grad column.                     
 
Peak 1 
VceR 
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Figure 5.5 A Coomassie blue stained SDS-PAGE gel showing VceR-His6 protein 
purified by size-exclusion chromatography. Lane 1-5 correspond to fractions from 
peak 1 in Figure 5.4. Lane 6: See blue marker (Invitrogen) in MES buffer 
 
  
 
5.4 Crystallization of VceR/dsDNA 
 
Initial crystallization trials of VceR/dsDNA complex were performed by Dr. David 
Albesa-Jove and Beth Ashbridge (Department of Chemistry, University of Durham). 
The P56 duplex (Figure 5.2) was used in their study. In their experiments, 2 M 
ammonium phosphate, 100 mM Tris-HCl at pH 8.5 (The Classics Suite, 27, Qiagen), 
was used to obtain crystals, which were taken as seeds in 1 M ammonium phosphate, 
100 mM Tris-HCl at pH 8.5 (The Classics Lite Suite, 27, Qiagen) to grow larger-
sized crystals.  Figure 5.6 shows the optimization procedure used in this study to 
obtain a 3.15 Å native data set. 
 
 
 
 
1       2         3           4           5        6         
VceR 
28 kDa 
18 kDa 
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Figure 5.6 The optimization procedure to obtain a 3.15 Å native data set. 
 
 
According to a crystallization product report (Qiagen), the pH of the crystallization 
buffer used by Dr. David Albesa-Jove (2 M ammonium phosphate, 100 mM Tris-
HCl at pH 8.5) is 4.01 and that of 1 M ammonium phosphate, 100 mM Tris-HCl at 
pH 8.5 is 4.7. In my work, the crystallization conditions around these were screened 
(Table 5.1 and 5.2). Tris-HCl was used as the buffer to adjust the pH of the 
crystallization condition. However, in this condition, 1-2 M of ammonium hydrogen 
phosphate changes the final pH dramatically and 0.1 M Tris-HCl loses its control 
over the pH. In ammonium phosphate and pH screen II, Tris-HCl was not used. 
Under buffer conditions B1, B2, B3, B4, C1, C2 and C3 of Table 5.1, and E1, E2, E3, 
F1, F2, F3, G1and G2 of Table 5.2, the VceR/dsDNA complex could form crystals. 
As a control, VceR cannot form crystals in these conditions (Figure 5.7 A). For the 
best diffracting crystals with this pair of oligos, the drop consisted of 1μl 10 mg/ml 
VceR/dsDNA (the molar ratio of VceR monomer : dsDNA= 2:1 for mixing before 
crystallization) in 50 mM MES, 200 mM KCl, 4 μM DTT at pH 7.0, plus 2μl of well 
solution, which was 1 M ammonium phosphate, at pH 4.05. 
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Table 5.1 Ammonium phosphate and pH screen I 
 
 
 
 
 
 
 
 
Table 5.2 Ammonium phosphate and pH screen II 
 
 
In order to optimize the crystallization conditions, different methods, such as low 
temperature, adding silicon oil to the drop and decreasing the concentration of 
protein, were tried to decrease the evaporation speed and nucleation forming in drops. 
The incubation at 4
o
C was chosen after comparison with drops from 20
o
C (Figure 5.7 
B and 5.7 C). The low temperature not only decreases the evaporation speed, but also 
increases the stability of protein in the drops, resulting in larger crystals (Figure 5.7 
B and 5.7 C). 
 
Micro-seeding was also used to grow bigger crystals in this study. The crystals in 
Figure 5.7 B were taken as the seeds and transferred into new drops containing 2 μl 
10 mg/ml VceR/dsDNA (the molar ratio of VceR monomer: dsDNA = 2:1) in 50 
mM MES, 300 mM KCl, 4 μM DTT at pH 7.0, plus 4 μl of well solution, which was 
a solution of 100 mM Tris-HCl, 1 M ammonium phosphate, at pH 4.05.  However, 
the diffraction power of the resulting crystals was not improved by seeding. 
 
 A1 A2 A3 A4 A5 A6 
B1 B2 B3 B4 B5 B6 
C1 C2 C3 C4 C5 C6 
D1 D2 D3 D4 D5 D6 
 
1 M 
ammonium 
phosphate 
2 M 
ammonium 
phosphate 
pH 3.8 
pH 4.4 
 A1 A2 A3 A4 A5 A6 
B1 B2 B3 B4 B5 B6 
C1 C2 C3 C4 C5 C6 
D1 D2 D3 D4 D5 D6 
 
0.75 M 
ammonium 
phosphate 
1 M 
ammonium 
phosphate 
pH 4.0 
pH 4.3 
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For the additive screening (Section 2.15), additive 10, (0.1 M ZnCl2) (Figure 5.7 D) 
and 53 (10% PEG3350) (Figure 5.7 E) gave much larger crystals and were selected 
for the subsequent crystallization optimization. 
 
5.5 Crystallization of VceR-CCCH/dsDNA 
 
In the crystallization of QacR, cysteines were mutated to serines to prevent serious 
cross-linking and oxidation problems observed in the wild-type protein (Schumacher, 
et al., 2002). In this study, cysteine 138, 142, 148 and histidine 156 were mutated to 
serine, serine, serine, and arginine, for crystallization and structure analysis. The site 
directed mutagenesis of pET21a-VceR was performed as described in Section 2.6. 
The mutagenic primers vceR-C148S-Forward and vceR-C148S-Reverse were used as 
detailed in Table 2.4. The pET21a-vceR ds-DNA was used as the template. Mutant 
strand synthesis using PCR was achieved with an extension time of 6 minutes. The 
clones were sequenced to ensure the correct was selected mutant. Then, VceR-C148S 
was used as the template and the primers vceR-C138S-C142S-Forward and vceR-
C138S-C142S-Reverse (Table 2.6, primers designed by Dr. M. Ines Borges-
Walmsley) were utilized to get VceR-C138, 142, 148S. Finally, the correct VceR-
C138, 142, 148S was used as the template and the primers vceR-H156R-Forward and 
vceR-H156R-Reverse (Table 2.6, primers designed by Dr. M. Ines Borges-Walmsley) 
were utilized to get the VceR-CCCH derivative. After sequencing, the correct clones 
were transformed into BL21(DE3) for over-expression.  
 
Purification of the VceR-CCCH derivative was performed as for VceR in Section 5.3. 
The VceR-CCCH/DNA crystallization was performed as for VceR/DNA. Figure 5.7 
F shows crystals formed by VceR-CCCH/dsDNA (P56) in the presence of PEG3350 
at 4
 o
C.  
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Figure 5.7 Crystals formed by VceR or VceR-CCCH in complex with the DNA 
duplex P56   (A) VceR-His6 precipitated in crystallization buffer (1 M ammonium 
phosphate, pH 4.0). (B) Crystals of VceR/dsDNA (P56) from the condition (1 M 
ammonium phosphate, pH 4.0), at 20
o
C. (C) Crystals of VceR/dsDNA (P56) from 
the condition (1 M ammonium phosphate, pH 4.0), at 4
o
C. (D) Crystals of 
VceR/dsDNA (P56) formed in the presence of Zn
2+
 at 4
o
C. (E) Crystals of 
VceR/dsDNA (P56) formed in the presence of PEG3350 at 4
o
C. (F) Crystals of 
VceR-CCCH/dsDNA (P56) formed in the presence of PEG3350 at 4
 o
C.  
 
 
 
 
A B 
C D 
E F 
200 µm 
 
300 µm 
 
250 µm 
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5.6 Crystal freezing and X-ray diffraction tests 
 
      
To freeze the crystals for X-ray diffraction at 100 K, 30% MPD, 30% PEG400, 30% 
sucrose, 30% PEG3350, saturated ammonium phosphate and 30% glycerol were 
tested to find out if they provided suitable cryo-protection. However, according to 
diffraction tests, no significant differences were found in these cryo-protectants. 30% 
glycerol was chosen as the cryo-protectant. A typical diffraction pattern from the 
SLS is shown in Figure 5.8.  The diffraction data are summarized in Table 5.3.  
 
 
           
 
 
Figure 5.8 Diffraction pattern of VceR-CCCH/P56 at SLS beamline X06DA. 
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Proteins dsDNA Crystals Diffraction limits 
VceR P56 150 μm in length, 
No additive 
4 Å  
VceR P56 150 μm in lenth, 
additive ZnCl2, 
(Figure 5.7D) 
Crystals 
disappeared in the 
30% glycerol as 
cryo-protectant. 
VceR-CCCH 
derivative 
P56 200 μm in length 
(Figure 5.7F), with 
additive PEG3350 
3.7 Å  
VceR-CCCH 
derivative 
P56 280 μm in length, 
with additive 
ZnCl2 
4.3-6 Å  
 
Table 5.3 Summaries of the diffraction limits for VceR/DNA crystals from P56 
30 bp duplex DNA. 
 
 
 
5.7 Oligodeoxynucleotide screening for diffraction quality improvement.   
 
 
In protein/DNA complex crystallization, the length and construction of the DNA 
fragment and the nature of the terminal nucleotides should be considered in 
establishing conditions to form crystals of protein/DNA complexes and for 
improving the diffraction of protein/DNA complex (Aggarwal, 1990; Pohl et al., 
1999).   
 
The oligodeoxynucleotides used for VceR/dsDNA complex crystallization were the 
original from Borges-Walmsley et al., 2005 and further oligonucleotide screening 
was on the basis of P56 duplex (Figure 5.2). To improve the diffraction quality, 
different pairs of oligodeoxynucleotides were designed (Table 2.5).   
 
P56-1 and P56-2 were designed to form 28 bp duplexes with a high order palindrome 
for VceR binding; P56-3 was designed as the 28 bp duplexes without site mutation 
from the original promoter sequence (P56); P56-4 was designed to form a 30-mer 
with one overhang; P56-5 was designed to form a 29-mer with one overhang; P56-6  
was designed to form a 28-mer with two overhangs; P56-7 was designed to form a 
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31-mer with blunt ends. P56-24, P56-26, P56-27, were designed to form 24 bp, 26 bp 
and 27 bp length duplexes on the basis of P56-1. All these oligo pairs were shown in 
Table 2.5. 
  
 
5.7.1 Purification of the VceR-CCCH/DNA complex 
 
 
VceR-CCCH was purified as described previously (Section 5.3). Gel filtration 
purified VceR-CCCH was mixed with DNA (Table 2.5), and incubated at 4
 o
C for 1 
hour. The mixture of VceR-CCCH and oligos were loaded onto a Hiload 16/60 
superdex 200 gel filtration column, pre-equilibrated with buffer (25 mM MES, 200 
mM NaCl, 6 mM DTT, pH 7.0) for protein/dsDNA complex purification. The 
VceR/DNA complex has an elution volume of 68.02 ml, in contrast to 80 ml for the 
VceR dimer on the same column (Figure 5.9). In addition, the 260/280 nm ratio, 1.7, 
for VceR/DNA complex, indicated the formation of VceR/DNA complex, which is 2 
for pure DNA and 1.2 for VceR. The purified complex was concentrated to 10 mg/ml 
for crystallization screening.  
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Figure 5.9 The elution chromatography of VceR-CCCH/DNA complex from a 
Hi-load 16/60 Superdex 200 prep grad column. The curve of UV 260 nm is shown 
in red and UV 280 nm in blue. 
  
 
5.7.2 Crystallization of purified VceR-CCCH/DNA complex 
 
As described in Section 2.14, the crystallization screening of purified VceR-
CCCH/DNA complex was performed. After 3 week incubation at 20
o
C, crystals of 
purified VceR-CCCH/P56 (30 bp oligos) were obtained in the following conditions: 
 
(1) A8 (0.1 M sodium acetate, pH 5.5, 1.8 M lithium sulphate) of the Clear strategy 
screen from Molecular Dimensions   
(2) B1 (0.1 M sodium citrate, pH 4.0, 0.8 M ammonium sulphate) of the JCSG-plus 
from Molecular Dimensions (Page et al., 2003). 
 
Crystals of purified VceR-CCCH/P56-1 (28 bp oligos) were obtained in the 
following conditions: 
VceR/DNA 
complex 
Unbound 
DNA 
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(1) C11 (0.1 M sodium acetate pH 4.6, 2 M ammonium sulphate) of JCSG-plus from 
Molecular Dimensions  
(2) B1 (0.1 M sodium citrate, pH 4.0, 0.8 M ammonium sulphate) of JCSG-plus from 
Molecular Dimensions  
 
The optimization was based on these crystallization conditions. A gradient of pH and 
concentration of precipitant was set up as shown in Table 5.4, 5.5 and 5.6. The 
crystals from these conditions are shown in Figure 5.10. Different DNA pairs (Table 
2.5) in complex with VceR-CCCH were purified by gel filtration and used in the 
crystallization conditions in Tables 5.4, 5.5 and 5.6. The VceR-CCCH/P56-24 and 
VceR-CCCH/P56-26 complexes were not stable. The crystals were frozen in liquid 
nitrogen and taken to the SLS for diffraction analysis. Crystals could be formed from 
VceR-CCCH/P56-3, VceR-CCCH/P56-5, VceR-CCCH/P56- 6, VceR-CCCH/P56-27 
and VceR-CCCH/P56-28, but the diffraction from them did not exceed 3.2 Å. The 
best diffraction was 3.15 Å from the VceR-CCCH/P56-1 crystal in 0.1 M Na citrate 
pH 4.0, 0.85 M ammonium sulphate) with 30% glycerol as cryo-solution. Table 5.7 
shows data collection statistics of a VceR-CCCH/P56-1 crystal. 
 
 
 
 
 
 
 
Table 5.4 Lithium sulphate and pH gradient screen 
 
 
 
 
 
 
 
  
Table 5.5 Ammonium sulphate and pH gradient screen I 
 
 A1 A2 A3 A4 A5 A6 
B1 B2 B3 B4 B5 B6 
C1 C2 C3 C4 C5 C6 
D1 D2 D3 D4 D5 D6 
 
pH 5.2 
 
pH 5.7 
 1.6 M 
lithium 
sulphate 
1.9 M 
lithium 
sulphate 
 A1 A2 A3 A4 A5 A6 
B1 B2 B3 B4 B5 B6 
C1 C2 C3 C4 C5 C6 
D1 D2 D3 D4 D5 D6 
 
pH 3.8 
 
pH 4.3 
 0.75 M 
ammonium 
sulphate 
0.9 M 
ammonium 
sulphate 
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Table 5.6 Ammonium sulphate and pH gradient screen II 
 
 
 
 
 
Figure 5.10 Crystals formed from the purified protein/DNA complex. 
(A) VceR-CCCH/dsDNA (P56) crystals formed in the crystallization buffer (0.1 M 
Na acetate, pH 4.8, 1.6 M lithium sulphate) at 20
o
C. (B) VceR-CCCH/dsDNA (P56-
1) crystals formed in the crystallization buffer (0.1 M Na citrate, pH 4.0, 0.85 M 
ammonium sulphate) at 20
o
C. (C) VceR-CCCH/dsDNA (P56-1) crystals formed in 
the crystallization buffer (0.1M Na acetate pH 5.4, 1.8 M ammonium sulphate) at 
20
o
C (D) VceR-CCCH/dsDNA (P56-1) crystals in cryo-solution under the flow of 
cold nitrogen (ice formed around the loop)                
 
 
 
 
A1 A2 A3 A4 A5 A6 
B1 B2 B3 B4 B5 B6 
C1 C2 C3 C4 C5 C6 
D1 D2 D3 D4 D5 D6 
 
1.8 M 
ammonium 
sulphate 
2.1 M 
ammonium 
sulphate 
pH 4.4 pH 4.9 
A B 
C D 
300 µm 
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 Native 
Beamline SLS X06DA 
Wavelength (Å) 1.000 
Resolution (Å)  43.17-3.15 
           (last shell) 3.25-3.15 
 Rmerge
 a b
  0.086(0.665) 
Total/Unique 
reflections 
72717/10918 
Completeness 97.8(96.3) 
Multiplicity 4.2  
I/σ(I) 19.3(1.8) 
Cell dimensions  a= b=90.2 Å, c=298.0 Å, α=β=γ=90° 
Space group  I 41/322 
Table 5.7 Data collection statistics of a VceR-CCCH/P56-1 crystal. 
a
 The values in parentheses of Rmerge, completeness, and I/σ(I) correspond to the 
outermost resolution shell. 
b
 Rmerge = ΣhΣj |I(h;j)- <I(h)>| /ΣhΣjI(h), where I(h;j) is the jth measurement of the 
intensity of the unique reflection h, and <I(h)> is the mean overall symmetry-related 
measurements. 
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5.8 Br-labelled crystals 
  
To provide phasing information, the QacR/DNA model was used in molecular 
replacement. However, the low identity (17.7%) between QacR and VceR hampered 
successful structure solution. Thus, brominated DNA oligonucleotides were designed 
and crystallized in complex with VceR.   
 
Brominated DNA P5-1-BrP6-1 (Table 5.8), in which thymines were substituted with 
5-Br-uracil, was synthesized from Operon, and co-crystallized with VceR-CCCH.  
Three wavelength MAD data sets were collected from a crystal of VceR-CCCH/P5-
1-BrP6-1 at the DLS.  A typical diffraction pattern for a VceR-CCCH/P5-1-Br 
crystal at the DLS is shown in Figure 5.11. Table 5.9 shows data collection statistics 
of a VceR-CCCH/P5-1-BrP6-1 crystal. 
P5-1-BrP6-1: 
5‘-TATAACTAAACGGTACGGTTTAGTTATA-3‘ 
3‘-ATATTGATTTGCCATGCCAAATCAATAT-5‘ 
Duplex-PLS1 (DPLS1) : 
5‘-TATAACTAAACGGTACGGTTTAGTTATA-3‘ 
3‘-ATATTGATTTGCCATGCCAAATCAATAT-5‘    
Duplex-PLS2 (DPLS2) : 
5‘-TATAACTAAACGGTACGGTTTAGTTATA-3‘ 
3‘-ATATTGATTTGCCATGCCAAATCAATAT-5‘    
 
Table 5.8 Brominated DNA duplexes for phasing calculation. Bold thymines 
were substituted with 5-Br-uracil.  
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Figure 5.12 A diffraction pattern for a VceR-CCCH/ P5-1-BrP6-1 crystal 
recorded at the Diamond Light Source. 
 
 
 
Palindromic sequences labelled with Br (DPLS1 and DPLS2, Table 5.8) were 
designed (explanation in Section 5.9). Purification of VceR-CCCH in complex with 
DPLS1 and DPLS2 were performed as for the VceR-CCCH/P56-1 complex and 
similar crystallization conditions were used. Crystals of VceR-CCCH/DPLS2 were 
obtained and a three wavelength MAD data set was collected. Table 5.10 shows data 
collection statistics of a VceR-CCCH /DPLS2 crystal. 
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 Br (nonpalindromic) 
 Peak Inflection point Remote 
Beamline DLS I04 DLS I04 DLS I04 
Wavelength (Å) 0.9200 0.9202 0.9132 
Resolution (Å)  48.83-3.25 48.91-3.48 48.86-3.48 
(last shell) 3.35-3.25 3.58-3.48 3.58-3.48 
 Rmerge
 a b
  0.096(0.623) 0.084(0.484) 0.087(0.516) 
Total/Unique 
reflections 
220277/9903 187621/7980 180026/7831    
Completeness 94.7(74.8) 92.6 (60.7)       91.3 (60.4)       
I/σ(I) 18.6(1.6) 19.1(4.5) 21.9(4.5) 
Cell dimensions  a=b=91.0, c= 299.9 
Å, α=β=γ=90° 
a=b=91.0, c= 299.9 
Å, α=β=γ=90° 
a=b=91.0,c= 299.9 
Å, α= β= γ=90° 
Space group I 41/322 I 41/322 I 41/322 
 
Table 5.9 Data collection statistics of a VceR-CCCH/P5-1-BrP6-1 crystal. 
a
 The values in parentheses of Rmerge, completeness, and I/σ(I) correspond to the 
outermost resolution shell. 
b
 Rmerge = ΣhΣj |I(h;j)- <I(h)>| /ΣhΣjI(h), where I(h;j) is the jth measurement of the 
intensity of the unique reflection h, and <I(h)> is the mean overall symmetry-related 
measurements. 
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 Br (palindromic) 
 Peak Inflection Remote 
Beamline DLS I04 DLS I04 DLS I04 
Wavelength (Å) 0.9198* 0.9204* 0.9050* 
Resolution (Å)  49.96-3.6 49.96-3.5 48.67-3.71 
           (last shell) 3.69-3.6 3.6-3.5 3.80-3.71 
 Rmerge
 a b
  0.103(0.586) 0.087(0.647) 0.121(0.645) 
Total/Unique 
reflections 
80590/7584 40124/8325 52413 /6986    
Completeness 98.6 (89.0) 93.0 (66.2)       98.9 (93.3)       
I/σ(I) 12.31(4.0) 10.81(2.6) 9.07(2.9) 
Cell dimensions  a=b=90.6, c= 299.4 
Å, α=β=γ=90° 
a=b=90. 6, c=299.4 
Å, α= β=γ=90° 
a=b=90. 6, c= 299.4 
Å, α= β= γ=90° 
Space group I 41/322 I 41/322 I 41/322 
 
Table 5.10 Data collection statistics of a VceR-CCCH /DPLS2 crystal 
a
 The values in parentheses of Rmerge, completeness, and I/σ(I) correspond to the 
outermost resolution shell. 
b
 Rmerge = ΣhΣj |I(h;j)- <I(h)>| /ΣhΣjI(h), where I(h;j) is the jth measurement of the 
intensity of the unique reflection h, and <I(h)> is the mean overall symmetry-related 
measurements. 
* These values are estimated of true energy only because no fluorescence emission 
scanning device is available. 
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5.9 Substructure solution of Br 
 
As described in 2.14.4, Xprep (Bruker AXS, Madison, USA) was used to produce 
input files for running on ShelxD (Schneider and Sheldrick, 2002; Sheldrick, 2008) 
in order to determine the Br positions. The anomalous signals of Br from a VceR-
CCCH/P5-1-BrP6-1 crystal are shown in Table 5.11. Even though the anomalous 
signal from Br scatterers is not poor, the correct position of Br could not be located. 
The possible explanation is that the pseudo-symmetry of the Br sites breaks the 
crystal symmetry (only half of 28 bp duplex in the asymmetric unit). Two pairs of 
brominated DNA duplex with palindromic Br sites were thus designed and tried 
(DPLS1 and DPLS2 in Table 5.8). However, the device for fluorescence emission 
scanning was not available at DLS when we tested these crystals. Consequently, the 
theoretical values were used. Thus, the anomalous signal of Br from these crystals 
(VceR-CCCH/DPLS2) is weak (Table 5.12) and the CC between the 3 wavelength 
data sets is low (Table 5.13). The correct positions of Br sites cannot be determined 
for phasing.  
 
 
 
Resolution 
(Å) 
8.0 6.0 5.0  4.8 4.6 4.4 4.2 4.0 3.8 3.6 3.4 
Anomalous 
signal/noise 
ratios 
(peak ) 
1.89 1.50 1.31 1.27 1.18 1.1 1.19 1.12 1.06 1.06 0.99 
 
 
Table 5.11 Anomalous signal/noise ratios of VceR-CCCH/P5-1-BrP6-1 data set.  
The values are based on variances of F
+
 and F
-
, calculated by Xprep. The cutoff of 
significant anomalous signals is shown in bold. 
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Resolution 
(Å) 
8 6 5.4  5.2 5.0 4.8 4.6 4.4 4.2 4.0  3.8 
Anomalous 
signal/noise 
ratios (Peak) 
1.34 1.30 1.24 1.20 1.15 1.14 0.95 1.07 1.15 1.03 0.92 
Anomalous 
signal/noise 
ratios 
(Inflection) 
1.07 1.18  1.2  1.05  1.17 1.16 1.07 1.17 1.12 1.00 1.01 
Anomalous 
signal/noise 
ratios(Remote) 
1.25 1.04 1.13 1.29 1.38 1.26 1.31 1.17 1.17 1.09 1.01 
 
Table 5.12 Anomalous signal/noise ratios of VceR-CCCH/DPAL2 data set.  The 
values are based on variances of F
+
 and F
-
, calculated by Xprep. The cutoff of 
significant anomalous signals of each data set is shown in bold. 
 
 
Resolution 
(Å) 
8 6 5.4 5.2 5.0 4.8 4.6 4.4 4.2 4.0 3.8 
Peak 
Against 
Remote 
(%) 
7.6 39.1 28.7 18.1 10.9 6.8 6.6 -8 2 10.6 4 
Inflection 
Against 
Remote 
(%) 
8.5 28.8 20.2 8.7 -15.9 -7.4 -4.0 2.4 1.7 -1.9 0.6 
Inflection 
Against 
Peak (%) 
20.3 30.4 23.5 1.7 3.9 4.5 14.3 -4.5 1.3 9.3 5.3 
 
Table 5.13 Low anomalous correlation coefficients (%) between peak, remote 
and inflection of VceR-CCCH/DPAL2 data set, calculated by Xprep.  
 
 
5.10 Preparation of selenomethionine-containing proteins 
 
As described in Section 2.14.2, selenomethionine substituted VceR-CCCH was 
prepared and purified. The crystallization of the Se-VceR-CCCH/DNA was 
performed as for VceR-CCCH/DNA (Section 5.7.1 and 5.7.2).  
 
5.11 Data collection and processing 
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Scanning the fluorescence emission spectrum of crystals of the Se-VceR/DNA at the 
SLS clearly showed the presence of Se in the crystals and was used in selecting the 
wavelengths for MAD. The data collection statistics of a Se peak data set is 
summarized in Table 5.14 and those of two Se-MAD data sets are summarized in 
Table 5.15 and 5.16. 
  
  
 Se peak 
Beamline SLS X06SA 
Wavelength (Å) 0.9793 
Resolution (Å)  49.95-3.50 
           (last shell) 3.60 - 3.50 
 Rmerge
 a b
  18.3(76.4) 
Total/unique 
reflections 
84400/8350 
Completeness 99.6(97.0) 
I/σ(I) 8.5(3.0)   
Cell dimensions  a= b=90.8, c=299.0 Å, α=β=γ=90° 
Space group I 41/322 
 
Table 5.14 Data collection statistics of a Se-VceR-CCCH/P56-1 crystal (Se data 
set I). 
a
 The values in parentheses of Rmerge, completeness, and I/σ(I) correspond to the 
outermost resolution shell. 
b
 Rmerge = ΣhΣj |I(h;j)- <I(h)>| /ΣhΣjI(h), where I(h;j) is the jth measurement of the 
intensity of the unique reflection h, and <I(h)> is the mean overall symmetry-related 
measurements. 
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 Se 
 Peak Inflection Remote 
Beamline  SLS X06SA SLS X06SA SLS X06SA 
Wavelength (Å) 0.9795 0.9797 0.9686 
Resolution (Å)  48.86-3.75   50.05-3.76 48.86-3.71 
           (last shell) 3.85-3.75 3.86-3.76 3.81-3.71 
 Rmerge
 a b
  11.4(49.1) 12.4(51.4) 11.4(55.7) 
Total/Unique 
reflections 
47061/6788 59929/6743 65011/6979 
Completeness 98.1 (91.2) 98.1 (89.9) 97.8(86.2) 
I/σ(I) 10.1(3.2) 10.6(4.3) 12.2(4.4) 
Cell dimensions  a=b=91.2, c=299.3 
Å, α=β=γ=90° 
a=b=91.0, c=299.0 
Å, α=β=γ=90° 
a=b=91.2, c=299.3 
Å, α=β=γ=90° 
Space group I 41/322 I 41/322 I 41/322 
 
Table 5.15 Data collection statistics of a Se-VceR-CCCH/P56-1 crystal (Se data 
set II)   
 
a
 The values in parentheses of Rmerge, completeness, and I/σ(I) correspond to the 
outermost resolution shell. 
b
 Rmerge = ΣhΣj |I(h;j)- <I(h)>| /ΣhΣjI(h), where I(h;j) is the jth measurement of the 
intensity of the unique reflection h, and <I(h)> is the mean overall symmetry-related 
measurements. 
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 Se 
 Peak   Inflection point Remote 
Beamline SLS X06SA SLS X06SA SLS X06SA 
Wavelength (Å) 0.9795 0.9797 0.9686 
Resolution (Å)  49.88-3.6 49.77-3.78 49.77-3.75 
           (last shell) 3.70-3.60 3.87-3.78 3.85-3.75 
Rmerge (%)
a b
  14.1(63.5) 17.5(48.4) 14.4(51.4) 
Total/unique 
reflections 
53691/7653     58934/6555 53756/6755 
Completeness 99.4(96.3) 98.3(84.7) 98.9(92.4)   
I/σ(I) 7.14 (2.2) 
 
5.35(2.5) 7.16(3.3) 
Cell dimensions  a=b=90.6, c= 298.4 
Å, α=β=γ=90° 
a=b=90.6, c=298.4 
Å, α= β=γ=90° 
a=b= 90.6, c= 298.4 
Å, α= β=γ=90° 
Space group I 41/322 I 41/322 I 41/322 
 
Table 5.16 Data collection statistics of a Se-VceR-CCCH/P56-1 crystal (Se data 
set III) 
a
 The values in parentheses of Rmerge, completeness, and I/σ(I) correspond to the 
outermost resolution shell. 
b
 Rmerge = ΣhΣj |I(h;j)- <I(h)>| /ΣhΣjI(h), where I(h;j) is the jth measurement of the 
intensity of the unique reflection h, and <I(h)> is the mean overall symmetry-related 
measurements. 
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5.12 Substructure solution of Se 
 
For Se substructure determination, the f’ and f’’ values for Se at peak, inflection 
point and high energy remote were obtained from 
http://skuld.bmsc.washington.edu/scatter/AS_form.html. Xprep (Bruker AXS, 
Madison, USA) was used to produce input files for running on ShelxD (Schneider 
and Sheldrick, 2002; Sheldrick, 2008) in order to determine the Se positions. 
However, the correct Se positions could not be determined from the Se data sets I, II 
or III (Table 5.14, 5.15 and 5.16) singly. Finally, two data sets (Se data set II and III) 
of three wavelengths (Table 5.15 and 5.16) and one peak data (Se data set I) (Table 
5.14) were scaled and merged together with Xprep (Bruker AXS, Madison, USA). 
Table 5.17 shows the anomalous signal/noise ratios of the merged Se-MAD data set 
and Table 5.18 shows the anomalous correlation coefficient between peak, inflection 
and high energy remote data of the merged Se-MAD data set. Using this merged data 
set, the 12 selenium positions in the asymmetric unit were located from a three-
wavelength anomalous dispersion experiment with ShelxD (Schneider and Sheldrick, 
2002; Sheldrick, 2008). Figure 5.12 shows the clear cutoff of occupancy between the 
12th and 13th sites and the statistics for CC (correlation coefficient between 
observed and calculated E values) and CC (weak) are consistent with the correct 
positions of the 12 Se. 
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Resolution 
(Å) 
8 6 5.3  5.1 4.9 4.7 4.5 4.3 4.1 3.9  3.7 
Anomalous 
signal/noise 
ratios 
(Peak) 
3.33 2.58 2.04 1.61 1.52 1.46 1.42 1.22 1.21 1.14 1.02 
Anomalous 
signal/noise 
ratios 
(Inflection) 
4.4 2.33 1.84 1.48 1.51 1.35 1.32 1.3 1.2 1.07 1.01 
Anomalous 
signal/noise 
ratios 
(Remote) 
3.31 1.81 1.39 1.29 1.38 1.26 1.31 1.17 1.17 1.09 1.01 
 
Table 5.17  Anomalous signal/noise ratios of merged Se data sets.  The values are 
based on variances of F
+
 and F
-
, calculated by Xprep. The cutoff of significant 
anomalous signals of each data set is shown in bold. 
 
 
 
 
Resolution 
(Å) 
8 6 5.3  5.1 4.9 4.7 4.5 4.3 4.1 3.9  3.7 
Peak 
against 
remote 
(%) 
68 80.0 68.5 49.9 48.7 40.5 30.9 26.7 25.1 15 9.1 
Inflection 
against 
remote 
(%) 
72.8 76.9 52.4 48.6 38.3 41.0 24.7 27.2 20.8 13.4 27.5 
Inflection 
against 
peak (%) 
57.7 85.8 63.2 56.0 56.4 43.4 37.9 29.0 22.8 16.7  25.4 
 
Table 5.18 Anomalous correlation coefficients (%) betweens peak, remote and 
inflection of Se merged data sets, calculated by Xprep. The cutoff of significant 
anomalous correlation coefficients between each data set is shown in bold. 
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Figure 5.12 The occupancies for selenium positions with CC 63.84% and 
CC(weak) 51.36%.  There is the clear cutoff of occupancy between the 12th and 
13th sites. 
 
5.13 Phasing and model building 
  
As described in Section 2.14.5, mtz files were produced for Sharp (Bricogne et al., 
2003) with columns containing native and three wavelength data sets. The high 
energy remote data set was used as the reference for scaling, and the default setting 
of Sharp was used. The 12 Se atom sites from ShelxD and their inversed sites were 
used as the input site in Sharp. In addition, the space group I4122 and I4322 were 
tested in Sharp. After the solvent flattening (54%) by DM, the map with space group 
I4122 was interpretable. Figure 5.14 shows the electron density map after solvent 
flattening in Sharp, which clearly reveals helical features.  
 
To build a polyalanine model, the connected helix 5 and helix 6 of the QacR 
monomer from the QacR model (PDB code 1JT0) was superimposed on the electron 
density map manually in Coot. More helices were superimposed on the electron 
density map and the model was extended to the whole dimer manually (Figure 5.13 
and 5.14). The electron density for the last 3 bp at the end of duplex is missed in the 
map after solvent flattening. For the DNA model, 11 bp duplex of B-DNA from Coot 
were manually superimposed on the electron density map. The crystallographic 
occupancy 
 
Se sites 
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symmetry operation of space group I 4122 was used to produce the preliminary 
model for two VceR dimers bound to a 22 bp duplex, which is shown in Figure 5.13.       
 
 
 
Figure 5.13 The ribbon representation of two VceR dimers bound to a 22 bp 
duplex.  
 
 
 
Figure 5.14 A 3.2 Å Se-MAD electron-density map at 1.0 σ superimposed with 
two VceR dimers bound to a 22 bp duplex.  
HTH DNA binding domain 
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5.14 Discussion 
 
5.14.1 Oligo design for protein/DNA co-crystallization 
 
The interactions between DNA molecules often generate crystal packing contacts, 
which make the choice of DNA fragments critical for the formation of X-ray quality 
protein/DNA co-crystals (Tan et al., 2000). However, there is no method to predict 
the correct DNA fragment to obtain X-ray quality complex crystals. The empirical 
search for fragments of different lengths and ends is the main strategy for selecting 
DNA fragments in protein/DNA co-crystallization. 
 
The 30 bp P56 DNA duplex (Figure 5.2), bound with VceR, was chosen as the 
starting point to generate the crystals of the VceR/dsDNA complex. However, the 
diffraction power of the crystals formed by VceR/P56 could not be improved 
(Section 5.4 and 5.5, and Table 5.3). Different pairs of oligodeoxynucleotides (Table 
2.5) were designed and used into co-crystallization trials. The complex crystals 
formed from 28 bp P56-1 gave the best diffraction. These results suggest that there 
was no better method to determine the length and the end of the DNA for 
protein/DNA co-crystallization, and that all possibilities for the DNA design to 
improve diffraction resolution should be put into trials.  
  
Although there is no method to predict the best DNA fragment for protein/DNA co-
crystallization, DNase I footprinting assays are important for defining the starting 
DNA sequence for protein/DNA co-crystallization. Any base bound to protein could 
be protected from the digestion by DNase I, which produces the DNA sequence for 
co-crystallization. This method has been widely used in protein/DNA co-
crystallization successfully, e.g. DtxR bound with the tox operator (White et al., 
1998). Interestingly, in the DtxR example, three structures of the DtxR/DNA 
complex were solved from three pairs of duplex DNA of 43 bp, 33 bp and 21 bp 
(Chen et al., 2000; White et al., 1998; Pohl et al., 1999), which indicates that 
different designs of the oligonucleotide can produce X-ray quality crystals. 
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5.14.2 Simple mixture or purification of protein/DNA complex for co-
crystallization 
 
The stoichiometry of the components of the protein/DNA complex should be 
considered in preparing the complex for co-crystallization. One method is the 
examination of the complex over a series of protein:DNA ratios using EMSA to 
determine the ratio for maximal complex formation. Alternatively, analytical gel 
filtration or dynamic light-scattering could be used to calculate the molecular weight 
of the protein/DNA complex, from which the ratio of protein to DNA in the complex 
can be known. The ratio of VceR monomer to DNA in the VceR/DNA complex is 
4:1, two dimers of VceR bound to DNA, indicated from analytical gel filtration and 
dynamic light-scattering. 
 
Usually, in the preparation of the protein DNA complex, an excess of DNA is used, 
because the efficiency of DNA annealing is less than 100%. In this study, the ratio of 
VceR to DNA was increased to 2:1 for co-crystallization, rather than 4:1 for complex 
formation. In addition, the purification of the protein/DNA complex for co-
crystallization was also tried. The advantage of this method is the high purity of the 
complex and the elimination of any unbound protein or DNA. However, before 
purifying the protein/DNA complex its stability should be considered, as the 
presence of an excess amount of unbound DNA could force the equilibrium (the 
equilibrium between free protein and DNA and the protein/DNA complex) to the 
protein/DNA complex forming and stabilize the protein/DNA complex, when there is 
a low protein-DNA binding affinity. 
 
5.14.3 Palindromic or nonpalindromic sequence in protein /DNA co-
crystallization 
 
A palindromic sequence has an identical sequence with its complementary sequence. 
The recognition sites of many restriction enzymes are palindromic. In TetR, the 
DNA sequence used in TetR/DNA complex crystallization was derived from the 
natural promoter with a perfect palindrome (Orth et al., 2000) In QacR/DNA 
complex crystals, the DNA used was mutated to form the complete inverted repeat 
(Schumacher et al., 2002). In this study, both palindromic and non-palindromic 
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sequences (Table 2.5) formed crystals with VceR. However, DNA with high 
palindromic order formed complex crystals more easily than the natural one with an 
imperfect palindrome (data not shown). This phenomenon could be explained by the 
fact that the optimization of the palindrome in the operator sequence increases the 
binding of the second dimer to the operator. This behaviour was found for TtgR, a 
TetR family repressor (Krell et al., 2007). Further studies will be needed to 
determine the effect of the palindromic sequence in the binding of VceR to the 
operator sequence. 
 
 5.14.4 Substructure and phasing 
  
The phase problem is an inevitable challenge in protein crystallography (Taylor, 
2003). Because of the presence of homology models and the availability of 
synchrotron beamlines, several methods, including MR (Molecular Replacement), 
SIR (Single isomorphous replacement), SIRAS (single isomorphous replacement 
with anomalous scattering), MIR (multiple isomorphous replacement), MIRAS 
(multiple isomorphous replacement with anomalous scattering), MAD (Multiple-
wavelength anomalous dispersion) and SAD (single-wavelength anomalous 
dispersion) are widely used to solve the phase problem (Taylor, 2003). For solving 
the phase problem for protein/DNA complexes, the incorporation of 
selenomethionine into the protein, the labelling of DNA and the soaking of heavy 
atoms into crystals have been utilized to obtain phasing, if there is no homology 
model available (Konig et al., 2009; Schumacher et al., 2002).  
 
In this study, because of the low sequence identity of VceR in comparison to QacR 
17.7% (generally, 25% or higher sequence identity is required for successful 
molecular replacement, Taylor, 2003), the use of the QacR/DNA model to solve the 
VceR/DNA structure was unsuccessful. Instead, bromines incorporated into the DNA 
and later selenomethionine in the protein were taken as anomalous scatterers to 
perform MAD or SAD experiments. Initially, the phasing experiments started with 
the brominated DNA pair P5-1-BrP6-1(Table 5.8). However, the location of the Br in 
this DNA duplex could not be determined, possibly due to the pseudo-symmetry of 
the Br sites, which breaks the crystal symmetry.   
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Further efforts were carried out using both symmetric brominated DNA (Table 5.8) 
and selenomethionine substituted VceR. However, the VceR-CCCH/DPAL2 crystals 
had a very weak anomalous signal (Table 5.12and 5.13), because of the incorrect 
wavelengths used in peak, inflection and remote data collection. 
  
Interestingly, merging of two three-wavelength Se data sets and one peak Se data set 
produced the correct substructure, as indicated by CC/low CC in ShelxD (Table 5.18) 
and following refinement of the Se positions in Sharp. This merging of several data 
sets could increase the anomalous signals for Se substructure calculation (Table 5.17), 
and will be a good method in solving the substructure of low resolution data sets. 
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Chapter 6  Final  discussion and future work 
 
6.1 Hpa1 
 
 
6.1.1 Fibril formation mechanism of Hpa1 
 
We found that  full length Hpa1 was able to assemble into fibrils at acidic pH (Figure 
3.8)  Similar pH-dependent fibril assembly has been widely reported (Cruz et al., 
2005; Lai et al., 1996; Morozova-Roche et al., 2000; Smith et al., 2003; Uversky and 
Fink, 2004). One explanation of this phenomenon is that the fibril forming precursors 
have low net charge or even zero at acidic pH, which accelerates fibril assembly 
(Chiti et al., 2002; Schmittschmitt and Scholtz, 2003). However, pHs around the pI 
of Hpa1 only induce precipitation of Hpa1 in this study (data not shown). The fact 
that the C-terminal  helical domain is the fibril forming domain of Hpa1, but cannot 
assemble into fibrils in the presence of the N-terminal  helical domain suggests that 
the assembly of fibrils by Hpa1 requires separation of the C-terminal  helical 
domain from the N-terminal  helical domain. Similar domains acting to prevent 
fibril formation were reported for lysozyme (Mishima et al., 2007).  A mechanism 
for fibril assembly was proposed that the fibril formed by full length Sup35 involves 
the intermolecular interaction of one region of Sup35 (Krishnan and Lindquist, 2005). 
Acidification of the pH might change the conformation of Hpa1 and promote the 
association of the C-terminal  helical domain with itself for fibril assembly.  
 
In addition, the fibril assembly of the C-terminal  helical domain of Hpa1 seems to 
be an inherent characteristic of the sequence component, which is independent of pH 
(Figure 4.5). Several characteristics of the amino acid sequence have been thought to 
facilitate fibril assembly. For example, aromatic moieties could be recognition 
interfaces, which mediate the early stage of amyloid formation, and the stacking 
interactions of these aromatic moieties provides an energetic contribution in the self-
assembly of amyloid structure (Azriel and Gazit, 2001; Gazit, 2002; Gazit, 2005; 
Gazit, 2007). However, there is no aromatic moiety in peptide 2 
(ASPLTQMLMNIVGEILQAQ) of Hpa1, which could facilitate the assembly into 
fibrils.  
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The other characteristic of the amino acid sequence required for fibrillogenesis is 
attractive electrostatic interactions. For example, K-E interactions seem to be 
essential for the fibril assembly, since the peptides KFFK or EFFE did not form 
fibrils when incubated alone, but did so when co-incubated (Tjernberg et al., 2002). 
The sequence of peptide 2 (ASPLTQMLMNIVGEILQAQ) has one negatively 
charged E, but no positively charged residues (K or R).  
 
On the other hand, the inherent aggregation propensity, which is dependent on the 
intrinsic physiochemical properties of the amino acids in the sequence, is thought to 
be one reason for fibril assembly (Chiti and Dobson, 2006; Routledge et al., 2009). 
Predictions of the aggregation-prone regions of whole length Hpa1 identified 
residues (Hpa1 90-101, LTQMLMNIVGEI) as the most aggregation-prone region 
(Conchillo-Sole et al., 2007) is in agreement with the experimental data that peptide 
2 is the segment of Hpa1 for fibril assembly. This result suggests the inherent 
aggregation propensity of peptide2 in this study is important for its fibril assembly.  
 
The determinants for fibril formation are not fully understood and there is no 
common motif among fibril forming proteins. The inherent aggregation propensity 
might be important for fibril assembly and more cases are needed to demonstrate this 
hypothesis in the future.   
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6.1.2 Secretion of Hpa1 through TTSS and its function in Xanthomonas 
 
 
Hpa1, the harpin of Xanthomonas, is secreted via TTSS (Zou et al., 2006). However, 
the in vivo state of Hpa1 and how Hpa1 is secreted through the narrow Hrp pilus of 
TTSS remain unknown. One possible explanation is that most effectors would be 
translocated or secreted in an unfolded state and TTSS chaperones maintain effectors 
in this state (Alfano and Collmer, 2004). However, such chaperones of the TTSS in 
Xanthomonas have not been reported. Further work could be performed using Hpa1 
as the bait in two hybrid screens with a library of Xanthomonas proteins to find this 
kind of chaperone. In addition, heat shock proteins (HSP) stabilize partially unfolded 
proteins, help in protein folding and prevent the unwanted protein aggregation 
(Ohtsuka and Hata, 2000). HSP was also found to disassemble the fibrils (Shorter 
and Lindquist, 2008; Shorter, 2008). The possible interaction between Hpa1 and HSP, 
and stabilization of Hpa1 by HSP, could be studied in future work. 
 
The data presented here have expanded the view for the function of harpins. Our 
finding of direct membrane damaging by fibrils of Hpa1 and its derivatives indicates 
their possible toxicity to the biological membrane, which has never been reported. 
However, the in vivo data are required to show this toxicity in its host plant rice and 
the biological function of fibril assembly of Hpa1 in the pathogenicity of 
Xanthomonas orzyae pv. oryzicola. 
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6.2 Crystallization of VceR in complex with its cognate DNA 
 
 6.2.1 DNA binding domain of VceR 
 
Three protein/DNA structures from the TetR family have been determined: one 
dimer of TetR bound to a 15 bp operator DNA (Orth et al., 2000), two dimers of 
QacR bound to a 28 bp operator DNA (Schumacher et al., 2002) and two dimers of 
CgmR bound to a 28 bp operator DNA (unpublished, PDB code 2yvh). As a 
conserved signature of the TetR family, TetR repressors use a helix-turn-helix (HTH) 
motif to bind the operator DNA (Ramos et al., 2005). VceR share 29.8% sequence 
identity with QacR in the DNA binding domain (Figure 5.1) and binds the 28 bp 
promoter DNA as a pair of dimers, as determined by SEC and dynamic light 
scanning (Borges-Walmsley et al., 2005). The model of VceR/DNA complex in this 
study shows VceR uses the same DNA binding style with QacR, two dimers bound 
with an operator DNA. Future work has to refine model and improve phasing to 
show the interaction between VceR and DNA. 
 
 6.2.2 Drug binding domain of VceR 
  
VceR, a TetR repressor, binds to a 28 bp sequence within the vceR-vceCAB 
intergenic region and thus repress the expression of the VceCAB drug efflux pump 
through steric hindrance of RNA polymerase binding to the operator (Borges-
Walmsley et al., 2005). A pump substrate, CCCP (carbonyl cyanide m-chlorophenyl-
hydrazone) binds to VceR and dissociates it from the binding site (Borges-Walmsley 
et al., 2005). As determined by stopped-flow fluorescence spectroscopy, the VceR 
monomer possesses two binding-sites that can be occupied by CCCP simultaneously 
(Borges-Walmsley et al., 2005). However, the drug binding pocket of VceR could 
not be located in this study.  The determination of the VceR/DNA complex structure 
could provide clues about the drug binding pocket of VceR. 
 
In the QacR drug binding pocket, Glu is widely used in the neutralization of the 
positively charged drug. Interestingly, Glu120 in the QacR-Et complex, Glu58 in 
QacR-Dq and QacR-Be complex have their counterparts in VceR Glu122 and Glu60 
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(Figure 5.1), which indicates their possible function in drug binding, considering that 
CCCP has a positive charge.  
 
In addition, different to QacR, VceR has an 8 amino acid insertion in the drug 
binding domain between helix 7 and helix 8 and a CCCH (Cys-Cys-Cys-His) motif 
(Figure 5.1). Future work has to determine the function of the CCCH motif, which 
may be involved in metal binding, and of this 8-residue insertion.   
 
6.2.3 Induction mechanism of VceR 
 
Upon binding of ligands, TetR and QacR undertake similar induction mechanisms 
(Section 1.10.1.3 and 1.10.2.2). Essentially, a conformational change in their C-
terminal drug binding domains is propagated to the DNA-binding domain by helix 
connecting the two domains and this increases the distance between the midpoints of 
the two DNA recognition helices, which then do not fit in the major groove of the 
DNA, causing TetR and QacR to dissociate from their cognate DNA (Orth et al., 
1998b; Orth et al., 2000; Schumacher et al., 2002). In addition, there is another 
species of TetR, revTetR, which is a derivative of TetR with a single site mutation 
and reverse activity, in that the binding of ligand increases its DNA-binding. 
RevTetR employs the disorder-order mechanism, which is that ligand-free revTetR 
has an unfolded DNA-binding domain, and the binding of ligand increases the 
folding of DNA-binding domain of revTetR that subsequently benefits DNA binding 
(Scholz et al., 2004; Resch et al., 2008). The induction mechanism of VceR is still 
unclear. Future work has to determine the crystal structures of VceR and the 
VceR/ligand complex to compare with that of VceR/DNA, which could show the 
induction mechanism of VceR. 
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